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Abstract 
Sub-micron bioactive glass particles (SMBGs) with composition 85 mol% SiO2 and 
15 mol% CaO were synthesised and characterised. Bioactivity was demonstrated by 
the formation of calcium apatite following 5 days immersion in simulated body fluid 
(SBF). The effect of a 24 h exposure of human mesenchymal stem cells (hMSCs) to 
SMBGs at concentrations of 100, 150 and 200 µgml
-1
 on cell viability, metabolic 
activity and proliferation was determined using the LIVE/DEAD, MTT, total DNA 
and LDH assays after 1, 4 and 7 days of culture. None of the SMBG concentrations 
caused significant cytotoxicity, except the highest doses of 150 and 200 µgml
-1
 which 
significantly decreased hMSC metabolic activity after 7 days of culture. Cell 
proliferation decreased as SMBG concentration increased; however none of the 
SMBGs tested had a significant effect on DNA quantity compared to the control. 
Confocal microscopy confirmed cellular uptake and localisation of the SMBGs in the 
hMSC cytoskeleton. Transmission electron microscopy revealed that the SMBGs 
localised inside the cell cytoplasm and cell endosomes. To correlate the 
physiochemical properties (agglomerated versus non-agglomerated) of SMBGs with 
cellular behaviour, mono-dispersed bioactive glass particles (mono-SMBGs) of 80 
mol% SiO2, 20 mol% CaO were synthesised with the diameters of 215 ± 20 nm. The 
effect of mono-SMBGs on both hMSCs and adipose stem cells (ADSC) were 
investigated using a range of cytotoxicity assays (LIVE/DEAD, MTT, Alamabar blue 
and Cyquant). Cytotoxicity data revealed that mono-SMBGs were non-cytotoxic to 
hMSCs or ADSC. TEM imaging techniques were applied to confirm the 
internalisation of the particles by the MSCs and ADSCs. It was shown, through 
confocal imaging, that mono-SMBGs were taken up readily by the cells through a 
clathrin and caveolae independent endocytosis process. In addition, the differentiation 
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of the stem cells was investigated but the cells maintained their phenotype. Overall, 
the results presented in this thesis are of great importance for assessing the toxicity of 
sub-micron bioactive glass particles that may either be used as injectables, generated 
by wear or degradation of bioactive glass scaffolds or be used for other medical 
applications such as drug delivery or stem cell tracking.  
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1. Introduction  
1.1 Research objectives 
The loss of bone tissue as a result of trauma, or removal of diseased or cancerous 
tissue, has led to a remarkable socioeconomic impact related to personal disability and 
high health care costs. It is estimated that more than 2.2 million bone graft procedures 
are performed each year worldwide with 1.5 million in the US alone [12]. The 
estimated cost of these procedures approaches over $2.5 billion per year [12]. The 
demand for biomaterials to replace and assist with the problems associated with 
weakening or failure of body parts has been rapidly increasing due to increasing life 
expectancy (i.e. an aging population).  
The current clinical procedures for the repair and reconstruction of large bone defects 
include transplantation which is limited in supply, and implantation, which aims to 
replace the targeted tissue rather than regenerate it. Synthetic orthopaedic implants 
that are designed to replace or augment tissue have limited lifespan and they do not 
tend to adapt to their physiological environment which leads to a revision surgery for 
the patient. Therefore an ideal solution would be a move from tissue replacement to 
tissue regeneration, in which case the material can stimulate and act as a template for 
bone regeneration. 
Bioactive glasses (BGs) have achieved significant attention as synthetic bone grafts in 
the form of dense particulates and scaffolds (temporary templates for tissue growth) 
for use in a range of orthopaedic and dental applications. Current commercially 
available BG particles include NovaBone
®
 (NovaBone
®
 Products LLC, Alachua, 
Florida). Novabone
®
 has the composition known as 45S5 Bioglass
®
 (46.1 mol% SiO2, 
26.9 mol% CaO, 24.4 mol% Na2O and 2.5 mol% P2O5). The particles are in the 
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micrometer size range (90-710μm) and are irregular in size and shape. Sub-micron 
BG particles (~ 250 nm) are an attractive alternative to BG microparticles for hard 
tissue regeneration. There are several potential applications of BG particles at 
nanoscale (<1 µm), making them superior over BG microparticles.  The small size 
and high surface area of BG at nano-scale would make them ideal for injection into 
the defect site to allow healing and regeneration of the surrounding bone. Also, they 
can be used as drug delivery vehicles, labelling for cancer diagnostics (for imaging 
cancer cells) and finally incorporating the particles into a polymer matrix to produce a 
nanocomposite with enhanced mechanical properties.  
Despite the great potential of BGs in general, concerns have arisen about their long 
term fate in the body. For example, small particles may be generated by wear of or 
degradation of implants, which could potentially cause adverse reactions with the 
surrounding target cells. Furthermore, there is increasing concern that nano-sized 
particles can cause undesirable health effects that cannot be predicted based on the 
physiochemical properties of the their bulk materials or chemical constituents. The 
shape and size-dependent physicochemical properties (e.g. small dimensions similar 
to large biomolecules or clusters of molecules, large surface area and high reactivity) 
that makes nano-sized materials functional can also make their interactions with 
biological systems difficult to predict using traditional risk assessment methodologies 
that have been developed for bulk materials. Therefore, it is critical to establish the 
interaction of BG particles (<1 µm) with various cell types to assess the risk of 
continued research and production of BG implants. Also, cellular response to BG 
particles will determine their most appropriate use in medicine. However, spherical 
and monodisperse bioactive glass particles have not been produced prior to this thesis. 
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The overall aim of this thesis was to synthesise and fully characterise spherical and 
monodisperse BG particles in the sub-micron region and to assess their impact on 
stem cells to predict whether or not the particles may cause an adverse reaction at the 
defect site. To date, there is limited data on the toxicity of nano-sized (in this thesis 
nano-sized is referred to particles of 1-1000 nm) BG particles and this needs to be 
addressed in order to ensure their safety for medical application. In this thesis the 
properties, including size and agglomeration state of the BG particles (diameters of 
approximately 250 nm) are related to their cytotoxicity and interaction with target 
cells using a fundamental mechanistic approach. It is only through this approach that 
we can predict which properties of nanomaterials (NM) may cause toxicity and 
implant failure.   
The first objective was therefore to synthesise novel monodisperse spherical glass 
particles of bioactive compositions using the sol-gel process. The second objective 
was to assess the response of stem cells to the particles, assessing toxicity, uptake and 
whether they trigger differentiation. Two different cell types were studied; human 
mesenchymal and adipose stem cells. 
 
1.2 Thesis roadmap 
This thesis begins with a detailed introduction and literature background to the subject 
of BGs at the nano-scale (Chapter 2). The objective of Chapter 3 is to familiarise the 
reader with specific instrumentation and techniques that have been applied to fully 
characterise BG particles and also their interaction with cells. Chapter 4 concentrates 
on synthesising a first generation of sub-micron BG particles (SMBGs) and the use of 
various techniques to fully characterise them. Bioactivity testing of SMBG using 
simulated body fluid (SBF) is covered in Chapter 5. Chapter 6 then assesses the 
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interaction of SMBGs with human mesenchymal stem cells (hMSCs), including 
toxicity tests and uptake studies. Characterisation studies showed the particles were 
slightly agglomerated, so a new method was developed to improve dispersity. Chapter 
7, therefore, describes the synthesis and characterisation of the mono-dispersed BG 
particles (mono-SMBG). Chapter 8 then investigates the effect of these particles on 
uptake into hMSCs and adipose stem cells (ADSCs), cytotoxicity and whether the 
particles triggered differentiation of the stem cells. Chapter 9 summarises the thesis 
and discusses how findings from Chapters 4-8 can be applied to determine the 
potential applications of BG nano-sized particles. 
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2. Literature review 
2.1 Overview of human bone 
Bone is an extremely dynamically adapted natural tissue that provides a structural 
framework and a source of minerals. Bone is remarkable for its hardness, toughness 
and regenerative capacity, as well as its characteristic growth mechanism. Figure 2.1 
illustrates the complex hierarchical structure of bone, which is the reason for its 
excellent properties.  
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Figure 2.1: The hierarchical structure of bone, modified from Rho et al
 
[1]. 
At nanostructural level, bone has a composite structure that is composed of the fibrous 
protein, mainly collagen type I, and is stiffened by an extremely dense calcium 
phosphate crystalline mineral filling. In mature bone, the matrix is usually hydrated, 
with 10-20% of its mass being water. Of its dry weight, 60-70% of bone is made up of 
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inorganic mineral salts (mainly carbonated apatite), 30-40% is collagen and the 
remainder (~ 5%) is non-collagenous protein and carbohydrates, mainly glycoproteins 
[13]. The overall proportion of these components varies with age, location and 
metabolic activities.  
At the macro-structural level of organisation, bone is principally composed of cortical 
(compact) and trabecular (cancellous) bone. Cortical bone has a dense structure and is 
of great importance in providing strength [14]. Trabecular bone has a low density and 
strength, but a very high surface area due to its complex porous network of trabeculae. 
The large spaces between the complex network of interconnected plates and rods of 
trabeculae contain bone marrow, where the marrow spaces act as a depository for the 
precursor cells, including mesenchymal stem cells, the progenitor cells of the bone, 
also known as pluripotential stromal stem cells.  
There are four types of cells associated with the bone matrix. The osteoprogenitor 
cells differentiate into osteoblasts, through cell division, prior to bone formation. The 
osteoblast cells are actively engaged in the manufacture and secretion of the 
components of bone matrix. They are mononucleated cells of approximately 15-30 
µm across which are responsible for bone formation. They also play a role in the bone 
mineralization by depositing osteoid tissue. The differentiated function of osteoblasts 
is to secrete matrix components such as collagen type I. Osteocytes are bone cells 
which are derived from osteoblasts and assist in the exchange of materials between 
the tissue fluids and bone matrix. They are mainly found enclosed within lacunae 
(holes) dispersed in the bone matrix. The osteoclasts are large mature short lived cells 
that arise from bone marrow mononuclear cells and are found on or near the bone 
surface and are associated with bone resorption.  
 
31 
 
2.2 Current clinical treatments of skeletal deficiencies 
The demand for biomaterials for the repair of weakened or failing body parts is 
rapidly increasing due to increasing life expectancy (i.e. an aging population). The 
consequence of living longer can often lead to a decrease in the quality of life due to 
the wear and tear of tissues of the human body. For example, in the UK alone one in 
three women and one in twelve men, over the age of fifty, suffer from osteoporosis, 
which reduces bone density and strength [15]. This reduction arises as a result of bone 
resorption occurring more rapidly than bone formation leading to ease of bone 
fracture and defects [16]. Bone surgical procedures are commonly applied to provide 
structural stability at the bone defect site. 
 
2.2.1 Bone transplantation 
Bone transplantation includes: 1. Autograft (graft harvested from the same 
individual); 2. Allograft (transplants of tissue from one human to another often taken 
from cadavers); 3. Xenograft (transplants of tissue from another species to human) 
[17]. However, there are limitations to the use of these techniques. Autografts (gold-
standard) suffer from limited supply of bone and cause donor site morbidity, which 
can cause intense pain and lengthen recovery time. Allografts and xenografts presents 
a risks of immune rejection and disease transmission [17]. Hence, these restrictions 
have encouraged the development of synthetic biomaterials for implantation. 
2.2.2 Implantation of biomaterials 
Implantation of materials that are biocompatible and biodegradable has extensively 
been used to repair or replace diseased or damaged bone tissues. Biocompatible 
materials for clinical use in bone applications can be divided into three categories: 
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i) Bioinert: The implant does not react or form a bond with bone  
ii) Resorbable: The implant is replaced by bone 
iii) Bioactive: Bioactivity was defined by Hench as “A bioactive material is 
the one that elicits a specific biological response at the interface of the 
material, which results in the formation of a bond between the tissue and 
the material” [18].   
 
The total hip replacement was introduced in the early 1940s and has made a 
significant impact on numerous patients suffering with osteoporosis and osteoarthritis. 
The first hip implants were made of inert materials, such as titanium and alumina, 
which had no reaction with the physiological fluid and originally fixed in place by 
cementing the implant into the host bone. Synthetic hydroxyapatite (HA) coatings 
were then introduced as bioactive materials that could bond the implant with bone 
[19]. However, many of those coatings have experienced non-uniformity, poor 
adhesion and low mechanical strength [19]. 
All orthopaedic implants have a limited life and they cannot adapt to their 
physiological environment over time, which inevitably leads to the requirement for a 
revision surgery for the patients. It is now well-accepted that biomaterials for the 
treatment of bone defects should provide a mechanical reinforcement of damaged or 
diseased bone tissue and take an active part in the process of bone reconstruction. 
Therefore an ideal solution would be a move from tissue replacement to tissue 
regeneration, in which case the material can stimulate and act as a template for bone 
regeneration. 
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2.2.3 Tissue engineering using stem cells 
Tissue engineering is an interdisciplinary field that combines the principles of biology 
and engineering to develop constructs that can restore and maintain the function of 
human bone tissue. Tissue engineering strategies (Fig 2.2) aim to regenerate tissue by 
seeding cells onto a scaffold/template, combined with body‟s own response, to direct 
these cells to regenerate the target tissue [20].  
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Figure 2.2:  The most common tissue engineering approach. 1) Cells are harvested 
from the patient and 2) expanded in vitro. 3) Cells are seeded onto an appropriate 
template / scaffold with suitable growth factors and cytokines and 4) cultured in vitro. 
5) Engineered tissue is re-implanted into damaged site.  
 
Tissue engineering and regenerative medicine are highly dependent on the cell types 
and on the cell response to achieve an efficient, long lasting and stable repair of the 
tissue. For successful tissue regeneration, the cells chosen must produce an 
extracellular matrix (ECM) in the correct organisation, secrete cytokines and other 
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signalling molecules, and interact with neighbouring cells/tissues [21]. Stem cells are 
strong candidates that are commonly being used in tissue regeneration applications. 
Stem cells are fundamental, highly specialised, cells which are present within every 
tissue. Stem cells can be embryonic (isolated from the inner cell mass of blastocytes) 
or adult cells (found in adult tissue) that are pluripotent and are able to differentitate 
into any cell type. By stimulating the osteogenic differentiation and bone forming 
properties of osteo-progenitor cells, tissue engineering can improve bone tissue repair. 
One common cell source for bone tissue engineering is the use of human 
mesenchymal stem cells (hMSCs). 
 
hMSCs are found in adult tissue, such as bone marrow, and have the capability to 
differentiate into myogenic, osteogenic, chondrogenic and adipogenic tissue [22]. 
hMSCs are a population of self-renewing cells, having the ability to generate identical 
copies of themselves with the same multilineage potential as the mother cell. hMSCs 
are normally isolated from aspirates of bone marrow harvested from the superior iliac 
crest of the human pelvis [23-25] and also from the tibia and lumbar spine [25]. They 
have also been isolated from adipose tissue, umbilical cord, synovium, amniotic fluid 
and dental pulp [22]. However, bone marrow aspirates are difficult to obtain for 
research applications due to the pain upon harvest and when they do they are usually 
in small quantities resulting in low cell number yields. hMSCs are typically isolated 
by their adherence to tissue culture plastic and have been shown to maintain their 
capacity to differentiate towards cells of connective tissue lineages, including bone, 
cartilage, muscle and tendon, and have therefore become an important target for tissue 
engineering, cell and gene therapy [22].  
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Despite the fact that hMSCs represent a small fraction of the total nucleated cells in 
marrow [25] they can be isolated and expanded with high efficiency and induce 
differentiation into multiple lineages under defined culture conditions [23]. However, 
one drawback of hMSCs is the decrease in proliferation rate and capacity to 
differentiate into a multiple mesenchymal lineage after successive passaging in vitro, 
reflecting the difficulty in maintaining stem cell plasticity [25]. This is challenging, 
considering stem cells have to be expanded in vitro to a number suitable for 
therapeutic applications. It is recognised that differentiation potency of the hMSCs are 
influenced by cell culture conditions including cell confluence which is known to 
decrease osteogenic efficiency. Nevertheless, hMSCs are precursors to osteoblasts 
and hence are an ideal cell source to use for bone regeneration applications.  
The differentiation of MSCs into bone cells (osteoblasts), cartilage cells 
(chondrocytes) and fat cells (adipocytes) has been widely studied over the past 
decades [22-26]. Differentiation is a sequence of procedures involving the 
development of stem/progenitor cell to a more specialised cell type that carry out a 
specific function. During the differentiation process, genes specific to the mode of 
differentiation are switched on and up-regulated. Differentiation can lead to changes 
in cell size, morphology, metabolic activity, biomechanical properties, extracellular 
matrix, and surface phenotype. Hence, it is a strongly regulated process that occurs in 
a precise manner. In a rat study, MSCs were able to repair an 8 mm defect in the 
femur when placed on a porous hydroxyapatite/β-tricalcium phosphate ceramics 
templates prior to implanting into bone defect [26]. The defect had completely healed 
after 8 weeks showing that MSCs can contribute to bone formation in vivo, since in 
the absence of MSCs (just the bioceramic template) the defect failed to heal. In 
another animal study, MSCs were used as cellular vehicles for the targeted delivery 
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and local production of anticancer agents, including therapeutic proteins at the cancer 
sites [27].  
 
2.3 Synthetic bone graft materials 
For a successful bone regeneration procedure, a synthetic graft should lead to 
osteointegration and promote osteogenesis. The graft should be osteoconductive and 
osteoinductive. The activity of osteoprogenitor cells around the implant represents the 
osteogenic potential of the bone substitute. Osteoinduction is the stimulation and 
activation of host mesenchymal stem cells to differentiate into bone-forming 
osteoblasts [28]. Osteoconduction refers to bone growth on the surface of a material in 
contact with host bone, therefore, osteoconductive materials bond with bone.  
Bioceramics are considered as bioactive materials that have widely been investigated 
and used for the repair of hard tissues including bone [29, 30]. They are amongst the 
most promising categories of biomaterials for bone regeneration applications. 
Bioceramics are prepared in many different compositions, depending on the 
properties and functions required. They can be polycrystalline (e.g. HA), glass-
ceramics (apatite/wollastonite glass-ceramic) or glasses (e.g. Bioglass
®
) [31]. 
Ceramics have high hardness (resistance to plastic deformation) and compressive 
strength but perform poorly in tension and undergo brittle fracture [32]. Despite the 
great potential of these materials, due to their low resorption rate, concerns have 
arisen regarding their long term fate in the body as wear particles, of nano- or micron-
size, may be released upon implantation. This could potentially cause adverse 
reactions with the surrounding cells. In the following sections (2.3.1 – 2.3.3) 
examples of the current synthetic bone graft materials that are of great interest are 
discussed. 
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2.3.1 Calcium phosphate ceramics 
Synthetic hydroxyapatite (HA, Ca10 (PO4)6 (OH)2), is a bioactive ceramic that is used 
in non-load bearing biomedical applications such as bone fillers in the form of a 
powder. HA has a similar composition, structure and Young‟s modulus to the mineral 
component of bone. HA is osteoconductive in vivo but has a slow reactivity. Synthetic 
HA is also brittle and undergoes extremely slow resorption (almost no resorption). 
For this reason, substitutions are frequently added to HA with other elements for 
improved bioactivity. One common example is silicon-substituted hydroxyapatite (Si-
HA) which has shown to improve its bioactivity [33]. Previous in vitro studies [34] 
revealed that the substitution of silicate ions for phosphate ions into HA increases 
osteoblast activity in comparison to pure HA. Silicate ions introduce defects in the 
structure making HA non-stoichiometric. In vivo studies have demonstrated that bone 
apposition to be greater at the surface of Si-HA compared to HA ceramic implants 
[35] since the release of soluble silicon is osteogenic. 
Beta-tricalcium phosphates (β-TCP) are also amongst calcium phosphate based 
bioceramics that are biocompatible and biodegradable with a similar chemical 
composition (Ca3(PO4)2) as human bone. The release of Ca and P from β-TCP 
bioceramics has shown to influence bone formation [36]. However, there is 
insufficient bone formation after resorption, making them unsuitable for bone tissue 
regeneration applications [37]. Due to the weak mechanical properties and rapid 
degradation of β-TCP, some studies have focused on mixing β-TCP with HA or 
polymer [38]. Also, previous studies have shown that β-TCP combined with MSCs 
prior to implantation facilitates osteogenesis [36]. Nevertheless, early bone formation 
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covers the surface of the material (β-TCP/MSCs) and hence the exposure to the 
solution will be limited resulting in slower resorption of β-TCP [36]. 
 
2.3.2 Bioactive glasses 
Bioactive glasses are promising materials for hard tissue regeneration because of their 
distinctive properties of rapid bone bonding and the ability to stimulate new bone 
growth [39]. Bioactive glasses are based on the silica tetrahedron (network former) in 
the presence of network modifiers such as Ca, Na and P. Bone bonding arises due to 
the formation of a carbonated apatite layer on the glass surface following contact with 
body fluid which bonds with the host bone [40]. Osteogenesis is thought to be 
stimulated by the release of ions from the glass, particularly Ca and Si, which triggers 
cell activity [39]. There are two routes by which bioactive glasses are produced: sol-
gel (section 2.5.1) and melt-derived. All early bioactive glasses were produced using 
the melt-derived method. This process involves melting the glass components at high 
temperature followed by casting of bulk implants or quenching and grinding to form 
powder [41].  
In 1969 a second generation of biomaterials, melt-derived 45S5 Bioglass
®
 with the 
composition 46.1 mol % SiO2, 26.9 mol% CaO, 24.4 mol% Na2O and 2.5 mol% P2O5, 
were discovered which formed a bond between the glass and the host tissue[18]. At 
the very early stages of the research it was believed that the glass should contain 
phosphorus and calcium in order to be bioactive. In the early 1990s it was shown by 
Ebisawa et al that phosphate-free glasses in the binary system SiO2-CaO exhibited 
both in vitro and in vivo bioactivity for the composition of 65 mol % SiO2 [42]. The 
phosphate in the glass only seems to accelerate/help the nucleation of the Ca-P phase 
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on the glass surface. It is not an essential component of bioactive glass as phosphate 
ions from the body fluid will be adsorbed onto the surface of the glass [43]. In 1991 
Li et al [44] synthesised different compositions of bioactive glass through the sol-gel 
process and reported that glasses containing upto 90 mol % silica was bioactive 
although bioactivity decreased with increased silica concentration in the glass. In 
2000, Martinez et al [45] studied the compositional range of 50-90 mol% SiO2 in the 
sol-gel binary glasses to investigate the compositional limits of bioactivity in 
simulated body fluid (SBF). Their results demonstrated that all glasses were bioactive, 
in that they formed an apatite layer in SBF, but with increased SiO2 in the 
composition the rate of formation of apatite decreased [45]. In general, bioactive 
glasses bond to bone at faster rate than other bioceramic materials due to their 
amorphous structure and surface reactive properties. Sol-gel derived bioactive glasses 
have a nanoporous texture resulting in higher surface area compared to melt-derived 
glasses, making dissolution faster in sol-gel derived glasses of similar composition. 
On the surface of sol-gel glasses, there are many silanol groups that act as nucleation 
sites for hydroxyl carbonated apatite (HCA- bone like mineral) layer formation, 
making these glasses more bioactive. Biaoctive glasses exhibit high osteoconductive 
and osteoinductive properties which are associated with the release of soluble silicon 
and calcium in highly bioactive glasses [32] which stimulates osteogenic cells and 
upregulates seven families of genes in osteoblasts, leading to bone formation [46].  
 
Sol-gel derived glasses have many advantages which makes them superior over 
traditional melt-derived glasses for bone regeneration. In comparison to melt-derived 
bioactive glasses, the sol-gel bioactive glasses: 
- Have significantly higher and tailorable degradability [47]; 
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- Are processed at lower temperatures (600-700°C); 
- Tend to have higher purity and homogeneity as a result of low processing 
temperature [48]; 
- Have mesoporous texture providing them with high surface area, which 
presents a higher number of sites for apatite nucleation [49]; 
- Have higher bioactivity due to the textural features of the gel such as pore size 
and pore volume affiliated with the large surface area and higher rate of dissolution 
[50]. 
Despite all the desirable results from sol-gel technique, there are some limitations to 
the process. These limitations include problems with dimensional changes on 
densification, and shrinkage and stress cracking on drying, hence careful attention is 
required during processing [51]. In addition, the process is time consuming and the 
raw materials tend to be expensive.   
 
2.3.2.1 Mechanisms of bioactivity 
Both melt-derived and sol-gel glasses have similar bioactivity mechanisms. The 
concept of bioactivity is based upon the surface chemistry of the material. In 1980‟s 
Kokubo et al [10] proposed SBF testing for predicting material‟s bioactivity, since it 
has similar ion concentrations and pH as blood plasma. SBF has commonly been used 
to assess the surface modification and the formation of crystalline hydroxy carbonated 
apatite (HCA), which has a similar structure to bone mineral, of bioactive glasses. 
HCA formation on the surface of bioactive glasses is thought to be an important 
phenomenon for materials to show bone bonding ability with the host tissue through 
interlocking with collagen fibrils. However, the validity of SBF testing has been the 
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subject of great debate. For example, the presence of proteins in the blood (including 
albumin and fibronectin), which are absent in SBF, are considered to be important in 
determining the failure or acceptance of an implant when placed into the body [52]. 
When a biomaterial is placed in vivo, proteins instantly become adsorbed on the 
surface of the implant [52], providing an indication of the clinical success. In addition, 
in a recent leading opinion review paper by Bohner and Lemaitre [53] they argued 
that there is a lack of scientific data to support the assumption that there is a 
correlation between apatite formation in SBF and bone bonding. In this review, 
calcium sulphate hemihydrate and dicalcium phosphate dihydrate materials were 
given as example of forming HCA on their surface in SBF but failed in vivo [53]. On 
the other hand, β-TCP bioceramic was given as an example of a material that does not 
always lead to apatite formation in SBF regardless of its bone bonding capability in 
vivo. Hence it was concluded that SBF bioactivity testing “may lead not only to false 
positive but also to false negative results” [53]. Nevertheless, SBF study is a popular 
way of testing the bioactivity of bone grafts by examining the formation of 
hydroxyapatite (HA) crystals on the surface of the material, which provides an 
indication of the bone bonding ability of materials in vivo.  
 
In 1979 Clark et al [54] proposed that when glass reacts with an aqueous solution, 
both chemical and structural changes occur as a function of time within the glass 
surface (stages 1-5). A final set of stages 6-11, biological reactions involving the 
bonding of HCA to the host tissue, were proposed by Hench et al in 1991 [21]. In 
bioactive silica- based glasses a silica-gel layer is formed by glass dissolution and 
surface polycondensation reactions that occurs before the calcium phosphate-rich 
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layer is formed [21]. The proposed 11 stages of bioactivity mechanisms for bioactive 
glasses are as follows [21, 55]: 
 
1. Rapid exchange of network modifiers (Na+ and Ca2+ ions) with H+ or H3O
+ 
present in solution through diffusion, which leads to formation of silanol 
bonds. The pH increases as a result of replacement of H
+
 ions by cations. 
Si-O
- 
Na
+
 + H
+
 + OH
-
 → Si-OH+ + Na+(aq) +OH
- 
 
2. Breakage of the Si-O-Si network due to loss of soluble silica in the form of 
Si(OH)4 and the formation of Si-OH (silanols) at the glass interface solution.  
Si-O-Si + H2O → Si-OH + OH-Si 
 
3. Condensation and re-polymerisation of SiO2-rich layer on the surface of the 
glass with reduced alkalis and alkali-earth cations concentration in the 
solution. 
 
 
 
4. Migration of Ca2+ and PO4
3- 
groups and deposition on the glass surface, 
forming a CaO-P2O5-rich film on top of SiO2-rich layer, followed by growth 
of amorphous CaO-P2O5-rich film.  
5. Crystallisation of amorphous CaO-P2O5 film by incorporation of OH
-
 and 
CO3
2- 
anions from the solution to form HCA layer. 
SiO
O
H2OOH
O
SiOH
O
O
O
+ Si
O
O
O
SiO
O
O
+
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6. Adsorption and desorption of biological growth factors on the HCA layer 
continues throughout the process in order to activate differentiation of stem 
cells.  
7. Action of macrophages to remove debris from the site allowing cells to 
capture the space. 
8. Attachment of stem cells on the bioactive surface. 
9. Differentiation of stem cells to form bone growing cells such as osteoblasts. 
10. Formation of extracellular matrix leading to the formation of bone. 
11. Crystallisation of inorganic calcium phosphate matrix to enclose bone cells in 
a living composite structure. 
 
The dissolution of bioactive glass occurs as a result of stages one and two, which 
affects the rate of HCA formation, but also releases dissolution products, which can 
interact with cells. 
In 1986, Carlisle‟s studies on chicks and rats revealed that bone grew rapidly in the 
presence of silicon, but in an environment lacking silicon retarded bone growth [56]. 
In 1992, it was proposed by Keeting et al [57] that soluble silicon was a powerful 
mitogen for human osteoblast-like cells, increased DNA synthesis and enhanced 
alkaline phosphatase activity and osteocalcin release. In 1993, it was illustrated that 
osteoblast cells tend to divide more rapidly on bioactive glass than synthetic 
hydroxyapatite (HA) [58]. All these results showed that silica plays an important role 
in HCA nucleation and crystalisation [59], tissue repair and osteogenesis [32]. In 2001 
Xynos et al showed that the dissolution products of Bioglass
®
 triggered the activation 
of specific genes in human osteoblasts and increased cell proliferation and osteogenic 
differentiation [46]. 
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2.3.3 Phosphate-based glasses 
The building block of phosphate based glasses is PO4
3- 
tetrahedron unit (Fig 2.3) and 
the network can be altered by the addition of network modifiers including Ca
2+
, Na
+
, 
Sr
2+
, K
+
, Mg
2+ 
and Fe
2+
. Network modifiers are known to affect the degradation rate 
of phosphate based glasses such that by selectively changing the amount of these 
components incorporated into the glass the degradation rate can be controlled [60]. 
Phosphate glasses have shown osteoconductive properties and lack osteoinductive 
effects [61].   
                         
 Figure 2.3: Phosphate tetrahedral unit. 
 
In ternary phosphate based glasses of CaO-Na2O-P2O5 by substituting Na2O with 
CaO, but keeping P2O5 constant, a glass system which is less degradable can be 
obtained. This is due to the fact that Ca
2+ 
ions have stronger field strengths than Na
+
, 
forming a structure with ionic bonding between two adjacent (PO4
3-
) tetrahedra, 
strengthening the P-O-P bond [62]. Therefore, by changing the amount of CaO in the 
phosphate based glass system the rate of dissolution and resorption can be modified 
from few hours to weeks [63]. Salih et al [64] investigated the biological response of 
human osteoblasts to phosphate-based glasses and found that in the presence of highly 
soluble glasses (low level of Ca
2+
) the cell proliferation was unfavourably affected 
growth and bone antigen expression was inhibited. In addition, they reported that less 
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soluble glass (high level of Ca
2+
) had a positive effect on cell proliferation and 
enhanced bone growth and antigen expression [64]. However, phosphate glasses tend 
to have high resorption rate compared to silicate glasses which implies that they 
disappear before bone apposition. Hence, the glass will release phosphoric acid as it 
dissolves, lowering the pH, causing problems (cell death) at the donor site. 
 
2.4 Nano and sub-micron particles for therapeutic applications 
Nanotechnology can be classified as the technology that is developed at the atomic, 
molecular, or macromolecular scale [65]. The use of nanotechnology in medicine is 
rapidly growing with the estimated number of papers in the field rising from 11 in 
1991 to nearly 30,000 in 2011. The exact size of the particle that should be termed a 
nanoparticle is still controversial; however, many people consider nanoparticles as 
ultra-fine particles which have one or more dimensions of the order of 100 nm or less. 
Nevertheless, in nano-medicine size dimensions of 1-1000 nm are included and have 
made an impact. This reflects the fact that in medicine, “nanotechnology aims to 
improve and optimise materials properties for their interaction with cells and tissues” 
to enable possible passive tumour targeting, crossing of the biological barriers and 
also to improve bioavailability [66]. This approach makes use of nanoscale materials 
larger than 100 nm [66]. This size range (from 1–1000 nanometers) enables the 
creation and use of structures, systems and devices that have novel properties with 
atomic-level control [65]. The exclusive properties and effectiveness of these particles 
arise from a multiplicity of attributes, including the similarities in size with 
biomolecules such as proteins. Living organisms are made up of cells which are about 
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10 μm across, but the cell organelles are much smaller and they are in the nano size 
domain.  
 
Nano- and sub-micron (NSM) particles present a particularly advantageous platform, 
demonstrating unique properties with great potential in wide range of therapeutic 
applications [67]. The unique properties such as low density, large specific surface 
area, stability [68] and size-dependent chemical and physical properties of NSM 
particles differentiates them from bulk materials. Due to these unique properties, 
nano-particles have widely been studied in biology and medicine. Nanoscale particles 
can hold advantages over microparticles including the fact that nanoparticles can 
travel through the blood stream without sedimentation or blockage of the 
microvasculature and can circulate in the body and penetrate tissues such as tumours 
[69]. Nanoscale particles have great potential as delivery vehicles for a range of 
therapeutic and diagnostic applications. Some of their applications include fluorescent 
biological labels [70], drug delivery vehicles to target sites for cancer therapeutic [71], 
deliver imaging agents for cancer diagnostics [72], gene delivery [73], and tissue 
engineering [74]. It is possible to chemically engineer the particles such that they 
recognise biophysical characteristics that are specific to the target cells. This will 
minimise drug loss and toxicity related with delivery to non-desired tissue.  
Nanotechnology has been applied to treat/prevent osteoporosis. Amorphous nano-
scale materials that are highly biodegradable (e.g bioceramics such as calcium 
phosphate) will release bioactive agents relatively fast. The use of these materials will 
allow the targeted release of bioactive agents that can rapidly increase bone formation 
through the attachment of the particles to areas of low bone density. One approach is 
to embed the particles with growth factors such as bone morphogenic proteins (BMP) 
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and to functionalise the surface of the nanoparticles with amino groups for attachment 
of entities to direct nanoparticles to osteoporotic bone. Once attached, the BMP would 
be released and hence stimulate bone formation. Balasundaram et al [75] have applied 
this to amorphous calcium phosphate nanoparticles and have functionalised the 
particles with versatile amino groups but have not as yet confirmed any positive in 
vitro response with regards to the effect of the particles on osteoporosis.   
 
For bone tissue regeneration, the scaffold should ideally have mechanical properties 
close to the host bone to withstand loading. Bone is a natural nanocomposite, 
therefore, organic/inorganic nanocomposites are amongst promising candidates for 
bone tissue regeneration with the challenge of mimicking the bone‟s hierarchical 
structures. The concept of regenerating bone for orthopaedic and spinal application 
has encouraged long-term research effort and, regardless of significant advancement, 
is still facing a number of clinical challenges. Often NSM particles are used together 
with a polymer to produce a nanocomposite scaffolds with a 3D structure, to closely 
mimic the in vivo conditions. Nevertheless, the two phases in a nanocomposite 
degrade at a different rate and so the particles can be released during implantation. 
This may result in adverse reactions with the surrounding cells. Hence, the interaction 
of NSM with various cells should also be considered and thoroughly studied. 
 
 Numerous studies have focused on the use of nanoparticles as coatings or 
incorporating nanoparticles into a scaffold to create composites for bone regeneration 
applications with only a few attempts to use the particles on their own. 
Nanocomposites produced from polymeric microspheres, using collagen as 
microsphere matrix, and nano-sized HA particles have been a popular choice since the 
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structure and composition mimics that of extracellular bone matrix [76]. Previous 
studies have shown that this HA-collagen microspheres nanocomposite supports 
osteoblast function, with increased release of alkaline phosphatase on HA-collagen 
microspheres compared to collagen microspheres, when using rat MSCs [76]. 
However, the substrate should ideally be made into 3-D scaffold rather than 2-D to 
closely assess the possible in vivo conditions. Previous studies have demonstrated the 
differentiation of MSC into osteoblasts with aqueous suspensions of amino acid-
functionalised calcium phosphate nanoparticles, creating a “living biocomposite” 
whereby the freely suspended enriched MSC populations became coated with 
biocompatible nanoparticles [77]. This approach allows the use of stem cells 
themselves to prepare a suitable inorganic scaffold to maintain cell viability in 
suspension as opposed to seeding cells onto a scaffold [77]. While the potential 
applications of nano-scale materials in modifying MSC differentiation in general has 
been investigated, the interaction between nano-scale bioactive glasses and MSCs has 
not thoroughly been studied and remains mostly unknown. 
 
2.5 Current synthesis methods for the production of bioactive glass 
particles 
Although the properties of bioactive glasses, as microparticles, fibres, plates and as 
scaffolds, have widely been investigated for many years, the synthesis of different 
compositions of submicron sized bioactive glass particles is still novel. In order to 
investigate the possible cytotoxic effect of bioactive glass particles it is required to 
produce them using possible synthesis routes for testing. There are different ways of 
producing these particles including: 1) Sol/gel process; 2) Microemulsion; 3) Gas 
phase synthesis that includes flame spraying and; 4) Electrospinning. 
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2.5.1 Sol-gel material processing 
The sol-gel process is a versatile solution process that has been widely used to design 
and manufacture bioactive glasses. It has been extensively studied due to the low 
temperature processing and the potential advantage of controlling composition and 
morphology of the material. The sol-gel derived bioactive glass nano or sub-micron 
powders are not only useful for coating applications but can also be used for direct 
applications in the body [78]. The sol-gel method is also one of the most common 
ways of producing nano-scale particles as it allows manipulation of the material 
structure at molecular level. The hydrolysis and condensation chemical reactions are 
usually performed at room temperature. Bioactive sol-gel glasses have functional 
surface chemistry due to their high concentration of silanol groups on the surface as a 
result of sol-gel processing conditions that provide sites for the HCA nucleation and 
crystallisation. This has led to development of glass systems of SiO2, CaO-SiO2 and 
CaO-P2O5-SiO2 using sol-gel processing [44, 79]. 
 
2.5.1.1 Sol-gel chemistry 
In this process, simple molecular precursors are converted into nanometer-sized 
particles to form a sol. A sol is a stable colloidal suspension of solid particles in a 
liquid. Colloids are solid particle with diameter of 1-100 nm. A gel is an 
interconnected, rigid network with pores of submicrometer dimensions and inorganic 
polymeric chains whose average length is greater than 1 µm [80]. These colloidal 
nanoparticles are then linked with one another in order to form 3D network (scaffold) 
or dried to form powder particles.  
 
50 
 
A typical sol-gel method involves the following steps: 
1) Mixing - hydrolysis and condensation polymerisation. 
Formation of a silicate network through sol-gel process follows two main stages of 
hydrolysis and condensation which occur during the mixing stage. Initially an 
alkoxide precursor, such as Si(OR)4, where R is CH3, C2H5 etc, is mixed with water. 
Silica alkoxides are the most thoroughly studied precursors and react readily with 
water at low or high pH. 
 
Both hydrolysis and condensation reactions (Fig. 2.4) occurs simultaneously. 
Generally, hydrolysis occurs through the addition of water which results in 
replacement of alkoxide group (OR) with hydroxyl groups (OH). In condensation 
reaction, silica atoms become cross-linked through bridging oxygen bonds (Si-O-Si) 
by losing water or ethanol (ethanol condensation), leading to formation of many silica 
nanoparticles [81]. The condensation reaction can continue to build larger and larger 
silicon containing molecules, leading to the process of polymerisation [2]. The 
condensation takes place in such manner as to maximise the number of Si-O-Si bonds 
and to minimise the number of terminal hydroxyl groups through internal 
condensation. The mechanism of hydrolysis and condensation will be discussed in 
section 2.5.1.2.  
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Figure 2.4: Hydrolysis and condensation reaction of sol-gel process during mixing. 
The hydrolysis reaction (i) leads to production of silanol groups and siloxane bridges 
are then formed in condensation reaction (ii).  
 
2) Gelation 
Gelation occurs via the growth and crosslinking of the colloidal silica particles 
forming a 3D networked silica gel.  
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4) Ageing 
Depolymerisation and re-precipitation of the silica network leads to increased 
thickness of the inter-particle necks and the strength and density of the gel [31]. 
Aging reduces risks of failure by removing small pores which may develop large 
capillary pressure during drying.  
5) Drying 
This involves the removal of liquid from the interconnected pore network. The gel is 
said to be dried when the adsorbed water is completely eliminated from the pores. For 
this, heating at a controlled rate at temperature of 60-130 °C is required. 
6) Stabilisation 
This step is critical in order to control the environmental stability of the material [31]. 
Thermal treatment (above 600 °C) will lead to removal of surface silanol (Si-OH) 
bonds from the pore network, resulting in a chemically stable ultraporous solid. If the 
stabilisation temperature reaches 800 °C, then most of the surface hydroxyl groups are 
removed. Hench et al [31], proposed that stabilisation increases the density, strength 
and hardness of the gels and converts the network into a glass. The last stage of sol-
gel process is densification, which involves heating the porous gel at high temperature 
(900-1150 °C), through which the pores are eliminated. 
Figure 2.5 is a representative diagram of the sol-gel process, showcasing the 
processing route that can be altered to create a range of final products. In the mixing 
step, the chosen precursor forms the low viscosity sol and as the network develops the 
viscosity significantly increases. During the mixing stage, the acid or base catalysed 
process will determine the outcome of the final product. To form powders the base 
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catalysed route is followed since the acid catalysed route is used to form large solids 
by bulk gelation. Before the network formation is completed the sol can be applied as 
a coating, impregnated into a composite, be pulled into a fibre or form powder with a 
well controlled size distribution [31]. Or alternatively, the sol can gel followed by 
drying through evaporation at elevated temperature (<800 °C). This gives rise to 
capillary pressure, due to evaporation of water and ethanol, which causes shrinkage of 
the gel network and resulting in a dried gel (xerogel), which can be grinded into 
powders. The resulting xerogel is frequently reduced in volume in comparison to wet 
gel. However, by drying the wet gel under supercritical conditions, by placing it in an 
autoclave, there is no interface between the liquid and the vapour hence there is no 
capillary pressure and relatively little shrinkage (supercritical drying) resulting in an 
aerogel. Both xerogel and aerogel are applicable for preparing dense ceramics and 
also their high porosity and surface area makes the process ideal for production of 
catalytic substrate and filters [2]. 
  
Figure 2.5: Overview of the sol-gel process and the changes in the process that lead 
to formation of different materials. Redrawn from reference [2]. 
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2.5.1.2 Mechanism of hydrolysis and condensation 
The silica network formation is greatly influenced by the rate of hydrolysis and 
condensation which occurs mainly during the mixing stage of the sol-gel process. One 
of the main factors controlling the rate is the pH of the solution. The sol-gel process 
can be either acid or base catalysed around the isoelectric point of silicic acid (pH 2) 
[49]. To produce individual particles, a basic environment is created to enhance the 
formation of dense, spherical particles by terminating the condensation reaction [82].  
In acidic and basic environments, the rate of condensation varies, such that in a very 
acidic environment, pH ≤ 2, the rate is minimised. When the pH is lower than the 
isoelectric point of silica (pH ~2) the initial hydrolysis reaction is completed very fast. 
It has been assumed that since the isoelectric point of silica is at pH 2, the catalyst 
below pH 2 is the H
+
 ions which form an active cationic complex. In sol-gel process, 
where we aim to produce a porous scaffold, the sol must undergo a fast increase in 
viscosity and so gel within a few minutes of foaming to stabilise the pores [3]. For 
this, hydrofluoric acid (HF) is often used to catalyse the condensation reaction [3].  
At high pH, a negative charge covers the surface of the particles and this stabilises the 
sol against aggregation. Above pH 2 the OH
-
 ion is the catalyst in that the active 
anionic silica is generated [82]. The condensation takes place in such manner as to 
maximise the number of Si-O-Si bonds and to minimise the number of terminal 
hydroxyl groups through internal condensation [2]. These particles condense to the 
most compact state leaving OH groups on the outside (Fig. 2.6). [2] 
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Figure 2.6: Base catalysed hydrolysis and condensation in silica sol-gel process. Re-
drawn from [3]. 
 
For base catalysed hydrolysis, the transition state is negatively charged. As each 
successive hydrolysis reaction occurs, the electron sharing ability increases which 
results in greater stabilisation of the transition state. The self-condensation of 
monomer catalysed by OH 
–
 ions is commonly written as [82]: 
 
2 Si (OH)4  (HO)3SiOSi(OH)3 + H2O 
 
Aggregates tend to form in neutral conditions, or between pH 4-8, while colloids form 
in a basic condition. When pH of the solution is greater than the isoelectric point of 
silica (pH >2) the condensation reaction is favoured and the rate is greatly increased. 
This slow hydrolysis and fast condensation leads to higher number of nuclei and 
therefore can be used to form distinct particles. At low pH < 2, fast initial hydrolysis 
and slow condensation leads to linear condensation and hence forming a 3D network, 
OH 
– 
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a gel. At a pH below 7, the polymerisation of silica is sufficiently slow to allow early 
stages to be followed. The polymer units or particles formed at low pH tolerate no 
charge and unless the silica concentration is very low, aggregation begins to occur 
soon after polymeric particles are formed. This is not only due to the lack of charge 
on the particles, but also the fact that particles are very small and stop to grow after 
they reach a diameter of 2-3 nm. As aggregation is mainly dependent on the number 
of particles per unit volume and less on their size, aggregation is thought to occur 
even at very low silica concentrations. However, above pH 7 particle growth 
continues up to a larger diameter. Hence, only at low pH the progressive 
polymerisation of monomer can be followed and the initial formation of 3D 
condensed silica polymers or nuclei particles can be observed [82] .  
 
Stöber et al [83] showed that using a basic catalysis (such as ammonia) for the 
hydrolysis of TEOS could control the morphology and size of the silica powders. The 
initial concentration of ammonia can influence the final size of the spherical powders. 
Van et al [84] developed spherical silica particles of low size and polydispersity 
which ranged from a few nanometers to micrometers with increasing ammonia 
concentration.  
 
2.5.1.3 Sol-gel derived bioactive glass nano and sub-micron 
particles 
Recently, Hong et al [4] used the sol-gel process to produce SiO2-CaO-P2O5 ternary 
glass-ceramic nanoparticles (20 nm). These ternary bioactive glasses were fabricated 
by the combination of two steps of sol-gel and co-precipitation method, in which the 
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precursor mixture was hydrolysed in acidic environment and condensed separately in 
alkaline condition. This was then followed by a freeze-drying process. Polyethylene 
glycol (PEG) was added into the sol during the synthesis process to enhance the 
dispersion of the nanoparticles. However, this processing technique did not cause 
enhanced dispersity and resulted in the formation of agglomerated particles (Fig. 2.7). 
Also, the composition of the SiO2-CaO-P2O5 glass-ceramic nanoparticles was not 
measured. The small size of the particles is likely to be responsible for their 
crystallisation during thermal stabilisation because the driving force for nucleation of 
crystals increases with specific surface area. In addition, the phosphate in the ternary 
system is not an essential component for bioactivity as the low quantities of phosphate 
in sol-gel bioactive glass forms orthophosphate [85], which is loosely bound to the 
glass network and lost rapidly in dissolution, and also, the surface will adsorb 
phosphate ions from the body fluid [43].          
 
                                      
 
200 nm
 
Figure 2.7: SEM images of bioactive glass nanoparticles with 55 mol% SiO2,          
40 mol% CaO and 5 mol% P2O5  prepared by the combination of two steps of sol-gel 
and co-precipitation method using Polyethylene glycol (PEG) [4].  
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The morphology and size of bioactive glass nanoparticles can be tailored by altering 
the synthesis conditions. Couto et al [5] combined chitosan- β – glycerophosphate salt 
formulation with bioactive glass nanoparticles using sol-gel process to produce 
injectable thermo-responsive hydrogels for bone applications. However, the bioactive 
glass particles were irregular in shape and size (Fig. 2.8) and chemical analysis was 
not performed to confirm the proposed composition of the glass.  
                                      
Figure 2.8: SEM micrographs of bioactive glass nanoparticles with composition of  
55 mol% SiO2, 40 mol% P2O5 and 5 mol% CaO prepared by sol-gel process using 
chitosan- β – glycerophosphate salt [5]. 
 
By applying sol-gel process, Hong et al [86] were able to produce rice-shaped 
bioactive ceramic nanoparticles of a diameter of 70 nm and length of 200 nm with 
low silica and high phosphorous content. Chen et al [87] investigated the effect of 
lactic acid, a hydroxyl-carboxylic acid as hydrolysis promoter, on the morphology of 
sol-gel derived nanoscale bioactive glasses of composition 60 mol% SiO2, 36 mol% 
CaO, 4 mol% P2O5. Their findings suggested that lactic acid reduces the bioactive 
glass particle‟s size compared to that without lactic acid. However, the particles are 
completely agglomerated and cannot be referred to as nanoparticles but cluster of 
many nanoscaled particles (Fig. 2.9). 
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2.5.2 Microemulsion 
Another technique to make nanoparticles is through microemulsions, which are 
colloidal „nano-dispersions‟ of water in oil (or oil in water) stabilised by a surfactant 
[88]. It is a thermodynamically stable transparent isotropic dispersion of two 
immiscible liquids.  In water- in- oil microemulsions, the aqueous phase is dispersed 
as microdroplets (1-50 nm) surrounded by the monolayer of surfactant molecule 
where these nano-sized “micro-water pools” supply the favourable micro-
environment for the synthesis of nanoparticles [89]. By adjusting the addition of water 
into the microemulsion system the diameter of the droplets can be controlled. 
Microemulsion has been a popular technique for producing nanoparticles with 
minimum agglomeration. Zhao et al [89] used this technique to prepare ternary 
bioactive glass nanoparticles of CaO-P2O5-SiO2 with an average diameter of 25 nm. 
However, the cytotoxic studies on these ternary bioactive glass nanoparticles were not 
addressed to support their use in bone regeneration. 
 
 
Figure 2.9: TEM micrograph 
of bioactive glass nanoparticles 
produced via sol-gel process 
with the addition of lactic acid 
[87]. 
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2.5.3 Gas phase synthesis (flame spray) 
Nanopowders can be synthesised by using metal-organic precursors and applying high 
temperature (above 1000 °C) using a furnace or flame. The theory behind all gas 
phase synthesis method is the formation of molecular nuclei followed by 
condensation and fusion (coalescence) resulting in the growth of nanoparticles at high 
temperatures [90]. The mean time that the particle is at high temperature plays a 
crucial role in controlling the final particle size [90]. A high cooling rate enables the 
formation of nanoparticles. The method takes advantage of high purity of products 
due to ease of purification of reactants and the reduced contamination by contact with 
the container. However, particles produced using flame methods with gas-phase 
precursors are normally agglomerated and it is usually difficult to produce 
multicomponent materials with homogenous chemical compositions due to the 
differences in the chemical reaction rates and the vapour pressure of the reactant [90]. 
Flame spraying is one of the most common gas phase synthesis method. The flame 
assisted liquid droplet-to-particle conversion process, called flame spray pyrolysis, is 
proven to be a successful method for preparing multicomponent nanoparticles directly 
from precursor solution [91]. By using the flame spray method, the preparation of 
different compositions of bioactive glass nanoparticles has become possible. Brunner 
et al [92] applied this technique to produce amorphous bioactive glass nano-powders, 
of various compositions, in the ternary (SiO2-CaO-P2O5) and quaternary (SiO2-CaO-
P2O5-Na2O) regions, with a primary size of 20-80 nm that were highly agglomerated 
and hence cannot be considered as nanoparticles.  
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2.5.4 Electrospining 
The electrospinning method produces anisotropic structures such as continuous or 
short fibres (Fig. 2.10) in the range of micro or nano-meter. Electrospun fibers can be 
deposited as non-woven mats, or aligned into uniaxial arrays and further stacked into 
multi-layered architecture [6]. In electrospinning, an electric field is applied to a 
liquid droplet and the body of the liquid becomes charged, whereby the electrostatic 
repulsion offsets the surface tension and the droplet is stretched. Electrospinning 
allows the production of long, thin, solid fibers as the electrified jet (viscous solution) 
is continuously stretched by electrostatic force [6].   
Kim et al [93] applied electrospinning to produce nanoscale sol-gel derived bioactive 
glass fibres. Various factors influence the diameter of the electrospun fibers, 
especially the viscosity of the electrospun solution and the applied electric field. Kim 
et al findings suggested that sol concentration was the most dominant factor in 
controlling the diameter of the nanofibers produced in their study [93]. Lu et al [94] 
investigated the effect of voltage on electrospun sub-micron bioactive glass fibers of 
70S30C (70 mol% SiO2 30 mol% CaO) and found that decreasing the applied voltage 
can facilitate the formation of finer fibers.  
                                       
Figure 2.10: Schematic illustration of the electrospining technique redrawn from [6]. 
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2.6 Nanotechnology’s impact on health 
As materials shrink to the nanoscale their properties may differ significantly from 
those of bulk materials of the same composition, leading to unexpected and 
sometimes undesirable reactivity. This may result in harmful interactions with 
biological systems and the environment, with the potential to generate toxicity [95-
97]. It has been suggested that nanoscale materials affect the biological behaviours at 
cellular, subcellular and protein level [98]. Humans may become exposed to 
nanomaterials through inhalation, ingestion and dermal routes or the nanomaterials 
may be directly injected into the human body for medical applications. Some of these 
nanoscale materials can go throughout the body (intentionally or unintentionally), 
depositing in targeted organs, penetrating through the cell membrane, lodging in 
mitochondria and therefore trigger injurious biological response [97]. Nanoscale 
materials are desirable as their small size can alter the physiochemical properties of 
the material and create an opportunity for increased uptake and interaction with 
biological tissue [97]. However, this increased mobility must be examined for 
possible toxicity. The physicochemical properties (e.g. small dimensions similar to 
large biomolecules or clusters of molecules, large surface area and high reactivity) 
that make nano-sized materials functional can also make their interactions with 
biological systems difficult to predict using traditional risk assessment methodologies 
that have been developed for “bulk” materials. Particle size and surface area are 
amongst some of the main characteristics of materials that may cause toxic response. 
This is based on the fact that with decreased particle size, the surface area increases 
and this allows a greater proportion of its atoms or molecules to be displayed on the 
surface rather than the interior of the material [97]. Also, increased surface area 
determines the number of reactive groups on the surface of the particles [97].  
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The differences in toxicity between micro- and nanoscale materials has been reported 
for materials including TiO2 particles [99], polystyrene particles [100], HA [101] and 
SiO2 [102]. In all cases, the materials imposed biological effects that were quite 
different from those of micro-scale materials. Park et al [103] investigated the affect 
of size on the cytotoxicity of embryonic stem cells in vitro using dense spherical silica 
nanoparticles of 10, 20, 80 and 400 nm. They reported that different sizes of 80 and 
400 nm of silica nanoparticles, at 100 μgml-1, in embryonic stem cells did not affect 
the metabolic activity after 24 h or 10 days, but smaller particles of 10 and 30 nm 
caused significant toxicity after 24 h. Therefore, size was reported to highly affect 
cytotoxicity [103] since smaller sized nanoparticles can interact readily with 
biomolecules either on the surface or within the cells [104]. Nevertheless, the 
correlation between the numbers of silica nanoparticles uptaken, by embryonic stem 
cells, with size was not studied. This is important as the small number of 
nanoparticles will be greater in a given mass than larger particles, when 100 μgml-1 is 
the constant dose. In a different study by Huang et al [105], it was reported that 
exposure of mesoporous silica nanoparticles (110 nm) to hMSCs for 1 h at 
concentrations of 0-200 μgml-1 had no significant effect on cell viability [105]. The 
results from these two studies indicate that the size of particles is not the only factor 
determining cytotoxicity of nanomaterials.   
Some other issues such as agglomeration must also be considered since highly 
agglomerated particles may result in the formation of secondary particles and so in 
some cases they tend to perform as larger particles than NSM particles. The surface 
chemistry of the nanoparticles is one of the factors which are thought to have an 
impact on the agglomeration/aggregation state of the particles and thus may affect the 
extent of toxicity and uptake by the cells. Motskin et al [101] investigated the effect 
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of the surface charge of HA nanoparticles on the uptake and cytotoxicity of 
macrophages. As part of their study, two differently produced HA nanoparticles of gel 
(~ 50 nm) and colloid (~ 49 nm) with surface charges of -31.15 and -10.28 mV 
respectively were investigated. It was reported that both HA nanoparticles induced a 
significant toxicity, with the gel HA nanoparticles exhibiting the greatest toxicity at 
all concentrations in all assays. It was reported that the significant level of cyotoxicity 
in gel HA nanoparticles was highly correlated with the amount of uptake since the 
cells took twice the number of gel HA than colloidal HA. Motskin et al [101] 
suggested that cellular particle load was the main cause of cyotoxicity and that surface 
charge highly effects the interaction of particles with cells. 
Interestingly there have been concerns over the induced oxidative stress and 
proinflammatory responses by silica nanoparticles in vitro. In a recent study by Lin et 
al [106] it was reported that SiO2 nanoparticles (46 nm) showed oxidative stress-
induced cytotoxicity in various mammalian cell lines. Oxidative stress occurs due to 
an imbalance in the pro-oxidant/antioxidant homeostasis. Various reactive oxygen 
species including superoxide, hydrogen peroxide, hydroxyl and other oxygen radicals 
are involved in oxidative stress, which are capable of directly oxidising the DNA, 
proteins and lipids. There have been a number of reports on the involvement of 
oxidative stress in various diseases, cancer and aging (ref). However, further studies 
are required to investigate the mechanism by which oxidative stress occurs.  
 
2.7 Particle agglomeration versus dispersed  
NSM particles, in the form of powder or colloidal suspensions, are commonly being 
used as raw materials to produce many different functional materials such as medical 
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devices, cosmetics and bioactive composites. Particles in a solution are usually 
charged and the counter ions to the charge on the particle are attracted 
electrostatically towards the surface of the particle forming an electrostatic shell. A 
fraction of these ions are adsorbed onto the surface while the rest of the ions surround 
the particles. Particles that are small in size and mass are subjected to Brownian 
motion (random movement of the particles by the solvent molecules that surround 
them) and so are able to form a stable, homogeneous suspension, which leads to 
repulsion and spontaneous dispersion in the liquid [107].  
The particle interactions, due to Brownian motion, have profound effect on the 
behaviour of the suspension, especially with respect to stability, settling and flow 
[108, 109]. The resulting forces can either be attractive or repulsive depending on the 
nature of the system. The forces can vary as the distances between the particles 
change. The main repulsion force comes from electrostatic interactions while main 
attraction force is due to the van der Waals force [109]. Colloids are described as 
stable if they remain well dispersed while unstable colloidal particles will tend to 
form aggregates. To prepare a stable colloidal suspension it is essential to initiate 
interactions between particles that resist Van der Waals attraction [110]. If the 
attractive forces holding the aggregates together are greater than the force used in 
stirring, milling or ultrasonication, then the aggregates are regarded as being 
permanently aggregated. An irreversible aggregation from the dispersed state is 
referred to as coagulations. Meanwhile, flocculations are weaker and reversible 
aggregations seen with weakly attractive forces [110].  
Figure 2.11 is a schematic illustration of the kinds of interactions discussed above. 
The figure represents the potential energy of the interacting particles as a function of 
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the distance of separation between them. On figure 2.11, the potential energy 
associated with repulsion is defined to be positive while the attraction is negative.  
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Figure 2.11: Potential energy curves for the interaction of two colloidal particles. 
Positive values correspond to repulsion and negative values to attraction between 
particles. Re-drawn from [108]. 
 
It is noteworthy that both attraction and repulsion vary with distance of separation 
between the bodies involved such that both modes of attraction become weaker as 
separation distance becomes larger (Fig 2.11) [108, 109]. At sufficiently large 
distances the particles exert no influence on one another [108]. 
Due to attractive forces, mainly Van der Waals, particles will have the tendency to 
agglomerate in suspension, except if they are stabilised by a corresponding repulsive 
force such as surface charge or a steric effect. It is known that in the absence of a 
stabilising influence the species will aggregate. In order to control aggregation of the 
particles, various methods have been used such as high energy ultrasonic wave, 
milling and chemical surface modification. The break up (fracture) of particles occurs 
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during milling because of the impact and high shear fields. Contamination of the 
particles by milling is also likely to occur [111]. The application of shear forces can 
disrupt aggregates and increases both the number of collisions between the particles 
and the energy of those collisions [110]. As a result, particles can collide with 
sufficient force to overcome the colloidal repulsive forces and form aggregates. 
Therefore, shear fields and body forces can both disperse and aggregate systems 
depending upon the nature of those forces [110]. For these reasons ultrasonication is 
usually performed. 
In addition, there are two different ways of chemically modifying the particles to 
prevent aggregation: The first method is to functionalise the surface of the particles 
with organic groups after the particles are synthesised, using surfactants. The second 
method is in situ modification, which is achieved by introducing organic groups onto 
the particles during synthesis. In the first method, the particles are re-dispersed after 
synthesis and drying in which particles have a tendency to agglomerate. While in the 
second method, the particle growth is controlled by the organic ligand in the solution, 
which attaches to the particle surface in the same process resulting in non-
agglomerated and/or re-dispersible particles. [112] 
 
Stabilisation of colloidal dispersion by electrostatic or steric effect (Fig. 2.12) is 
required to avoid particles adhering to one other. There are two fundamental 
mechanisms by which dispersion stability can be achieved. In an electrostatically 
stabilised dispersion, agglomeration is prevented due to generation of charges on the 
surface of the particle. Steric stabilisation is achieved when large molecules are 
adsorbed on the surface hence producing a physical barrier between them [111]. This 
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involves adding a polymer to the system which adsorbs onto the particle surface and 
prevents particle attraction. Non-adsorbing polymer can osmotically drive particles to 
an aggregated state. Commonly the concentration of the polymer or surfactants 
required to achieve stability depends upon the ability of the particles to adsorb. 
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Figure 2.12: Schematic diagram of types of colloidal suspension: steric stabilisation 
(left) and electrostatic stabilisation (right). 
 
2.8 Cell culture 
Cell culture in the biomaterials field is the closest approach to predicting how cells 
may behave in vivo when they are exposed to a biomaterial. It is an easy environment 
to manipulate and monitor to study the cellular behaviour. The technique reduces the 
need for animal testing in the preliminary stages of biomaterial development. 
Nevertheless, there are advantages and disadvantages of in vitro studies; In vitro 
studies allow rapid, large scale testing using human cells. But, it is difficult and 
challenging to relate the results to a complex in vivo environment. 
There are two main types of cell culture; 
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i) Primary culture, which is obtained directly from animal or human tissues and 
cultured either as small pieces of tissues or after isolation of single cells by 
enzyme digestion (e.g. trypsin and collagenase). The main disadvantage of 
primary cultures is that they become senescent (lose their ability to 
multiply) and lose some phenotypic characteristics after a limited period of 
time. The main advantage of primary cultures is that they retain many of 
their original characteristics in their limited life span. 
ii) Continuous cell lines can be maintained in culture either for a limited number 
of cell divisions or indefinitely. Many of these cell lines are derived from 
cancerous tissues of patients. These continuous cell lines have the 
advantage of unlimited availability, but have the disadvantage of not 
preserving all of the original cellular characteristics. 
Once the cells attach themselves to the substrate they start to divide and multiply to 
form a layer (commonly known as confluent layer) covering the substrate. Most of the 
cells, especially the primary cells become contact inhibited and stop growing when 
they form a confluent layer, but tumour cells tend to form multiple layers. 
In order for cells to survive in vitro they require carbohydrates (mainly glucose) as an 
energy source, amino acids (usually glutamine) for both energy and as an amine donor 
in the synthesis of nucleic acid, vitamins for cell growth, multiplication and 
precursors for essential metabolic cofactors, fatty acids and proteins [113]. The basal 
medium contains the essential inorganic salts, amino acids, glucose, vitamins, fatty 
acids and some proteins. It also contains phenol red and bicarbonate based buffering 
system to facilitate inspection and control of medium use. The buffering system in 
combination with 5% CO2 atmosphere preserves the optimum medium pH (~7.0-7.5) 
required for cells in culture. The phenol red (pink at optimum pH) in the medium act 
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as a pH indicator and turns yellow when the medium becomes acidic and purple when 
the medium turns basic. The basal medium is normally supplemented with 10% fetal 
bovine serum (FBS), which is enriched with proteins and growth factors. A 
combination of different antibiotics and/or anti-fungal agents can also be added to the 
cell culture medium to stop contamination or bacterial growth. The cells are grown in 
a humid incubator at 37 ºC (optimum temperature) with 5% CO2 atmosphere. It is 
necessary to follow sterile procedures when handling cells in culture to avoid 
microbial contamination.  
 
2.9 Particle uptake by cells 
The potential benefit of NSM particles in biology and medicine is that they are small 
enough to target and enter cells. This particle-cell interaction is highly dependent on 
the particle‟s size, shape and surface chemistry which subsequently affect cellular 
internalisation and intracellular trafficking. The entry of any NSM particles into any 
cell type requires the particles to cross the plasma membrane, which consists of lipid 
bilayer with attached proteins, which prevents cells from dissolving in water and 
controls what substances migrate into and out of the cells (Fig. 2.13). There are 
different mechanisms by which a particle can enter the cells including diffusion, 
facilitated diffusion, active transport and endocytosis. 
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Figure 2.13: Schematic representation of cell membrane - lipid bilayer, by which 
particles may be transported to the cells. 
 
There is an overall intracellular negative charge due to unequal distribution of charged 
ions across the plasma-membrane that is driven by the activity of ion channels and 
pumps (e.g sodium/potassium pump). In fact, the transport of substances into and out 
of the cell is driven by this negative electrical (and chemical) membrane potential 
[114]. Uptake is mainly governed by either active or passive transportation of 
particles into the cells. Active transport of substances across the membrane, which is 
carried out by proteins, occurs against the concentration gradient using energy in the 
form of adenosine triphosphate (ATP).  However, the passive transport does not 
require any energy and it is achieved through diffusion or facilitated diffusion 
(through transmembrane transport proteins channels) where particles move down their 
concentration gradient without any input of energy. However, in facilitated diffusion, 
carrier proteins (which form the protein channels) are used to move the particles 
across the membrane. These carrier proteins only bind to specific molecules (e.g. 
sugar or amino acids) and facilitate their diffusion by changing shape and moving the 
molecules down their concentration gradient into the cell, where it is released. The 
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transport of particles into the cell via these protein channels, through facilitated 
diffusion, requires particles to be as small as 10-30 nm [114]. Therefore, a possible 
route of entry for larger particles would be through endocytosis which involves 
incorporating the particles into membrane-bound vesicles derived from invagination 
or pinching-off of the plasma membrane [115].  
 
2.9.1 Endocytic pathway 
Eukaryotic cells (animal cell) continually take up fluid and various sizes of molecules 
by the process of endocytosis. The particle to be ingested is progressively covered by 
a small portion of the plasma membrane, which first buds inward and pinches off to 
form intracellular endocytic vesicle and then matures into late endosomes (Fig. 2.14).  
                                  
 
Figure 2.14: Illustration of the pathway for cellular uptake and internalisation of a 
solid particle (red) via endocytosis. 
 
The ingested particle is then delivered to the lysosome, accompanied with a major 
drop in pH, where it is digested. Cells use endocytosis to defend themselves, feed 
themselves and to maintain homeostasis.   
73 
 
Endocytosis is a regulated energy dependent cellular uptake process which is 
characterised based on vesicle formation and intracellular fate of the internalised 
particles. The different pathways for endocytosis include: 
a) Phagocytosis  
b) Pinocytosis 
i) Macropinocytosis  
ii) Caveolae-dependent uptake 
iii) Clathrin-mediated endocytosis 
 
a) Phagocytosis 
Phagocytosis involves the ingestion of large particles via large vesicles called 
phagosomes (>250 nm), whereby the cells use actin cytoskeleton (via pseudopodia) to 
push a protrusion of the plasma membrane to surround these particles [116]. 
Phagocytosis proceeds through four steps: attachment (binding to the phagocytic cell 
surface), engulfment (by a phagosome), fusion with lysosomes (releasing digestive 
enzymes such as lysozyme), and degradation [115] (Fig. 2.15).  The phagocytosis 
process is restricted to specialised cells including macrophages. 
                                
Figure 2.15: Schematic diagram of steps in phagocytosis process. 
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b) Pinocytosis 
Pinocytosis involves taking up small particles, solutes and fluid from the environment 
and incorporating it into vesicles for digestion („cell-drinking‟) [116]. Pinocytosis 
occurs in all cells by different mechanisms of macropinocytosis, clathrin-mediated 
endocytosis and caveolae-mediated endocytosis [117].  
 
i) Macropinocytosis  
Macropinocytosis is a form of bulk uptake of fluid and solid particles into 
cytoplasmic vacuoles called macropinosomes. This process occurs through surface 
ruffling and is followed by sealing of the opening with the formation of discrete 
vacuoles, the macropinosomes, which are accumulated within the cell and are about 
0.5-5 µm in length [116]. Macopinocytosis is actin dependent similar to phagocytosis. 
The vesicle then travels into cytosol and fuses with other vesicles such as endosomes 
and lysosomes (2.16). Macropinocytosis represents a well-organized approach for 
non-selective cellular uptake of particles with size >1 µm. 
 
                          
 
Figure 2.16: Schematic diagram of macropinocytosis showing surface ruffling of the 
membrane followed by fusion of lysosomes (digestive enzymes) with the vacuole. 
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ii) Caveolae-dependent uptake 
Caveolae are small (~50 nm), flask-shaped invaginations of the plasma membrane 
enriched in cholesterol, diverse signalling molecules and membrane transporters. The 
shape and structural organization of caveolae are presented by caveolin (cholesterol 
binding protein), that self-associates to form a striated caveolin coat on the surface of 
the membrane invaginations [118]. The budding of caveolae from plasma membrane 
is driven by the GTPase activity of dynamin [119]. The caveolin coat is believed to 
stabilise the membrane and to classify the size and shape of caveolae [115].  
. 
iii) Clathrin-mediated Endocytosis  
Clathrin-dependent, receptor-mediated, endocytosis occurs at the specialised areas on 
the plasma membrane called coated pits, formed by a protein clathrin [115]. Clathrin 
molecules assemble into a basket-like network on the cytosolic surface of the 
membrane, and it is this assembly process that starts shaping the membrane into a 
vesicle. Clathrin itself is not involved in capturing specific molecules for transport. 
This is achieved by a second class of coat proteins called adaptins, which secure the 
clathrin coat to the vesicle membrane as well as helping in selecting cargo molecules 
for transport [116]. 
 
In order to gain a better understanding of cellular uptake mechanisms, inhibitors are 
often used including [120]: Amiloride-HCl which can block Na
+
/H
+
 channels and 
inhibit uptake the particles via macropinocytosis; Amantadine-HCl inhibitor and 
dynamine-GTPase inhibitor Dynasore are known to inhibit the clathrin-mediated 
endocytosis by preventing budding of clathrin-coated pits; and genistein usually 
blocks tyrosine kinases involved in caveolae-mediated uptake. Zhang et al 
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investigated the effect of these inhibitors on the uptake of 80 nm and 500 nm SiO2 
particles when exposed to human dermal fibroblasts for 1 h [120]. They demonstrated 
that the 80 nm SiO2 particles were mostly taken up through macropinocytosis and 
clathrin-mediated endocytosis. The caveolae-mediated uptake pathway was observed 
suggesting compliant property of the caveolae [120]. The internalisation of the        
500 nm SiO2 particles was mostly via macropinocytosis and the clathrin-mediated 
endocytosis pathway. The stronger blocking effect of amiloride-HCl to the 500 nm 
SiO2 particles (80 % and 60 % for 500 nm and 80 nm, respectively) shows that uptake 
of the particles of a larger size depends more strongly on the macropinocytosis 
pathway.  In a different study by Gratton et al, the effect of particle design (size and 
surface charge) on human cervical carcinoma epithelia (HeLa) cells was investigated 
[121]. For this study, the lithographic fabrication method of PRINT (Particle 
Replication In Non-wetting Templates) was applied to prepare cylindrical shaped 
micro and nanoparticles of various sizes (ranging from 150 nm – 3 µm) from cationic 
cross-linked poly(ethylene glycol) hydrogels. Initially, HeLa cells were treated with 
known biochemical inhibitors of energy-dependent processes to examine the effect of 
size on uptake. Based on their findings, it was reported that the upper size limit of any 
nanoparticle internalised into non-phagocytotic cells by means of nonspecific 
endocytosis can be up to 3 µm. In the same study by Gratton et al, the effect of 
surface charge on the uptake by HeLa cells was investigated by treating the particles 
with acetic anhydride to passivate surface amine group, thereby changing zeta 
potential (surface charge) from +34 to -33.7. It was reported that the „charge effect‟ 
on uptake by the cells was greatly noticeable. The positively charged particles were 
taken up to a much higher degree (84 % of cells) in comparison to the negatively 
charged particles, of the same size, that were not internalised to any significant 
77 
 
amount (<5 %) proposing the great effect of surface charge in the internalisation of 
PRINT particles. Nevertheless, in a different study on the effect of surface charge of 
HA nanoparticles (-9.59, -10.28 and -31.15 mV) it was reported that the particles 
were readily taken up by macrophages [101].  
Huang et al [122] investigated the effect of differently shaped particles of spherical 
(100 nm), short rod (240 nm) and long rod (450 nm) mesoporous silica nanoparticles 
on cellular uptake. It was reported that all three differently shaped particles were 
readily internalised in human melanoma (A375) cells. The particles were seen to 
encapsulate into vesicular or cytosolic compartments. The cellular internalisation 
studies revealed that the rod-shaped particles were taken up faster than sphere shaped 
particles. Huang et al [122] proposed that differently shaped mesoporous silica 
nanoparticles are first internalised by A375 cells by non-specific cellular uptake and 
merge with endosomes and subsequently escape from the endosomes and enter the 
cytoplasm. However, the route by which the nanoparticles escape from the endosome 
into the cytoplasm was not thoroughly and accurately studied. There are many 
different factors contributing to the uptake of any micro- or nano-sized particles by 
cells. These factors include: composition, size, shape, surface area and most 
importantly the cell type to which the particle is exposed. Some of these factors are 
the subject of investigation in this thesis. 
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2.10 Scope of the thesis  
The overall aim of the PhD was to produce bioactive glass particles and evaluate their 
in vitro effects on stem cells to get an insight with regards to their most appropriate 
use in medicine.  
Specific goals were as follows: 
1) To synthesis and characterise bioactive glass particles, in the nanoscale, using 
the sol-gel process.  
2) To assess the bioactivity of BG particles in simulated body fluid to examine 
their capability of forming hydroxyapatite mineral on their surface. 
3) To determine the effect of BG particles on human mesenchymal stem cell‟s 
viability and to investigate the uptake of SMBGs by hMSCs using 
microscopic techniques.  
4) To use sol-gel process in order to produce mono-dispersed BG particles to 
correlate the physiochemical properties (agglomerated and non-agglomerated 
state) of BG particles with any possible changes in cell behaviour as a result of 
uptake and internalisation by stem cells. 
5) Study the effects of BG particles on the differentiation of hMSCs and adipose 
stem cells in vitro. 
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3. Instrumentation 
This section aims to familiarise the reader with the instrumentation and techniques 
that have been used throughout this thesis.   
 
3.1 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) is a powerful technique that not only 
provides high spatial resolution information on colloidal systems (size, shape, 
dispersity and aggregation) at nanoscale, but it is often used to obtain information 
about the crystallinity and chemical composition of the material.  
 
3.1.1 Electron/specimen interaction 
Electrons can be used in microscopy both to generate an image of the sample with 
high spatial resolution and also to produce a wide range of secondary signals that can 
be exploited to gain information about the material being analysed. In the electron 
microscope, an ultrathin specimen is imaged, which is typically 100 nm thin. For such 
a thin sample most of the electrons travel through as the direct beam. Electrons 
interact with the atoms in the sample via columbic forces which cause the electrons to 
be scattered. This process results in energy transfer to the atomic nucleus, electrons 
and a change in their momentum vector. Electron-specimen interactions can be 
divided into elastic (which show no detectable change in energy) and inelastic (where 
the primary electrons loose a detectable amount of energy).  
 
The main forward scattering events are described in Figure 3.1. The signals generated 
as a result of these electron-specimen interactions can be used for imaging, acquiring 
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diffraction patterns and also for energy-dispersive X-ray spectroscopy (EDX) which 
can be used for chemical analysis of the sample.  
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Figure 3.1: Diagram of signals generated when a high energy electron beam interacts 
with a thin specimen. 
 
Elastic scattering occurs either when the electrons are deflected by the electric field of 
the atomic nucleus or when the incident electrons interact with the electrons of the 
atoms in the specimen [123]. Elastically scattered electrons are used to study the 
crystal structure of crystalline specimens. 
Electrons that lose energy on interaction with the sample are called inelastically 
scattered electrons. These energy losses can be used to gain characteristic information 
about the composition and electronic properties of the sample.  Many of the inelastic 
scattering events in the electron microscope result in the generation of X-rays that 
have energies characteristic of the elements present in the sample.  Inspection of these 
X-rays is known as energy dispersive X-ray spectroscopy (EDX) and is discussed 
later in this chapter. 
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The probability of an electron passing through the sample and undergoing a scattering 
event depends on factors such as the energy of the incoming electrons, the atomic 
number of the element in the sample, and the thickness of the sample. 
 
3.1.2 TEM setup and imaging 
Figure 3.2 is a schematic diagram of the lens configuration in the TEM used to 
produce an image. TEMs are operated in a vacuum in order to avoid scattering of the 
electrons by gas molecules. The electron source (gun) emits electrons (e
-
), which are 
accelerated by an electric field using voltages of typically between 100-300 kV. The 
work performed during this thesis was conducted on the JEOL FX2000 TEM.  This 
TEM uses a thermionic tungsten filament electron source where electrons are produced 
when the filament is heated to a high enough temperature to cause emission of the 
electrons by enabling them to overcome the work function of the source material. The 
electrons then become focused by a set of condenser lenses. In this microscope there 
are 2 controllable condenser lenses. The first condenser sets the demagnification of 
the gun cross over and so controls the beam current density. The second condenser 
lens is used to vary the convergence of the beam, giving either a focused beam or a 
well-spread, parallel illumination. In practice, the condenser lens 2 is varied by 
changing the “intensity” (or brightness) knob on the TEM control panel. The 
objective lens focuses electrons emerging from the sample into a diffraction pattern 
on the back focal plane. By adjusting the strength of the objective lens, the image 
formed on the viewing screen can be focused. An objective aperture can be inserted at 
the back focal plane to select the angular range of the electrons contributing to the 
final image. This is crucial for imaging cell-nanoparticle interactions to increase 
mass-thickness contrast. The intermediate lens can be adjusted to produce an image or 
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diffraction pattern.  The projection lens is used to magnify the image or diffraction 
pattern onto the viewing screen. The viewing screen of a TEM is typically a phosphor 
screen which converts the incident electrons into visible photons for imaging.  
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Figure 3.2: Schematic of a TEM operating in imaging mode. Figure modified from 
[7] 
 
3.1.3 Bright field TEM imaging and mass-thickness contrast 
Bright field imaging mode uses the direct electron beam to form an image. To 
improve image contrast, the objective aperture can be inserted to select the direct 
beam. This increased contrast is observed as the objective aperture selects the annular 
range of electrons collected. The contrast observed in the image can arise from mass-
thickness variations in the specimen which is the contrast mechanism that is 
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commonly used for imaging biological specimens. As electrons pass through the 
sample they are scattered off-axis by elastic scattering events. The cross-section of 
scattering depends on the atomic number, Z, and on the density and thickness of the 
sample. Therefore, if an objective aperture is inserted, areas of the sample that have 
higher mass-thickness (ρt) will produce areas of lower intensity in the resulting TEM 
image than areas of lower mass-thickness. 
 
3.1.4 Energy dispersive x-ray spectroscopy 
Energy dispersive X-ray spectroscopy (EDX) provides qualitative and quantitative 
elemental analysis using X-rays which have characteristic energies from each 
element, thus providing information about the chemical composition of a material. 
[123] 
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Figure 3.3: Generation of X-ray as a result of electron-specimen interaction. 
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The principle underlying the operation of EDX is the detection of X-rays which are 
produced when the electron beam is accelerated onto the sample.  The electron beam 
excites the atoms in the sample that subsequently produce X-rays with discrete 
energies which are different for every element. This occurs when a high energy beam 
interacts with the inner shell electron, and depending on the amount of this energy, the 
electron can be ejected from the shell, leaving a hole (Fig. 3.3). In such conditions the 
atom is left in an excited state, leaving the atom ionised. The ionised atom can return 
to its lowest energy level by filling the missing electron from the outer-shell. This 
electron transition is accompanied by the production of an X-ray with energy equal to 
the difference between the electron shells involved in the transition (Fig. 3.3). The 
number and energy of the X-rays emitted from the specimen are then measured by a 
detector recording an energy spectrum of intensity as a function of energy.  The 
characteristic peaks of the energy spectrum provide information about the 
composition of the sample being studied since they are related to the characteristic 
energies of electron transitions. 
 
3.1.5 Limitation of TEM 
Overall, TEM is a powerful technique with high spatial resolution. In this thesis TEM 
has been applied for imaging and chemical analysis, however, there were some 
limitation to the technique primarily by specimen preparation concerns. Sample 
preparation for cell studies is challenging and time consuming. During sectioning of 
the specimen not only the knife can be damaged but also sections can result in being 
either too thick or too thin for analysis. Samples, especially those with cells, can 
easily be damaged under beam if not coated properly and if not stable under electron 
beam.  
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3.2 Confocal Microscopy 
Confocal microscopy is a laser scanning microscopic technique which is commonly 
used for 3D visualisation of cell structure, morphology, organelles and cytoskeletal 
organisation. It is a powerful tool for visualising fluorescent specimens. There are two 
types of imaging mode in confocal microscopy; fluorescence and reflection imaging. 
Reflection imaging uses reflected light where the wavelength of emitted light has the 
same wavelength as reflected light. Fluorescence is the property of some atoms and 
molecules to absorb light at a particular wavelength and to subsequently emit light of 
longer wavelength and a different colour. 
 
In a confocal microscope a laser is used to provide the excitation light (to obtain very 
high intensities). The laser light reflects off a dichroic mirror, which directs it to an 
assembly of vertically and horizontally scanning mirrors. The dichroic mirror reflects 
light shorter than a certain wavelength, and passes light longer than that wavelength. 
From there, the laser hits two mirrors which scan the laser across the sample. If the 
sample is stained with flourchrome probes, dye in the sample fluoresces, and the 
emitted light (green) gets de-scanned by the same mirrors that are used to scan the 
excitation light (blue) from the laser. The emitted light passes through the dichroic 
mirror and is focused onto the pinhole. The light that passes through the pinhole is 
measured by a detector, ie, a photomultiplier. [124]  
 
The pinhole is critical as this removes out of focus light and selects out certain 
wavelengths and reduces background haze from other colours. The principle of 
confocal microscopy is that the out of focus light is removed from the image by the 
use of a suitable positioned “pinhole”. This improves the resolution of the image and 
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also allows for the use of fluorescent probes to select out certain emission 
wavelengths. 
 
Images from the confocal microscope can be reconstructed into 3D. For this a z-
series, a sequence of optical sections, are collected at different levels perpendicular to 
the optical axis (the z-axis) within a specimen. Z-series are collected by coordinating 
step-by-step changes in the fine focus of the microscope with sequential image 
acquisition at each step. The steps in focus are usually accomplished by a computer-
controlled stepping motor that changes focus by predetermined increments. [124]  
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  Figure 3.4: The set up in the confocal microscope. 
Overall, confocal microscopy allows increased effective resolution with improved 
signal–to-noise ratio. It produces images with reduced blurring from light scattering.  
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3.3 Dynamic light scattering (DLS) 
DLS relies on the fact that particles in a suspension are moving by diffusion. The 
technique allows size measurements, typically in sub-micron region, based on the 
scattering of light. In dynamic light scattering (DLS), a monochromatic beam of laser 
light is imposed on a sample, and the light scattered by particles in the illuminated 
volume is analyzed by a detector placed at an angle θwith respect to the transmitted 
beam. Larger particles scatter predominantly at smaller angles whereas smaller 
particles scatter light at larger angle. The light collected by the detector fluctuates with 
time since the particles in the illuminated volume are in Brownian motion. DLS 
measures Brownian motion and relates this to the size of the particles. Brownian 
motion is the random movement of the particles due to the bombardment of the 
particles by the solvent molecules that surround them. The measurements obtained 
from DLS are usually from particles suspended in liquid and so the larger the particle 
the slower the Brownian motion. For accurate DLS size interpretation, a stable 
temperature is required since any changes in temperature will affect Brownian 
motion. 
DLS measures the radius in suspension of both primary and secondary particles. The 
technique is easily automated and the measurements are reproducible. However, high 
dilution is required to avoid multiple scattering. The results obtained by DLS can 
easily be influenced by clusters or agglomeration of particles, hence, sonication is 
often performed prior to measurement to achieve maximum dispersity. 
 
3.4 Zeta potential 
Zeta potential is a physical property exhibited by particles in suspension. Charged 
particles in a suspension form a double layer because of an uneven distribution of 
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cations and anions in the surrounding area of the charged particles. This electric 
double layer is divided into the Stern layer, where the negative surface charge attracts 
positive ions on the surface and become tightly bound to the surface, and a diffuse 
layer, where ions are less associated and diffuse more freely around the particles 
[125]. Within the diffuse layer is a boundary near the particles where the ions and the 
particles form a stable entity and therefore move together [125]. Hence, zeta potential 
is the shear plane between particles and solvent under flow which can be used to 
measure stability of the particles [110]. The zeta potential not only depends upon the 
particle surface but also the dispersant. It can be affected by small changes in pH or 
ionic strength of the medium. The particles in a suspension interact according to the 
magnitude of the zeta potential and not their surface charge, thus it can be used to 
predict dispersion stability. If all the particles within a suspension have a large 
positive or negative zeta-potential, this indicates that they are repelling each other and 
hence there is no tendency for the particles to attract. There is usually a limit between 
stable and unstable aqueous suspensions which is generally taken at either +30 mV or 
-30 mV. Potential stability of the colloidal system >±30 mV negative or positive 
values are more stable.  
 
Zeta potential measurements are made in a zeta-sizer nano-instrument for which they 
use laser Doppler electrophoresis. For measurements, voltage is applied across a 
capillary cell and the speed of particle moving relative to the liquid they are 
suspended in under the influence of applied electric field is measured, process known 
as electrophoresis. Hence, the electrophoretic mobility of the particles in a suspension 
is measured [125]. If an electric field is applied via electrodes immersed in the sample 
suspension, this will cause the charged particles to move towards the electrode of 
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opposite charge. This velocity, by which the particles move, is dependent upon the 
electric field strength or voltage gradient, the dielectric constant of medium, viscosity 
of the medium and the zeta potential [125]. All the parameters are known except from 
zeta potential, which can be determined by converting the electrophoretic mobility of 
the particles to zeta-potential by the software. This is a general way of evaluating the 
stability of dispersions by determining the magnitude of zeta-potential [111]. The zeta 
potential is the overall charge a particle acquires in a specific medium.  
However, there are some problems associated with zeta potential measurements. If the 
sample being tested is soluble within the chosen medium this may cause 
misinterpretation of the results. This is due the fact that the release of ions from the 
sample can change the ionic concentration of the medium and also the surface charge 
hence influencing measurements.  
 
3.5 Nitrogen Adsorption 
Gas adsorption is one the most frequently used techniques to evaluate total surface 
area, both internal and external, and pore size distribution. Nitrogen is the most 
commonly used adsorptive gas as it is readily available in high purity form, has a well 
accepted cross sectional area and provides strong gas-solid interactions [126]. The 
technique is non-destructive and it can be used to calculate the total specific surface 
area and hence the average size of dense nanoparticles. The Barrett Joyner Halenda 
(BJH) model, which is based on the evaporation of a condensed meniscus from 
cylindrical mesopores (pores in the range 2 – 50 nm), can be used to obtain pore size 
distributions of materials, however, there is no differentiation between inter and intra-
particle porosity. The technique is only practical if the pores are in microporous 
(<2nm) and mesoporous range [127]. The isotherm curves (Fig. 3.5) are generated by 
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measuring the volume of nitrogen adsorbed and desorbed at different relative 
pressures. Six types of adsorption isotherm are shown in Figure 3.5 and each type of 
isotherms was allocated to specific adsorbents with specific porosity, pore size, shape 
and interconnectivity [8].  
 
                              
Figure 3.5: Different types of adsorption isotherms. Isotherms I, II, II and VI have 
overlapping absorption and desorption curves, refering to samples which do not have 
mesoporosity. Isotherms IV and V do not overlap, creating hysteresis loop, suggesting 
that the samples are mesoporous. [8] 
 
3.6 X-ray diffraction 
XRD can be used to identify crystalline phase within a structure. The crystal structure 
can be determined by analysing the position and intensities of diffraction peaks. In 
XRD, an electromagnetic wave of wavelength λ, is targeted at the sample, which 
rotates at an angle θhkl at constant velocity. The diffraction pattern is produced 
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according to Bragg‟s Law which gives the angles for coherent and incoherent 
scattering from a crystal lattice: 
nλ=2dhklsinθhkl 
where dhkl  is the interplanar spacing. 
 
 The technique is very reliable, but it is mainly useful for crystalline materials and it is 
difficult to identify amorphous fraction in the sample. Some of the advantages of the 
methods include: measurements in air or necessary atmosphere are allowed, the 
preparation of the sample is relatively easy and the average crystal structure of the 
material can be quantitatively evaluated [112]. With regards to the sol-gel derived 
bioactive glasses, XRD is applied to check and ensure that the glasses are amorphous, 
with no striking peaks in XRD spectrum. This is important for bioactivity studies of 
bioactive glasses in general. 
 
3.7 Fourier transform infrared (FTIR) 
This is a surface analysis technique which is versatile, rapid, non-destructive, and 
cost-effective and does not require any specific sample preparation. It is used to 
identify specific chemical groups in the sample. Infrared (IR) radiation is used to 
excite vibration modes in molecules adsorbed on a surface.  
 As a quanta of IR light interacts with a covalent bond, it may absorb the energy 
causing it to vibrate faster. IR absorption only occurs when the radiation has sufficient 
energy for the transition to the next allowed vibrational energy state. The functional 
groups, structural units, in a material absorb IR radiation at a characteristic peak, 
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which is related to the wave number. FTIR produces a plot of IR radiation intensity, 
in absorbance or transmittance, against wave number. FTIR is a valuable technique 
for examining bioactivity of the glasses as silicate and phosphate bonds have 
characteristic IR absorption bands. However, for the studies carried out in this thesis, 
FITR was only applied to detect any organic peaks within the sample and could not 
have been used for examining bioactivity of nanosized particles due to difficulty in 
filtering and drying of the sample that is required for analysis.  
 
3.8 Inductive coupled plasma spectrometry (ICP) 
ICP provides elemental analysis of solutions. It measures elemental concentration in 
the parts per million [ppm] to parts per billion [ppb] range and is highly sensitive. The 
key components of the ICP spectrometry are: (i) the sample introduction system 
(nebuliser), (ii) spray chamber, (iii) the ICP torch, (iv) the high frequency generator, 
(v) the transfer optics and spectrometer, (vi) the high interface and the computer 
[128]. A solution of an element whose concentration is to be determined is pumped 
into a nebuliser where it is mixed with Argon gas to form an aerosol. Larger droplets 
are removed from the sample aerosol as it passes through the spray chamber before it 
enters the ICP torch. ICP enables elements to emit characteristic wavelength specific 
light which can then be meausured. The light emitted by the atoms or ions in the ICP 
is converted to an electrical signal by photomultiplier in the spectrometer. The 
intensity of this electrical signal is compared to a previous measured intensity of a 
known concentration of the element, and a concentration is computed [128]. The ICP 
method is destructive, and it requires the analyser to be in solution. This requirement 
for sample dissolution in itself may set a practical limit to the number of elements 
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which can be simultaneously measured. Also, another problem associated with ICP is 
that the emission spectra are complex and inter-element interferences are likely to 
occur if the wavelength of the element if interest is very close to that of another 
element [129].  
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4. Synthesis and characterisation of sub-micron bioactive glass 
particles
 1
 
 
4.1 Introduction 
Current commercially available BG particles include Perioglas
®
 and NovaBone
®
 
(NovaBone Products LLC, Alachua, Florida) which are used in a wide range of dental 
and orthopaedic applications. They have the composition known as 45S5 Bioglass
®
 
(46.1 mol% SiO2, 26.9 mol% CaO, 24.4 mol% Na2O and 2.5 mol% P2O5). The 
particles are in the micrometer size-range (90-710μm) and are irregular in size and 
shape. Particles of < 5 µm are used as Novamin
®
, which is used in new toothpastes.
 
Sub-micron bioactive glass particles (SMBG) are an attractive alternative to bioactive 
glass microparticles for hard tissue regeneration as their small size and higher specific 
surface area makes them ideal for injection into the bone defects or incorporation 
within a polymeric matrix to synthesise porous composite scaffolds. 
Sol-gel derived bioactive glasses tend to have high surface area which significantly 
enhances their solubility [130]. Recently, Hong et al [131] used the sol-gel process to 
produce SiO2-CaO-P2O5 ternary glass-ceramic nanoparticles with diameter of 20 nm. 
The small size of the particles can trigger crystallisation of these nanoparticles during 
thermal stabilisation because the driving force for nucleation of crystals increases 
with specific surface area. Also, in their study [131],  chemical composition analysis 
was absent to confirm the exact composition of these small SiO2-CaO-P2O5 ternary 
glass-ceramic nanoparticles. In addition, it is possible that the small size of the 
                                                          
1
 Another form of this chapter has been published in Biomaterials. [174] Labbaf S, Tsigkou O, Muller 
K.H, Stevens M.M, Porter A.E, Jones J.R. Spherical bioactive glass particles and their interaction with 
human mesenchymal stem cells in vitro. 32(4): p. 1010-1018. 
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particles may be responsible for toxic response when in contact with cells, however, 
cell studies were not present to confirm the safety of these particles for bone 
applications [131]. Sol-gel glasses can be bioactive at high silica contents not only 
because they have high specific surface area but also because they contain a broad 
distribution of network connectivity2. This is due to hydrogen acting as an additional 
network modifier, disrupting the silica network and creating a high concentration of 
Si-OH groups [81]. This increases the rate of dissolution and provides sites for apatite 
nucleation.  
In previous reports, particles of the 100S (100 mol% SiO2) composition have been 
produced by the Stöber process [132]. This process was modified by Zhao et al [133] 
to produce particles of silica spheres from silica/hyperbranched polyester 
nanocomposites via the sol-gel method by using Boltorn
TM
 (H20) polymer as a 
templating agent (Fig. 4.1). This hyperbranched polyester has a 3D architecture and 
16 hydroxy end-groups per molecule and an average molecular weight of 1735 g mol
-
1
 [128]. The use of Boltorn
TM
 polymer into the synthesis route enhances the 
dispersability and the formation of spherical particles.  
                                  
Figure 4.1: Chemical structure of Boltorn 
TM
 (H20) polymer [9]. 
                                                          
2
 Network connectivity is defined as the average number of bridging oxygen bonds per silicon atom. 
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An aim of this work was to synthesise binary SMBGs, using the method developed by 
Zhao et al [133] using Boltorn 
TM
 (H20) polymer as the templating agent and to 
investigate the effect of this polymer on the size and dispersability of SMBGs. 
 
4.2 Materials and methods 
4.2.1 Processing of bioactive glass sub-micron particles 
The methodology used by Zhao et al [133] for the synthesis of 100S (100 mol% SiO2) 
was modified to obtain 70S30C (85 mol% SiO2 and 15 mol% CaO) particles, using 
the sol-gel process. But the synthesis route resulted in the formation of 85S15C (85 
mol% SiO2 and 15 mol% CaO) sub-micron bioactive glass particles (SMBGs). This 
process involves the hydrolysis of tetraethyl orthosilicate (TEOS, Si(OCH2CH3)4), 
and condensation of resulting species. The effect of Boltorn
TM
 polymer (H20 
hyperbranched polyester, Pertorp AB, UK, which will be referred to as B-polymer) 
content on particle size and dispersability was then investigated by using molar ratio 
of templating polymer to TEOS of 1 : 1, 1 : 5.7, 1 : 2.8 and 1 : 2.2. According to 
previous protocol by Zhao et al [133], B-polymer was mixed with 50 ml of 1,4-
dioxane which was stirred at a temperature of 90 °C. Then 2.6 ml of H2O and 9.7 ml 
of NH3.H2O were added to the mixture, followed by the addition of 2.8 ml of TEOS 
dropwise at 50 °C. The mixture was gently stirred for 1 h for complete hydrolysis to 
occur; after which 1.26 g of Ca(NO3)2.4H2O was added. The mixture was stirred for a 
further 24 h. The experimental setup is illustrated in Fig. 4.2. A reference sample with 
no B-polymer (PO) templating agent was also synthesised. The resulting colloidal 
suspension of the mixture was then centrifuged to obtain a white solid suspension. 
The deposited solid was vacuum dried to remove excess water from the solid 
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particles, producing a white powder. To remove the organic phase and the nitrate 
from the network, the resulting powders were calcined in air. A molar ratio of 
templating polymer to TEOS of 1 : 2.8 was the only concentration that formed 
dispersed spherical SMBGs. The effect of calcination temperature on the structure of 
SMBGs was investigated by calcinating at 680, 700 and 800 °C (heating rate of 3 °C, 
hold for 3 h followed by a cooling rate of 5 °C). 
 
H2O in 
H2O out 
Condenser
Hot plate
Magnetic bar
Stopper
Temperature 
Control 
Oil bath held 
at 50  C
3 neck-round 
bottom flask
 
Figure 4.2: Experimental setup for SMBG particle synthesis. 
 
4.2.2 Acid digestion compositional analysis 
Acid digestion method was applied to measure the composition of SMBGs. 0.1 g of 
finely ground SMBG was mixed carefully with 0.5 g of anhydrous lithium metaborate 
in a clean dry platinum crucible using a glass rod. The mixture was fused for 1 h at 
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1400 °C and then left to cool. The crucible was then immersed in 80 ml of 10 vol% 
nitric acid to completely dissolve the flux and then transfered to a 100 ml 
polypropylene volumetric flask and made up to the mark. A series of dissolution 
studies were carried out to measure the concentration of ionic species using 
inductively coupled plasma optical emission spectroscopy (ICP-OES, Thermo 
Scientific Icap 6000series).  
 
4.2.3 Particle characterisation 
X-ray Diffraction (XRD) spectra were collected on a Philips PW1700 series 
automated powder diffractometer using Cu K radiation at 40KV / 40mA. Data was 
collected between 5-80° 2θ with a step of 0.04° 2θ and a dwell time of 1.5 seconds to 
identify whether the particles had crystallised.  
 
In order to confirm the removal of the organic component from the SMBGs, fourier 
transform infrared (FTIR) spectra were collected on the PerkinElmer Spectrum
TM
 100 
FT-IR spectrometer, in the range of 600-2200 cm
-1
. 
 
Nitrogen sorption (Autosorb AS6, QuantaChrome) was performed to measure the 
porosity of the SMBG by applying the BJH method [127] to the N2 desorption 
branches of the isotherms. BET analysis was used to determine the specific surface 
area of the SMBG [134]. The samples were prepared by degassing at room 
temperature overnight.  
 
Dynamic light scattering (DLS, Malvern instrument 2000) was applied to investigate 
the size distribution of SMBGs in 100% EtOH following 30 min ultrasonication to 
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investigate their ability to disperse in solution and also to gain a better understanding 
of the nature of the bonding between the particles.  
 
The zeta-sizer [Malvern instrument 2000] technique was also used to determine the 
zeta-potential value of the SMBG particles in order to investigate aggregation state 
and any changes in stability over the pH range of 2-11. 
 
For transmission electron microscopy (TEM) analysis, SMBGs were dispersed in 
100% EtOH and collected on 300 mesh copper TEM grids coated with lacey carbon 
film. In order to quantify the particle size, the diameter of individual particles (n=149) 
was measured from TEM micrographs using Image J software. TEM imaging and 
energy-dispersive X-ray (EDX) chemical analysis were performed on the JEOL-
2000FX TEM, with an operating voltage of 200kV and a 10 µm objective aperture to 
increase mass-thickness contrast. Multiple areas from 2 grids were analysed in the 
TEM. 
 
4.3 Results 
4.3.1 Characterisation of SMBGs  
The initial aim of this study was to produce bioactive glass particles with 70 mol% 
SiO2 and 30 mol% CaO but with the current synthesis route this was not possible. The 
compositional analysis (ICP-OES) found the SMBG composition to be 85 mol% SiO2 
and 15 mol% CaO (86.02 mol% SiO2 and 13.98 mol% CaO, ±0.34). In order to 
increase the CaO mol% in the final composition the amount of Ca(NO3)2.4H2O was 
increased during the processing. However, this increase in calcium resulted in lower 
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CaO mol% in the final composition (~ 10 mol% CaO).  Hence, by altering the 
synthesis route it was not possible to produce SMBG with higher CaO than 15 mol%. 
The XRD spectra in Fig. 4.3 show that the SMBGs were fully amorphous when 
sintered at 680 and 700 °C, but when sintered at 800 °C a peak at a 2θ value of 30º 
was observed that corresponded to the wollastonite (β-CaSiO3) phase [135]. Hence, 
an ideal sintering temperature for the SMBGs is in the range 680<T<800 °C in order 
to retain the particles in the amorphous state. For this study, a sintering temperature of 
680 °C was chosen for further investigation. 
      
W
 
Figure 4.3: XRD spectra of SMBGs which had been calcinated at 680, 700 and     
800 °C. W indicates a peak corresponding to the presence of a crystalline wollastonite 
phase 
3
. 
 
The B-polymer was mixed with the TEOS during the sol-gel process so that it could 
act as a template to prevent agglomeration and further condensation of the SMBGs. 
                                                          
3
 XRD analysis were performed by Mr Richard Sweeny, Imperial College London. 
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This created a composite (SMBG-H20) which was calcined to remove the polymer 
and reduce the silanol groups from the glass surface and nitrate by-products from the 
glass network. Fig. 4.4 shows FTIR spectra before and after calcination at 680 ºC. The 
vibrational band at around 1650 cm
-1 
in the uncalcined
 
material corresponds to an 
ester group [133] and represents the organic phase. The absorption band at 1020 cm
-1
 
corresponds to the mode of the Si-O-Si asymmetric bond stretching vibration 
representing the silica network of the SMBGs. The band at 970 cm
-1
 for the non-
bridging oxygen vibration was present before calcination (SMBG-H20) but not after, 
suggesting the formation of more bridging Si-O-Si bonds, representing an increase in 
network connectivity, at the expense of Si-OH bonds during calcination. 
SMBG-H20
SMBG
 
Figure 4.4: FTIR spectra of SMBGs before (SMBG-H20) and after (SMBG) 
calcination at 680°C. 
Nitrogen adsorption/desorption isotherms for SMBGs (Fig. 4.5) were type II 
isotherms which indicated that the material has high affinity for nitrogen and could 
either be non-porous or have a microporous (pores < 2 nm) structure [8]. The mean 
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BET surface area was 28 m
2
g
-1
. It is possible that the surface area results were also 
influenced by agglomeration between some of the particles which makes a large part 
of the surface of the particles inaccessible to N2 molecules. 
 
               
Figure 4.5: Nitrogen adsorption/desorption isotherm for SMBGs (sintered at 680°C). 
The curve represents a type II isotherm suggesting that the material has high affinity 
for nitrogen making the structure either non-porous or microporous (pores < 2nm).  
 
The effect of the amount of polymer on the size and morphology of the SMBGs, after 
the removal of polymer, were studied using TEM (Fig. 4.6), which shows particles 
that were formed using different polymer : TEOS ratios. In the absence of polymer 
(Fig. 4.6a) many chain-like clusters formed that were not classified as SMBG. Also, 
the incorporation of calcium into the silicate networks did not yield spherical, dense 
and discrete particles (Fig. 4.6). 
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Figure 4.6: TEM micrographs of the effect of B-polymer content on particle 
formation using molar ratio of templating polymer : TEOS of, a) no polymer; b) 1 : 1; 
c) 1 : 5.7, and d) 1 : 2.2. 
 
A bright-field TEM image of an optimised SMBG samples synthesised using a molar 
ratio of templating polymer to TEOS of 1 : 2.8 polymer is presented in Fig. 4.7a, 
where particles were spherical. The average particle diameter measured using TEM 
was 250 nm (±75nm, n=149). EDX spectra (Fig. 4.7b) confirmed that Si and Ca were 
present in the SMBGs.  
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Figure 4.7: a) TEM micrograph of the optimised SMBGs (polymer : TEOS ratio of 1 
: 2.8 and sintered at 680 °C). b) EDX analysis taken from a SMBG showing Si, O and 
Ca peaks. 
 
4.3.2 Dispersion of 85S15C SMBGs 
One strategy is to incorporate 85S15C SMBG particles into polymer matrix to 
produce a nanocomposite, for which we require the particles to be fully dispersed. 
Also, it is ideal to have particles in dispersed state in order to better examine how they 
would interact with the cell in vitro. Particles tend to agglomerate in suspension due 
to the dominant intermolecular Van der Waals forces between the particles. These 
attractive forces will increase the affinity of the particles to agglomerate in 
suspension, unless stabilised by an equal repulsive forces such as surface charge or 
steric effects.  
An evaluation of the optimal sonication time for the dispersion of SMBGs was 
conducted using DLS. The results of this analysis are shown in Fig 4.8. The DLS 
results illustrate that the modal diameter of the particles reduced from ~300 nm to 170 
nm, from 10 min to 30 min of sonication, respectively, indicating an improved 
105 
 
dispersion. The results obtained using DLS were in good agreement with the TEM 
image in Fig 4.7a, which confirmed that the particles were more dispersed after 30 
min sonication. 
                       
Figure 4.8: The effect of sonication time on the size distribution of the SMBG 
measure by dynamic light scattering (DLS). 
 
In Fig 4.9 results on the changes in ζ-potential and particle size of SMBGs with pH 
are presented. Fig. 4.9a shows that at pH 3 the agglomerates are not stable due to 
lower surface charge, which is insufficient to separate the particles since the ζ-
potential values are greater than -30 mV (less negative). Overall, the ζ- potential 
decreases with increasing pH (Fig. 4.9a). There is a significant drop in ζ- potential 
value (Fig. 4.9a), from -45 mV to -120 mV at pH 9, which may suggest that the 
particles are not stable, but are dynamic due to charge exchange and the formation of 
charge cloud around the particles that may be taking place during dissolution resulting 
in bolus loss of Ca
+2 
ions from the bioactive glass at higher pH. At a threshold pH the 
Ca
+2 
ions may cancel out the negative charge on the silica and so increase the ζ- 
potential. These findings are in close agreement with the zeta-sizer values in Fig. 
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4.9b, showing a decrease in size of the particle with increasing pH i.e. particles 
become less agglomerated. 
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Figure 4.9: Zeta-sizer measurements taken from SMBGs showing a) the variation in 
ζ-potential value and b) the variation in particle size, with pH. (n=3, where n is the 
number of repeats of each measurement). Error bars represent the mean ± SD.  
a) 
b) 
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4.4 Discussion 
85S15C SMBGs with a mean particle size of 250 nm (±75 nm) were successfully 
synthesised using the sol-gel process. The sol-gel process is a versatile process 
whereby the growth mechanism, size and number of the nanoparticles in a solution 
are mainly influenced by the rate of hydrolysis and condensation reactions [83]. By 
controlling these two reactions during processing, the structure of final material can 
be manipulated. For the synthesis of SMBGs, an ammonia catalyst was used to favour 
the formation of spherical particles and to gain control of morphology and size by 
controlling the rate of the condensation reaction. During the initial mixing stage of 
sol-gel process, many of the functional OH groups at the surface of the polymer bond 
to the surface of the hydrolysed silica particles. The remaining Si-OH groups undergo 
further condensation and result in the formation of more –Si-O-Si- bonds. The 
mechanism for incorporation of calcium into the glass network as network modifier, 
when using calcium nitrate precursor, has only recently been understood [81]. The 
calcium nitrate remains in the pore liquor, as a by-product of the condensation 
reaction and excess water from the hydrolysis, until drying is carried out. The calcium 
nitrate deposits onto the silica particle surfaces during drying and the calcium only 
enters the glass network, by diffusion, when a temperature of 450 °C is reached 
during calcination [10]. Using this method, it was not possible to synthesise spherical 
SMBGs with higher calcium content than 15 mol%. This probably arises as the 
calcium must diffuse into the particles from their surface. The coating of the particles 
with B-polymer prior to the addition of calcium nitrate may limit the deposition of 
calcium onto the particles during drying and therefore limit the diffusion of calcium 
into the particles. Regardless of increasing the calcium content (three times higher) 
the final composition of CaO was in fact reduced to 10 mol%. For these reasons, it is 
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challenging to incorporate Ca into the network and the current processing route limits 
CaO content to 15 mol%.  
Based on the XRD results, a sintering temperature of 680 °C was chosen for further 
investigation for several different reasons: i). A temperature greater than 450 °C is 
needed for calcium to be incorporated into the silica network [136]; ii). Above 500 °C 
the organic phase is removed; iii). A temperature above 600 °C is needed to remove 
residual nitrate and silanol groups, and iv). Above 800 °C the glass begins to 
crystallise. Therefore, a temperature of 680 °C was chosen as it is believed that the 
maximum bioactivity would be achieved at a minimum stabilisation temperature  
[137, 138], where the dissolution rate would be the most rapid corresponding to the 
lowest network connectivity and highest Si-OH group content. 
The surface area of sol-gel derived sub-micron SMBG (28 m
2
g
-1
) is much higher than 
that of commercially available melt-derived microparticles (2.7 m
2
g
-1
) [139] which is 
clearly due to the small size of SMBGs. The reason for the non-porous nature of these 
sol-gel derived SMBG obtained in this study, compared to conventional sol-gel 
particles, which have a surface area greater than 100 m
2
g
-1
 [139], is that conventional 
sol-gel particles are made using acid catalysed hydrolysis. During the acid-catalysed 
sol-gel process the nanoparticles in the sol assemble during the condensation reaction 
and form a structure composed of many sub-units (nanoparticles) that subsequently 
fuse together [81]. As a result, they tend to leave interstitial spaces between the 
nanoparticles which become nanopores. For the production of SMBG the 
condensation reaction is controlled by using base catalysts that prevents the 
nanoparticles from fusing together, leaving individual, dense particles [83]. 
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The size, shape and dispersability of particles have been found to greatly influence 
their interaction with cells [101-103, 121, 140]. Generally NSM particles have the 
tendency to agglomerate in media due to attractive forces that exist between the 
particles. Dispersion of the SMBG powders was evident when the size distribution 
analysis using DLS was conducted immediately after cessation of ultrasonication at 
various time points (Fig. 4.8). The dispersion was delineated using TEM, which 
revealed that the agglomerates were held together by weak interparticle bonds that 
were re-dispersed by ultrasonication (Fig. 4.7a).  
To further investigate the dispersion of SMBG particles, ζ-potential measurements 
were used to analyse the changes in agglomeration state as a result of pH variation in 
a suspension. As the pH increased the particles began to disperse with ζ-potential 
values of less than -30 mV. This suggests that the particles had more surface charge 
and repelled each other, leading to improved particle dispersion. The optimal pH 
value, which resulted in some dispersion of SMBG particles, was recorded to be in the 
pH range 7-9. At a pH above 9, the sizes of the nanoparticles reduced to ~50 nm, 
which is significantly smaller than the average size of SMBG which is ~ 250 nm. This 
implies that above pH 9 the particles have begun to dissolve with the possibility of 
Ca
+2
 being released from the bioactive glass and also that the OH
- 
would dissolve the 
silica over time. In addition, the Si-O-Si bonds are likely to hydrolyse at a pH above 
9, and that this hydrolysis becomes more rapid as the pH further increases (i.e. 
becomes more basic). These suggestions may account for the reduction in particle size 
at above pH 9. Hence the optimal pH value, which resulted in some dispersion of 
particles, was recorded to be in the range of 7-9. To understand the variation at pH 9, 
it would be interesting to measure the ζ- potential value as a function of time, to 
examine whether the particles are dissolving over time and if the dissolution of the 
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particles influences the ζ- potential. The ζ- potential values obtained are not accurate 
if the particles dissolve as it may cause some misinterpretation of the results. Other 
factors which may influence ζ-potential values, such as ionic strength, require further 
investigation. 
 
4.5 Summary 
Spherical bioactive glass particles with a mean diameter of 250 nm were successfully 
produced using an optimised sol-gel processing route. The use of polymer in the 
processing method showed to have a major role in the size and formation of spherical 
dense particles. The Ca precursor was shown to have an effect on the formation of 
SMBG particles.  
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5. Bioactivity studies of SMBGs 4 
5.1 Introduction 
Bone bonding ability of bioactive glasses is thought to arise due to the formation of an 
apatite layer on the glass surface which forms when they are in contact with body 
fluid [2]. The detailed mechanism by which the apatite layer is formed is discussed in 
Chapter 2 (section 2.3.2.1). 
When bioactive glass was first introduced it was believed that the formation of the 
surface apatite layer required the presence of phosphorus and calcium in the glass 
structure. Later it was found that the phosphate in the ternary glass system is not an 
essential component for bioactivity, as it has been discussed in 2.3.2. Phosphate-free 
glasses in the binary system SiO2-CaO have been shown to exhibit both in vitro and in 
vivo bioactivity [42, 141].  
 
SBF testing is a common way of studying the bioactivity of bone grafts by examining 
the formation of hydroxyapatite (HA) crystals on the surface. SBF has similar 
concentration of ion and is buffered to the same pH (7.4) as the human blood plasma 
(Table 5.1). Apatite formation on the surface of a bone graft has been shown to be an 
important phenomenon for them to form a bond to bone. 
 
 
 
                                                          
4
 Another form of this chapter has been published in Biomaterials. [174] Labbaf S, Tsigkou O, Muller 
K.H, Stevens M.M, Porter A.E, Jones J.R. Spherical bioactive glass particles and their interaction with 
human mesenchymal stem cells in vitro. 32(4): p. 1010-1018. 
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Table 5.1: Ion concentration (mM) and pH of blood plasma and simulated body fluid 
[10] 
Ca2+ K+ Na+ Mg2+Cl- HCO3- Buffer pHHPO2-4SO2-4
1425.02.5 103 1.5 27.0 0.5 1.0 7.4
142.05.02.5 147.0 1.5 4.2 7.40.5 1.0
Blood
plasma
Simulated 
body fluid
 
 
In this study the nature of apatite deposits on the surface of sub-micron bioactive glass 
particles (SMBGs) with the composition of 85S15C (85 mol% SiO2 and 15 mol% 
CaO) is investigated by immersing the particles in SBF. Also, dissolution of SMBGs 
in SBF contribute towards understanding SMBG dissolution in body fluid and ionic 
concentration that cells may be exposed to during in vitro cell culture. 
 
5.2 Materials and methods 
Sub-micron bioactive glass (SMBG) particles were prepared as previously described 
in Chapter 4, using a molar ratio of 1 : 2.8 polymer templating agent : TEOS and a 
calcination temperature of 680 ºC. 
5.2.1 Bioactivity testing in simulated body fluid 
To test the bioactivity of SMBGs, simulated body fluid (SBF) solution was prepared 
following the procedure proposed by Kukubo et al [10]. The components and 
methods for making the SBF solution is summarised in Table 5.2.  
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Table 5.2: Ingredients and method used for making SBF solution [11]. 
Ingredients Amount 
Deionised Water 
NaCl 
NaHCO3 
KCl 
K2HPO4.3H20 
MgCl2.6H20 
Diluted 1M HCL aqueous solution 
CaCl2.2H20 
Na2SO4 
(CH2OH)3.CNH2 
Dilute 1M HCL aqueous solution 
 
Deionised water 
750ml 
7.996g 
0.350g 
0.224g 
0.228g 
0.305g 
39ml 
0.368g 
0.071g 
6.057g 
Heat SBF to 37°C and adjust pH to 7.34 
with HCl 
Fill the bottle to the 1L mark 
 
The SBF preparation method can lead to precipitation of apatite in the solution, if the 
recipe described in Table 5.2 is not followed rigorously. The reagents should be 
dissolved in succession to avoid precipitation. 
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For SBF testing, 0.01 g of SMBGs with 85S15C composition, sintered at 680 °C, 
were immersed in 40 ml of SBF at 175 rpm for 48, 120 and 168 h at 37 °C. At the end 
of each time-point (48, 120, 168 h), the SMBGs were dispersed in SBF by 
ultrasonication, before being collected on 300 mesh lacey carbon film TEM grids 
[33]. The pH of the solution was measured using a pH meter.  
 
5.2.2 TEM studies 
The formation of the apatite layer on the surface of the particles was characterised by 
TEM, selected electron diffraction (SAED) and EDX using the JEOL-2000FX TEM 
at 200 kV and an objective aperture of 10 µm. Images were taken following short 
exposure times to the electron beam to ensure that no beam damage was induced to 
the particles during analysis.  
 
5.3 Results 
Table 5.3 summarises the pH values measured after ion release of the SMBGs. The 
pH increased over time, suggesting that calcium and silica ions were being released 
and hence ion exchange was taking place. This leads to Si-OH groups forming on the 
particle surface which act as a nucleation site for the formation of crystals of 
hydroxyapatite (HA) layer. 
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Table 5.3: The change in pH of SBF solution after immersion of SMBGs for 48, 120 
and 168 h. 
             Time/hours         pH of SBF  
       (Reference) 
     pH of solution containing 
             bioactive glass 
48 7.34 7.38 
120 7.34 7.44 
168 7.34 7.49 
 
TEM, EDX and SAED studies were performed to determine whether the SMBGs had 
dissolved and if crystalline apatite had formed on the surface of the particles. After  
48 h immersion in SBF, the outer shell of the SMBGs had reduced contrast with 
several fine, dense particulates surrounding them, indicating that dissolution of the 
particles had occurred (Fig. 5.1a). Fig. 5.1b illustrates that deposits had nucleated on 
the surface of clusters of the particles within 48 h of immersion. Changes in the 
morphology and size of these particles could also be observed (Fig. 5.1b). The loss of 
mass-thickness contrast arising from the particles, in the regions around the outer 
shell, was not caused by electron beam damage as adjacent regions of apatite did not 
display a similar loss of contrast after irradiation with the electron beam. Also, in the 
control experiment (particles alone), where particles were exposed to the electron 
beam for the same amount of time under the same conditions these morphological 
changes observed in SBF were not seen. 
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Figure 5.1: a) TEM micrographs of SMBG immersed in SBF at pH 7.4 and 37 °C for 
a-b) 48 h showing dissolution of the particles and nucleation of a finer particulate 
phase on their surface. c) 120 h exposure to SBF showing more widespread deposits 
on the surface of the SMBGs. SAED pattern obtained from the cluster of particles 
showing crystalline spots corresponding to HA. d) EDX analysis of SMBGs after 
immersion in SBF for 120 h.  
118 
 
After 120 h immersion (Fig. 5.1c), deposits on the surface of the SMBG were 
widespread and the particles had noticeably decreased in size (reduced from 250 nm 
to > 150 nm in size). Fig. 5.1c shows crystalline spots in SAED pattern from these 
deposits that are consistent with the known hexagonal form of crystalline 
hydroxyapatite (HA) that has lattice parameters a = b = 9.4104 Å, c = 6.874760 Å. 
EDX spectra (Fig. 5.1d) showed that the deposits were calcium and phosphorus rich, 
which further confirmed the formation of HA.  
After 168 h immersion in SBF the size of the particles had decreased further 
indicating more extensive dissolution of the SMBGs (Fig. 5.2a). The morphology and 
size of the particles has changed such that they are no longer spherical, dense and 
discrete particles. This observation can be correlated with the increase in pH of SBF 
solution after 168 h (Table 5.3), which suggests that the particles are dissolving. 
 
                                 
HA
1 µm
       
Figure 5.2:  TEM micrographs of SMBGs after immersion in SBF for 168h. 
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5.4 Discussion 
Simulated body fluid (SBF) tests aid the evaluation of the dissolution–precipitation 
mechanism of apatite formation on the surface of bioactive glasses. The changes in 
morphology and size of SMBGs and also the change in mass-thickness contrast from 
the particles suggest that dissolution has occurred. After 120 h in SBF an extensive 
apatite phase had formed and the particles greatly reduced in diameter (<150 nm), less 
than the mean diameter of the particles before immersion (250 nm, ±75 nm). 
Dissolution from the SMBG leads to a supersaturation of Ca ions in the SBF solution 
and subsequent reprecipitation of Ca and P rich crystals and apatite formation on their 
surface. The fact that SMBGs dissolve in SBF could also suggest that they may 
dissolve in physiological environment if they are to be applied in vivo. 
 
5.5 Summary 
Following immersion in SBF the particles appeared to have partially dissolved, 
forming a crystalline hydroxyapatite layer on their surface after 120 h.   
 
 
 
 
 
 
 
 
 
120 
 
6. Cytotoxicity and uptake of SMBGs by human mesenchymal stem 
cells (hMSCs)
5
 
6.1 Introduction 
Despite the great potential of BGs as porous scaffolds for bone regeneration [137], 
concerns have arisen about their long term fate in the body as wear particles of nano- 
or micrometer size may be generated after implantation, which could potentially cause 
adverse reactions with the surrounding cells. These cellular reactions may be due to 
particular characteristics of the particles including their size, high surface area to 
volume ratio or their surface chemistry. To date, very little is known about the 
interaction of SMBG with the body with regards to their toxicity. It is hypothesised 
that SMBGs enter cells by endocytosis, localise inside endosomes and dissolve 
resulting in raised localised soluble silica and calcium concentrations. A localised 
increase in intracellular silica or calcium could cause a marked effect on cell 
metabolism [142] or inflammatory response [143]. As particles dissolve 
intracellularly, they may also break up into finer particles which are able to escape the 
endosomal pathway and enter the cell cytoplasm or even the nucleus causing raised 
levels of cytotoxicity. This process has been demonstrated previously with HA 
particles exposed to human macrophage cells [101] and will therefore be investigated 
here for SMBGs. 
Imaging the intracellular fate of SMBGs can help to elucidate how they enter the 
cells, their biodistribution, retention and degradation inside the cell and whether, as a 
result, they affect any cellular function [144]. Previously silica particles have been 
                                                          
5
 Another form of this chapter has been published in Biomaterials. [174] Labbaf S, Tsigkou O, Muller 
K.H, Stevens M.M, Porter A.E, Jones J.R. Spherical bioactive glass particles and their interaction with 
human mesenchymal stem cells in vitro. 32(4): p. 1010-1018. 
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imaged inside cells with confocal microscopy, by fluorescently labelling the particles 
[105, 145]. Transmission electron microscopy has also been used to image, at high 
resolution, the intracellular distribution and stability of HA and silica nanoparticles 
[101, 103, 145]. However, visualising the subcellular distribution of SMBG in the 
TEM is challenging as it is difficult to prepare sections across the SMBG-cell 
interface due to differences in the hardness of the two materials. In this study we 
demonstrate that it is possible to image unlabelled SMBGs in 3D using confocal 
microscopy in reflectance mode and also to prepare sections of cells, which have 
internalised SMBGs via ultramicrotomy for analysis by TEM imaging. 
Bone-marrow derived human mesenchymal stem cells (hMSC) are an attractive cell 
source for tissue-engineering applications because of their relative ease of isolation 
and expansion from adult bone marrow aspirates and their potential for pluripotent 
differentiation into mesenchymal tissues [25]. Previous studies have reported that 
cells derived from bone marrow can be stimulated towards osteogenesis when in 
contact with bioactive glasses [146]. hMSCs are also believed to egress from bone 
marrow and migrate towards the site of bone injury, home there and differentiate to 
promote repair [147]. Also, hMSCs are precursors to osteoblasts, hence the effect of 
particles on their behaviour is critical. For these reasons, hMSCs are a relevant cell 
type to use to test the biocompatibility of SMBGs. 
The overall aim of this study was to investigate the effect of SMBG particles (Chapter 
4) on cell viability, metabolic activity and proliferation of hMSCs, using 
LIVE/DEAD, MTT, total DNA and LDH assays. Finally, TEM and 3-D confocal 
microscopy were applied to assess the distribution of SMBGs inside hMSC and 
whether they dissolve intracellularly.  
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6.2 Materials and methods 
6.2.1 SMBGs 
Sub-micron bioactive glass (SMBG) particles for this study were prepared as 
previously described (Chapter 4) using optimised synthesis route with a molar ratio of 
1 : 2.8 polymer templating agent : TEOS calcinated at 680 ºC. 
 
6.2.2 hMSCs 
hMSCs were purchased from Lonza (Lonza, UK) and maintained in low glucose, 
phenol red free, Dulbecco‟s Modified Eagle Medium (DMEM) supplemented with 
10% (v/v) batch tested Fetal Bovine Serum (FBS), 50 U/ml penicillin and 50 μg/ml 
streptomycin, 1% (v/v) L-glutamine (all from Invitrogen, UK) (which will be referred 
to as complete medium). The cells were maintained in a humidified cell incubator 
with 5% CO2 in air, at 37 
o
C.  The cells were split once or twice weekly by incubation 
with 5 ml of trypsin-EDTA (1x) (Sigma, UK) at 37 
o
C for 5 minutes to detach the 
cells from the surface. Medium was changed the following day and then every 3-4 
days. Cells used for experiments were at passage 3. 
 
6.2.3 Trypsinisation of the cell 
Medium was aspirated and cells were washed once in PBS and then trypsinised as 
described in 6.2.2. During this time cells were viewed under the light microscope to 
monitor the progress of detachment. At the end of 5 min, if all cells were not 
detached, the edge of the flask was tapped sharply to hasten cell detachment. 
Following addition of 10 ml of complete medium (twice the volume as trypsin) to 
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neutralize tryptic activity, cell suspension from each flask were transferred to 50 ml 
conical tubes and pelleted by centrifugation at 300 g for 5 minutes. The supernatants 
were aspirated off, without disturbing the pellet, and the remaining cell pellets were 
evenly resuspended in culture medium by repeated pipetting.  
 
6.2.4 Cell counting by trypan blue 
The cell number in a culture can be counted by using the trypan blue dye and a 
hemacytometer. Trypan Blue is a vital dye which is excluded by live cells or tissues 
with intact cell membranes and hence viable cells are not coloured.  Here, cells in 
suspension were mixed thoroughly with one volume of 0.4% (w/v) trypan blue 
(Sigma, UK). Haemocytometer was used to count the viable cells (white) in five 
squares of one chamber.  
 
Total viable cells counted in five of 0.1 cm2 squares      X    Dilution factor 
5
X 10,000Cells/ml   =
 
The total number of cells in the original cell suspension was then calculated: 
 
Total cell number : Cells/ml  x  Number of ml in the original solution
 
 
6.2.5 Cryopreservation of the cells 
Cells were frozen down in freezing media containing 10% (v/v) dimethyl sulfoxide 
(DMSO) (Sigma, UK) and 90% (v/v) FBS. Cell suspensions were centrifugated for 5 
minutes at 300 g and supernatants were aspirated off. Cell pellet was resuspended in 
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900 µl FBS by repeated pipetting and the 100 µl of DMSO was added to the 
suspension. The cell suspensions were then transferred to 1 ml cryotubes (NUNC, 
Denmark), and were initially stored in -80 
o
C freezer over night (cells freeze at a rate 
of 1 
o
C/min) and then stored in liquid nitrogen (-195 
o
C).  
To retrieve the cells from liquid nitrogen, initially cells were thawed in a water bath at 
37 
o
C and then transferred to a 50 ml falcon tube containing 8 ml of complete 
medium. Cell suspensions were centrifuged at 300 g for 5 minutes to remove the 
DMSO. 
 
6.2.6 Cell assays 
Cells were seeded at a density of 10,000 cells/cm
2 
and cultured with complete 
medium containing SMBGs at concentrations of 0, 100, 150 and 200 µgml
-1
. The 
SMBG concentration was determined by drying to constant weight, then heat-
sterilised at 120 °C for 2 h, followed by UV sterilisation. The solution containing the 
SMBGs was ultrasonicated to ensure an even suspension prior to adding to cells. Cells 
were exposed to a pulse of SMBG for 24 h followed by chase periods of 1, 4 and 7 
days. In accordance with previous studies [105, 148] a pulse of 24 h was chosen as it 
has been demonstrated that hMSCs already internalise NPs by this time point. The 
pulse-chase experiment was performed by removing the culture medium containing 
the SMBGs after 24 h, washing the cells with PBS and adding fresh complete medium 
to the cells.  
The viability of cells was assessed using the LIVE-DEAD assay (Molecular Probes, 
UK), MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Sigma), 
total DNA measurements and Lactate dehydrogenase (LDH) Cytotox-one
TM
 assay 
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(Promega, UK). Statistical analysis was performed using the Sigma Stat software 
using the Student‟s t-test. p-values of <0.05 were considered as statistically 
significant. 
 
6.2.6.1 LIVE/DEAD 
The LIVE/DEAD viability/cytotoxicity assay (Molecular Probes, Leiden, The 
Netherlands) provides a two-colour fluorescence cell viability assay. This is based on 
the simultaneous determination of live and dead cells with two probes (calcein AM 
and ethidium homodimer-1) that measure two recognized parameters of cell viability- 
intracellular esterase activity and plasma membrane integrity, respectively. Live cells 
take up and metabolise calcein-AM and fluoresce green. Dead (necrotic/late 
apoptotic) cells have breached membranes, which allow entry of ethidium-homodimer 
1 that gives a red fluorescence when bound to nucleic acids in the nucleus.  
The LIVE/DEAD assay was performed to examine SMBG cytotoxicity after 24 h. 
The assay utilises two fluorescent dyes to label live and dead cells. The cytoplasm of 
live cells was stained with 2 μM calcein (green) and the nucleus of dead cells stained 
with 4 μM EthD-1 (red). Stained cells were viewed using the Olympus BX-URA2 
fluorescence microscope. Images were captured within 15 min of labelling using a 
Zeiss Axiocam digital camera and analysed using KS-300 software (Imaging 
Associates).  
 
6.2.6.2 MTT 
Cell metabolic activity and consequently cell viability and proliferation over time was 
assessed using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 
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a colorimetric assay. MTT measures the intracellular enzymatic conversion of MTT 
by mitochondrial dehydrogenase into formazan in viable cells. At the end of each time 
point, 20 μl of 5 mg/ml of MTT solution were added to each well and incubated for   
2 h at 37 °C. Sample solutions were then removed and 200 μl of dimethyl sulfoxide 
was added to each well to dissolve the insoluble purple formazan product into a 
colored solution. Plates were then incubated for 5 min to dissolve the crystals. 
Absorbance was measured at 490 nm using the microplate spectrophotometer Anthos 
2020 (Anthos Biotech, Salzburg, Austria). The results represent the mean values ± 
standard deviation (SD) of two individual experiments each performed in 
quadruplicate. 
 
6.2.6.3 Total DNA 
The effects of three different concentrations of SMBG on cell proliferation were also 
assessed by measuring total cellular DNA in culture. At the end of each time point, 
medium was removed and extra pure water was added to each well followed by at 
least three freeze-thaw cycles to lyse the cell membranes. Then, 50 μl of the cell 
lysate and bis-Benzamid 33258 (Hoechst stain) (Sigma) in TNE buffer (10 Mm Tris, 
1 mM EDTA, 2 M NaCl, pH 7.4) were transferred to a new 96 well plate to measure 
DNA content. The Hoescht stain binds to DNA and fluoresces. A standard curve was 
constructed using calf thymus DNA (Sigma) to determine the DNA concentration. 
Fluorescence was measured on a fluorescence plate reader (SpectraMAX GemimXS 
plate reader) at an excitation/emission wavelength of 360/460 nm. The results 
represent the mean values ± SD of two individual experiments each in quadruplicate. 
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6.2.6.4 LDH 
The CytoTox-ONE
TM
 (Promega, UK) assay which assesses the cell membrane 
integrity by measuring the leakage of lactate dehydrogenase (LDH) from cells, was 
used to calculate the percent of live and dead cells following exposure. To perform 
the assay, LDH in the supernatant and in the adhered cells was measured separately. 
50 μl of centrifuged supernatant was added to 50 μl of reconstituted substrate mix and 
was incubated at room temperature, protected from light, for 30 min. Adherent cells 
were then lysed by adding 100 μl 0.9% Triton-X100 and incubated for 15 min at      
37 °C. Following incubation, 50 μl of the cell lysate was then added to 50 μl of LDH 
assay mixture in a 96 well plate. Absorbance was measured at 490 nm with a 
reference wavelength of 620 (Anthos 2020 Biotech, Salzburg, Austria). The total 
number of viable cells is directly proportional to the LDH in the adherent cell lysates, 
whereas the total number of dead cells is directly proportional to the LDH in the cell 
supernatant according to the manufacturer‟s instructions. Live cell percent is 
normalised to the total number of live cells of the control at day 1.  
 
6.2.7 Uptake studies 
6.2.7.1 Confocal microscopy 
For 3D confocal microscopy imaging, the hMSCs were grown on chamber slides 
(LabTek, UK) and exposed to SMBGs at a concentration of 100 μg/ml for 24 h. They 
were then fixed in 4% (w/v) paraformaldehyde in phosphate buffer solution (PBS), 
with 1% sucrose at 37 °C for 20 min, washed with PBS and permeabilized with 
buffered 0.5% Triton X-100 (10.3g sucrose, 0.292 g NaCl, 0.06 g MgCl2, 0.476 g 4-
(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid (HEPES), in 100 ml water (pH 
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7.2) at 4 °C for 5 min. The cells were subsequently incubated for 1 h with Alexa 568-
conjugated phalloidin (1:100, Molecular Probes, UK). Background labelling was 
minimised by washing with 0.5% Tween. Samples were mounted in Vectashield with 
DAPI (Vector Laboratories, UK), and viewed with a Leica SP5 MP inverted (SAFB 
408) confocal microscope. The SMBGs were imaged in reflectance mode from the 
internalised particles. Z-plane stacks were taken to generate 3-D reconstructions. 
 
6.2.7.2 TEM 
For TEM analysis, the cells were treated with 100 μg/ml of SMBGs for 24 h. 
Following exposure, the cell monolayers were washed with 0.9% saline and fixed 
with 4% gluteraldehyde in PIPES buffer (0.1 M, pH 7.2) for 1 h at 4 °C.  
Gluteraldehyde cross links with tissue proteins, lipids, nucleic acids and 
carbohydrates and therefore stabilizes the cell in a structural condition approximate to 
its live state. The fixative was then removed and samples were washed with saline to 
remove all unbound glutaraldehyde. Scraped cells were then centrifuged into pellets 
and washed in saline. This was followed by incubation in a solution of 1% osmium 
tetroxide containing 1.5% potassium ferricyanide and 2 mmol/L calcium chloride in 
0.1 m PIPES buffer at pH 7.4 for 1 h at room temperature. Osmium tetroxide binds to 
lipids, enhancing contrast in image and also acts as secondary fixative. The cells were 
then washed 6 times in deionised water (DIW) and dehydrated with graded solutions 
of EtOH (70, 95, and 100%) for 5 min in each solution. Samples were then embedded 
in Quetol resin (Agar Scientific, UK) under vacuum for 3 days and cured in fresh 
resin for 24 h at 60 °C. Thin sections (60–90 nm) were cut using a 35º diamond knife 
on a Leica Ultracut UCT ultramicrotome and collected immediately onto bare 300 
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mesh copper grids and dried to eliminate any possibility that the SMBGs dissolved in 
the water bath of the diamond knife. To check that the SMBG particles were not 
modified during the fixation, embedding and microtoming process, the resin-
embedded SMBG particles, which had not been exposed to cells, were prepared using 
the protocol described above. 
 
Post-staining 
To improve contrast from cell organelles, selected TEM sections were post-stained 
with saturated 1% methanolic uranyl acetate and lead citrate using a drop-to-drop 
method. Uranyl acetate reacts with phosphate and amino groups and binds specifically 
to nucleic acids and certain proteins are stained. This method involves placing a drop 
(20 µl) of uranyl acetate stain per grid on parafilm in a petri dish. The grids were then 
placed section side down on the drop of stain. After 5 minutes, 4 successive drops of 
distilled water per grid were placed on parafilm in a petri dish for washing. The first 
drop was then rinsed and the same grid was moved to the second, third and forth 
drops, each for 3 minutes. Following staining with uranyl acetate, a drop (20µl) of 
lead citrate stain per grid was placed on parafilm in a petri dish (add sodium 
hydroxide pellets to petri dish) and avoid exposing to air. The grids were then placed 
grid side down on the drop of stain and left for 10 minutes. The grids were washed a 
few times as explained earlier. Lead citrate is an electron opaque stain which stains 
cytoplasmic membranes, ribosomes, glycogen, and nuclear materials.  
 
TEM imaging and EDX were performed on JEOL-2000FX Electron microscopes, 
with an operating voltage of 120kV and a 10 µm objective aperture to increase mass-
thickness contrast. Multiple areas from 2 samples were observed in the TEM. 
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6.3 Results   
6.3.1 hMSC response to SMBGs 
The LIVE/DEAD cytotoxicity assay (Fig. 6.1) showed a high number of live cells 
following exposure to 100 and 200 µgml
-1
 of SMBG after 24 h with few dead cells. 
The LDH assay (Fig. 6.2a) also demonstrated that none of the SMBG concentrations 
tested were cytotoxic after 1, 4 and 7 days. The %LDH release in viable cells 
decreased at day 4, but increased at day 7. This was consistent with the increase in 
%LDH of dead cells that were seen to be highest in day 4 and decreased in day 7. 
Also, at day 7 the %LDH is highest compared to day 1 and 4. Exposure to SMBGs 
caused a dose and time dependent decrease in metabolic activity with the MTT assay 
(Fig. 6.2b). A significant decrease in metabolic activity was only found after 7 days in 
culture with 150 and 200 µgml
-1
 of SMBGs (p < 0.05). Total DNA measurements 
(Fig 6.2c) demonstrated that cell proliferation increased in a dose-dependent manner, 
with increasing SMBG concentration the cell proliferation decreased, however none 
of the SMBG concentrations tested had a significant effect on DNA quantity 
compared to the control cells. 
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Figure 6.1: Fluorescent Microscopy of LIVE/DEAD cytotoxicity assay.  hMSC a) 
without SMBGs b) 100 µgml
-1
 and c) 200 µgml
-1
 of SMBGs after 24 h incubation at 
37 °C. The figure shows the cell population with the cytoplasm of the live cells 
stained with the Calcein AM (green) and the nucleus of the dead cells stained with 
EthD-1 (red).  
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a) 
b) 
c) 
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Figure 6.2: Cytotoxicity assays.  Cell viability was monitored using: LDH release, b) 
metabolic activity (MTT), and c) total DNA of hMSCs after a 24 h pulse of SMBGs 
followed by 4 and 7 days chase. Values represent the mean ± SD of two individual 
experiments each performed in quadruplicate. (*p < 0.05 relative to control, without 
SMBG). 
 
6.3.2 Uptake of SMBGs by hMSC 
To monitor the cellular uptake of the SMBGs, hMSCs were exposed to 100 µgml
-1
 of 
SMBGs in medium for 24 h. Traditional 2D bright field TEM images and 3D 
confocal microscopy reconstructions were compared to determine whether the 
SMBGs were taken up by hMSCs. The light reflectance property of these SMBGs 
enabled their visualisation inside the hMSCs using confocal microscopy without the 
need of fluorochrome tag (Fig. 6.3). Optical sections were taken at intervals of 2 μm 
along the z-axis and reconstructed in 3D images to reveal randomly distributed 
SMBGs spread between the actin microfilaments (Fig 6.3 b, c, d) of the hMSCs. 
These dense particles were not seen in the control cells (Fig. 6.3a). 
To check that the SMBG particles were not modified during the fixation, embedding 
and microtoming process, the resin-embedded SMBG particles, which had not been 
exposed to cells, were also prepared (Fig 6.4).  Fig. 6.5b-c represents the uptake and 
internalisation of SMBGs by hMSC. Again, the dense particles were not observed in 
control cells (Fig. 6.5a). In post-stained sections, clusters of SMBGs were 
encapsulated inside membrane-bound endosomes (Fig 6.5d, region i) and also inside 
the cell cytoplasm (Fig. 6.5d, region ii).  
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Figure 6.3: Confocal 3-D imaging of a live hMSCs incubated without SMBGs b) 
with 100 µgml
-1
 of BGP for 24 h at 37 °C.  c-d) 3D reconstructions from boxed region 
in (b). The particles were internalised inside the cell and associated with the actin 
fibres of the cell. (Red= actin fibres, blue = nucleus and green = SMBG);  
 
In some regions inside the cell there was a reduction in mass-thickness contrast from 
the centre of the SMBGs suggesting that the particles had partially dissolved and 
begun to hollow out (Fig. 6.6a, region iii). EDX of the particle in Fig. 6.6a (region iii), 
confirmed the presence of Ca and Si in the particles (Fig. 6.6b). No Si was detected 
away from the particle. The size of the particles also appeared decreased inside the 
cells as a function of time in culture, providing further possible evidence for SMBG 
dissolution (Fig. 6.6c, region ii). Some regions adjacent to the endosomal membrane 
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(Fig. 6.6a, region iv) were rich in calcium only and lacked an observable silicon peak 
(Fig. 6.6c). Overall, these results are of great importance since if the particles hollow 
out rather than shrinking in size with dissolution, this may have an impact on the fate 
of the particles once their taken up, i.e. where they go inside the cells and as a result 
how they influence cellular behaviour. 
 
1 µm 0.2 µm
 
Figure 6.4: BF-TEM micrographs of thin sections of resin embedded SMBG 
particles. In some areas the particles have shattered under the knife. Holes were also 
observed in the sections/resin implying that the particles had chipped out of the resin 
during sectioning. 
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Figure 6.5: TEM micrographs of hMSC following incubation a) without SMBGs 
(post-stained) b-d) with 100 µgml
-1
 of SMBGs for 24 h. b) Particles being taken up 
and c) internalised inside a cell. d) Clusters of SMBGs were encapsulated inside 
endosomes (region i) and individual SMBGs were present inside the cell cytoplasm 
(ii) (post-stained section), (N: the nucleus, NM: the nuclear membrane, ER: the 
endoplasmic recticulum, C: the cytoplasm). 
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Figure 6.6: TEM micrographs of hMSCs exposed to 100 µgml
-1
 of SMBGs after 24 h 
exposure (post-stained). a) A hollow nanoparticle adjacent to the nuclear membrane 
(region iii). Particles around the endosomal membrane (region iv), b) EDX analysis of 
region iii, showing peaks of Si and Ca and c) region iv showing peaks of Ca. 
 
6.4 Discussion 
Although hMSC response to SiO2 particles has been investigated previously, [105, 
122, 149], the response of SMBGs with hMSCs has not. Therefore this was an aim of 
this study. Unlike bulk materials, the biological response of small particles is highly 
dependent on their size and their specific surface area [104, 150]. It is difficult to 
compare with previous studies because of the differences in the particle size and 
composition and in the cell types investigated. The majority of studies with hMSCs 
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have used mesoporous silica sub-micron particles designed for drug delivery 
applications. In these previous studies, no toxicity was observed when hMSCs were 
exposed to hexagonal mesoporous silica (mean diameters of 110 -160 nm) of various 
concentrations (0-200 µgml
-1
) for different exposure times (10 min – 1 h), although 
the cells were only monitored for 24 h after exposure [105, 122, 149]. Several studies 
on dense silica (calcium-free) particles are based on targeting cancer cells. Viability 
of human lung (bronchial alveolar cell line) cells decreased when exposed to            
50 µgml
-1
 silica nanoparticles (mean size of 46 nm) for 24 h [106]. A reduction in 
viability was also seen in HeLa cells (a commonly used immortalised human cell line 
derived from cervical cancer) exposed to silica particles (mean diameter of 200 nm) 
for 4 h [121].  
 
Cell function is controlled through numerous intracellular signalling events which can 
be triggered or altered by the uptake of the particles [122]. Uptake by endocytosis is 
greatly influenced by the physical properties of the particles including their surface 
charge, size and shape [122, 150, 151]. A common feature of all the cells in the 
previous studies was that uptake of the particles was observed. The spherical particles 
used in the current study were slightly larger than those used previously, so it was 
important to observe whether the particles were taken up by the hMSCs and to assess 
whether the particles caused any toxicity. 
 
Some spherical SMBGs (mean surface area 28 m
2
g
−1
 and diameter of 250 nm) 
appeared to have been internalised by hMSCs in endosomes via the non-specific 
cellular uptake of endocytosis (Fig. 6.5-6.6). Notably a few individual SMBGs 
appeared to localise inside the cell cytoplasm, suggesting that they may have escaped 
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the endosomal pathway (Fig. 6.5-6). This is a similar uptake route to what was 
observed previously with mesoporous silica particles [122].  
 
Several of the SMBGs appeared to dissolve inside the hMSCs (Fig 6.6). The particles 
appeared to reduce in density in their centre, in some cases forming hollow spheres. 
Calcium containing SMBGs are expected to be more prone to dissolution than silica 
particles in aqueous environments because calcium disrupts the silica network, 
reducing its network connectivity (mean number of bridging -Si-O-Si- bonds per 
silicon atom) and therefore its stability in solution [81]. The hollowing out of 
spherical bioactive glass microparticles (300-355 µm) has previously been observed 
extracellularly [152]. Intracellular dissolution of the particles would mean increased 
soluble silica and calcium ion content within the cell. Changes in intracellular calcium 
are essential regulators of many physiological processes including oxidative stress and 
cell death. During overload of the intracellular calcium mitochondria maintain 
calcium homeostasis by orchestrating a diverse range of cellular activities and 
ultimately cell death [153, 154]. Therefore the decrease in cell metabolic activity 
observed (MTT, Fig. 6.2b) after 7 days of culture for the higher concentrations of 150 
and 200 µgml
-1
could be attributed to the mechanism of calcium homeostasis by the 
mitochondria. In addition, this decrease in metabolic activity could not be interpreted 
as decreased proliferation (increased cell death) since it does not correlate with the 
amount of total DNA at day 7 (Fig. 6.2c), which indicates that none of the SMBG 
concentrations significantly reduced cell number.  
In addition, some SMBGs were also observed to remain in the extracellular 
environment (not removed by the media changes and washes), which could contribute 
to the decrease in metabolic activity. The particles would also dissolve as function of 
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time, releasing soluble silica and calcium ions. Previous studies that administered 
bioactive glass dissolution products to human osteoblasts [46] and that cultured 
osteoblasts on 70S30C (70 mol% SiO2, 30 mol% CaO) scaffolds [141] showed that 
the dissolution products caused a decrease in metabolic activity, which correlated to 
enhanced extracellular matrix deposition. Also, the LIVE/DEAD (Fig. 6.1) and LDH 
assays (Fig. 6.2a) indicated that the SMBGs did not cause significant levels of 
cytotoxicity. It would be important to establish whether the effect on cell proliferation 
is the result of position and trafficking of SMBG inside the cell, therefore, further and 
more thorough uptake studies are essential as they will provide insight into the SMBG 
interactions with the cells and consequently allowing their most appropriate use for 
bone tissue regeneration applications. 
 
6.5 Summary 
The viability assays confirmed that none of the SMBG concentrations tested here 
induced any major cytotoxicity when exposed to hMSCs and were only seen to reduce 
cell metabolism at higher doses of 150 and 200 µgml
-1
. The combination of cell 
viability assays and imaging techniques was critical in understanding SMBG 
interactions with hMSCs. The present study showed that SMBG were internalised into 
hMSCs resulting in partial dissolution of the SMBGs. 
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7. Optimised spherical mono-dispersed sub-micron bioactive glass 
particles: synthesis and characterisation 
 
7.1 Introduction 
The submicron bioactive glass particles (SMBGs) discussed so far (Chapters 4-6) are 
a useful tool for investigating the effects of small particles on cellular response and 
have potential applications in medicine due to their unique characteristics of small 
size and high surface area. However, the number of potential therapeutic applications 
of SMBGs could be increased by increasing their dispersability and creating a 
narrower size distribution. Ideally, the particles should be mono-disperse. The 
potential application of mono-dispersed sub-micron bioactive glass particles (mono-
SMBGs) in medicine includes injection into bone defects for healing and regeneration 
of bone tissue, labelling for cancer diagnostics (for imaging cancer cells), drug 
delivery by functionalising the surface, and finally the incorporation of the particles 
into a polymer matrix to produce a nanocomposite with enhanced mechanical 
properties. Controlled dispersion of the particles would also be beneficial in assessing 
the biological response of individual SMBGs of known size to make a comparison 
with the agglomerated SMBGs that were assayed in the previous chapters. Previously 
in vitro and in vivo studies have shown that the use of agglomerated nanoparticles 
may cause inaccurate assessment of nanoparticle toxicity and hence misleading 
conclusions [155-157]. In addition, agglomeration can strongly hinder determination 
of fundamental dose-response relationships [158].   
Despite numerous studies on the production of mono-dispersed silica particles [83, 
132, 159-161], the synthesis of mono-SMBGs, with controlled shapes and sizes, has 
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not been reported. SMBGs tend to aggregate during processing because of their 
increased surface area [162]. Hence, improving the dispersity SMBGs would have a 
great impact on the number of their applications.  
For the synthesis of 85S15C SMBGs (Chapter 4), a polymer was used as a templating 
agent to enhance the dispersion of the final particles. However, the polymer was 
shown to interfere with the incorporation of the calcium into the silicate network, and 
hence resulted in lower calcium content in the final composition. The aim of this 
Chapter was to incorporate up to 30 mol% CaO into the silica network, and also to 
simultaneously obtain a uniform size, shape and dispersion of individual bioactive 
glass particles. The effect of calcium on the morphology, shape and dispersion of 
SMBGs was then determined.  
In the sol-gel process, two main reactions of hydrolysis and condensation take place 
(sections 2.5.1.1 and 2.5.1.2). The rate of hydrolysis and condensation is 
predominantly controlled by the reaction conditions (reagents and pH) which may 
result in either a 3D silica network (generation of a gelled monolith) or in the 
formation of single mono-dispersed particles [159]. Recently, Rao et al [159] 
produced mono-dispersed silica nanoparticles by ultrasonication technique using the 
sol-gel method. They investigated the effect of each reagent (ethanol, ammonia, 
TEOS and water) on the size, shape and mono-dispersity of silica nanoparticles. One 
requirement for the preparation of a stable dispersion is to increase the repulsive 
forces between the particles, so that the agglomeration of the particles is restrained/ 
suppressed, or is kinetically slow. Ultrasonication is a technique frequently used to 
produce dispersed particles as it is capable of overcoming the weak van der Waals 
forces holding the particles together. An aim of the current study was to apply the 
synthesis route by which Rao et al [159] produced mono-dispersed silica 
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nanoparticles to obtain mono-dispersed and amorphous binary bioactive glass 
particles containing up to 30 mol% CaO with diameters less than 1 micrometer.  
 
7.2 Materials and methods 
7.2.1 Synthesis 
The methodology applied by Rao et al [159] for the synthesis of 100S (100 mol% 
SiO2) was modified with the aim of obtaining 70S30C (70 mol% SiO2 and 30 mol% 
CaO) mono-SMBGs. The mono-SMBGs were prepared using the sol-gel process, by 
hydrolysis of Tetraethyl orthosilicate (TEOS, (Si(OCH2CH3)4) in ethanol in the 
presence of an ammonia catalyst in an ultrasonication bath [159]. Initially, 4.5 ml of 
EtOH (99.99%) and 0.5 ml of H2O were kept in the sonication bath for 10 minutes. 
Then, 100 µl of TEOS was added while sonicating and left for a further 20 minutes 
before 5 ml of ammonium hydroxide (NH3.H2O) was added dropwise as a catalyst. 
Calcium nitrate tetrahydrate (Ca(NO3)2. 4H2O) is the common precursor for 
introducing calcium into the sol-gel process and is usually added 1 h after adding 
TEOS to water. The effect of Ca(NO3)2.4H2O on the particle formation and 
composition was investigated by adding it at different stages during the mixing 
process (before and after the addition of TEOS) and also by using different molar 
ratios of Ca(NO3)2.4H2O to TEOS of 0.42:1 (the ratio that is commonly used for 
70S30C sol-gel bioactive glasses), 1.3 : 1 and 4 : 1. The white suspension was then 
centrifuged to obtain white solid deposit. The deposited solid was dried to remove 
excess water from the solid particles, producing a white powder, which was then 
calcined at 680 °C to produce mono-SMBG particles. The sintering temperature was 
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chosen as it was the optimal sintering temperature for the previous study on SMBGs 
(Chapter 4). The process is presented in Figure 7.1. 
 
Ethanol and H2O kept in the 
sonication bath for 10 minutes.
Add TEOS  and leave for a 
further 20 minutes. 
Add ammonium hydroxide dropwise
and leave to mix for 60 minutes.
Addition of Calcium nistrate.
White solid suspension centrifuged 
and dried at 100 °C.
Calcination at 680 °C to obtain
mono-disperse spherical particles.
 
Figure 7.1: Schematic diagram of the sol-gel steps applied to prepare mono-SMBGs. 
 
7.2.2 Characterisation 
The following techniques were used as described in sections 4.2.2-4.2.3: Acid 
digestion compositional analysis using ICP-OES and TEM to determine particle size, 
XRD. All techniques were used in the same manner. 
In order to investigate the size distribution of mono-SMBGs dynamic light scattering 
(DLS, Malvern instrument 2000) was used. To obtain a better understanding of the 
stability and surface charge of the mono-SMBGs, zeta-potential measurements (n=5) 
were also applied on Malvern instrument 2000. For both size and zeta-potential 
analysis, mono-SMBGs were suspended in 100% EtOH prior to measurements. 
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7.3 Results 
Spherical, mono-dispersed bioactive glass particles (mono-SMBG) with controlled 
shape and a very narrow size distribution were successfully produced by adapting and 
optimising a sol-gel processing route using ultrasonication during synthesis [159]. 
Compositional analysis (ICP-OES) showed that the mono-SMBGs had a composition 
of 80 mol% SiO2 and 20 mol% CaO (mean values were 80.92 mol% SiO2 and 19.18 
mol% CaO, ±0.26). XRD of the new particles following sintering at 680 °C 
confirmed that they were amorphous due to the absence of sharp diffraction peaks 
(Fig. 7.2).  
                          
Figure 7.2: XRD trace of mono-SMBGs calcined at 680°C 6. 
 
The effect of calcium on the size and morphology of the mono-SMBGs was studied 
using TEM (Fig. 7.3 and Fig 7.4). The addition of calcium prior to adding TEOS 
during the mixing stage resulted in the formation of many chain-like clusters that 
                                                          
6
 XRD analysis were performed by Mr Richard Sweeny, Imperial College London. 
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were not classified as sub-micron SMBG (Fig. 7.3a). The molar ratio of 
Ca(NO3)2.4H2O : TEOS during the synthesis of mono-SMBG, where calcium was 
added after the addition of TEOS, showed to have a significant effect on the 
morphology and formation of the particles (Fig. 7.3b-c and Fig. 7.4). Figure 7.3b-c 
clearly shows that the changes in Ca(NO3)2.4H2O content in the synthesis route to 
increase the final mol% of CaO, influences the formation of spherical dense mono-
SMBGs. Although, Figure 7.3c represents dense spherical particles of the same size, 
the particles are agglomerated and the increases in calcium content (Ca(NO3)2.4H2O : 
TEOS molar ratio) had led to the formation of many small clusters around the 
particles (Fig. 7.3 c). Therefore, mono-dispersed, spherical and dense SMBGs, with a 
molar ratio of Ca(NO3)2.4H2O  : TEOS of 1.3 : 1, which are shown in the bright-field 
TEM image in Figure 7.4a, are regarded as optimised. These results confirm that there 
is a threshold amount of Ca(NO3)2.4H2O that results in the formation of optimised 
mono-dispersed SMBGs. The average particle diameter measured using TEM was 
215 nm (± 20 nm, n=185). EDX analysis (Fig. 7.4b) confirmed the presence of Si and 
Ca in the new SMBGs with a composition of 83 mol% SiO2 17 mol% CaO. 
Forthwith, the new optimised mono-disperse SMBGs are referred to as mono-SMBG. 
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Figure 7.3: Bright field TEM micrographs showing the effect of calcium on particle 
formation prepared by: a) addition of calcium prior to TEOS and b) using molar ratio 
of Ca(NO3)2.4H2O : TEOS of 0.42 : 1 -c) using molar ratio of Ca(NO3)2.4H2O : TEOS 
of 4 : 1, respectively. 
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Figure 7.4: a) Bright field TEM micrograph of the optimised mono-SMBG prepared 
by the sol-gel process, with a molar ratio of Ca(NO3)2.4H2O : TEOS of 1.3 : 1. b) 
EDX analysis of a mono-SMBGs (labelled A) showing Si, O and Ca peaks. 
 
Evaluation of the size distribution of mono-SMBG was conducted using DLS as 
shown in Fig 7.5. DLS results revealed a narrow size distribution with a mode of    
220 nm. The particle sizes obtained from DLS is larger by 5 nm than that from TEM 
analysis (215 nm ± 20 nm, n=185). The difference in the results from the two 
techniques may be due to the fact that DLS measures the hydrodynamic radius [12], 
hence the results obtained from TEM images are closer to the actual size of the 
particles.  
b 
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Figure 7.5: Dynamic light scattering (DLS) of the size distribution of the mono-
SMBGs.  
 
In order to acquire a better understanding of the dispersion stability and surface 
charge of mono-SMBGs, zeta potential (ζ-potential) measurements were applied (Fig. 
7.6). The ζ-potential of the mono-SMBG was - 28 mV (n = 5, ± 3.5 mV).  
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Figure 7.6: The zeta-potential distribution (5 measurments taken) of mono-SMBGs. 
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7.4 Discussion 
80S20C (80 mol% SiO2 20 mol% CaO) mono-SMBGs with diameter of 215 nm (± 20 
nm, n=185) were successfully synthesised by using the sol-gel process. In 1968, 
Stober et al [83] reported a new method for synthesising spherical and mono-
dispersed silica nanoparticles from TEOS in the presence of alcohol and ammonia 
(catalyst of the reaction). Since this seminal work, there have been various studies on 
this subject. In addition to investigations on the effect of variable on the synthesis of 
mono-dispersed silica particles, Rao et al [159] applied an ultrasonication technique 
during the synthesis of the particles to achieve an enhanced reaction rate and 
dispersion of the particles. Based on their findings, the aim of the work described in 
this chapter was to produce mono-disperse bioactive compositions by employing 
ultasonication during synthesis. It was suggested that ultrasonication helps in the 
preparation of a stable sol and that enough energy is provided by ultrasonic treatment 
to lead to the formation of isolated particles as a result of preventing non-covalent 
bonding and particle agglomeration [163]. Preparation of dispersed binary SiO2-CaO 
bioactive glass particles with controlled size and shape is challenging compared to 
silica particles due to the difficulty of incorporating Ca into silica network. In fact, the 
mechanism by which calcium incorporates into the glass network as network 
modifier, when using calcium nitrate precursor, has only recently been understood 
[81]. As discussed in Chapter 5, the calcium nitrate remains in the pore liquor (by-
products of the condensation reaction) until the particles are dried, then the calcium 
deposits onto the silica particle‟s surface. The calcium enters the glass network, by 
diffusion, when a temperature of 450 °C is reached during calcination [136]. 
151 
 
In this study, the effect of calcium on the formation of SMBGs was investigated. The 
addition of calcium prior to adding TEOS and ammonia (catalyst) led to the formation 
of clusters. A molar ratio of Ca(NO3)2.4H2O : TEOS of 0.42 : 1 and 4 : 1 resulted in 
the formation of aggregates (Fig. 7.3b-c). Using the current synthesis route it was not 
possible to synthesise spherical mono-SMBGs with calcium content higher than 20 
mol%. This may be due to the fact that the presence of ammonia not only affects the 
reaction rate, but also provides negative surface charge and so leads to repulsion 
between the particles. Calcium may interrupt this repulsion by changing the surface 
chemistry of the particles, providing +ve sites on the surface, causing further 
attraction. As calcium is increased above a threshold value the surface of the particles 
will become coated with Ca
2+
, making the surface more positively charged, and hence 
reducing the repulsion causing attraction between the particles. According to Lin et al 
[81] calcium dissolves in the sol and remains dissolved in pore liquor after gelation 
and during drying calcium nitrate deposits onto silica particle‟s surface. As a result, 
the final composition of BG would be affected if the pore liquor is removed prior to 
drying [163]. During the processing of mono-SMBGs it is necessary to centrifuge the 
sol prior to drying to remove the supernatant and to obtain a solid deposit, which 
otherwise would not be possible. However, centrifugation of the suspension may 
result in the removal of the pore liquor leading to reduced calcium content and hence 
affecting the final composition of the glass [164]. Therefore, it is challenging to 
incorporate Ca into the network. In this study, the optimal condition that resulted in 
the formation of mono-dispersed, dense and spherical SMBG with maximum CaO 
content in the glass network, was a molar ratio of calcium : TEOS of 1.3 : 1 (Fig. 7.4). 
In addition, the fact that all the mono-SMBGs are spherical may facilitate the 
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exchange of cations and hence encourage the hydroxyapatite deposition from body 
fluid [165]. 
To measure the surface charge of mono-SMBG the magnitude of ζ-potential was 
obtained. It was found that the ζ-potential value of mono-SMBG was - 28 mV (n = 5, 
± 3.5 mV). The surface of sol-gel derived bioactive glasses is covered with many 
residual OH
-
 groups, making the surface negatively charged causing repulsion 
between the particles. It is believed that a highly +ve or –ve ζ-potential value is an 
indication of particle stability and also repulsion. However, in Chapter 4 it was shown 
that the ζ-potential values of SMBGs were more negative (~ -40 mV) than the mono-
SMBGs (- 28 mV), in the same pH range, but yet less dispersed. This suggests that 
sonication during processing is more important than the ζ-potential value in order to 
obtain dispersed particles. Nevertheless, further insight into various parameters 
affecting the state and stability of mono-SMBGs, including the effect of pH and 
solution ionic strength, is required as both can alter the ζ-potential measurements. For 
example, increased ionic strength or changing pH close to isoelectric point of the 
particles will enhance agglomeration. Here, ultrasonication of the particles and 
electrostatic stabilisation during synthesis of mono-SMBGs, in the presence of 
ammonia, led to well controlled dispersion of the particles. 
 
7.5 Summary 
Spherical mono-dispersed bioactive glass particles with controlled shape and a very 
narrow size distribution (diameter of was 215 nm, ± 20 nm, n=185) were successfully 
produced using an optimised sol-gel processing route using ultrasonication during sol-
gel synthesis. The amount of calcium precursor, and the point at which it was added 
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to the mixture during synthesis, was shown to have an effect on the formation of 
mono-SMBGs and resulted in a composition of 80S20C (80 mol% SiO2 20 mol% 
CaO). A Zeta-potential value of - 28 mV (n = 5, ± 3.5 mV) was measured which is 
another factor controlling the dispersion and stability of mono-SMBGs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
154 
 
8. Cytotoxicity, uptake and differentiation studies of mono-dispersed 
bioactive glass particles using human mesenchymal and adipose 
stem cells 
 
8.1 Introduction 
In this chapter the cellular response of the mono-disperse bioactive glass particles 
(mono-SMBG) to bone marrow and adipose tissue derived stem cells is investigated. 
Potential applications of these sub micron bioactive glass particles in stem cell 
research includes: intracellular delivery of molecules (ranging from drugs to proteins 
and DNA) and stem cells tracking. For these applications, the presence of the particles 
must not undesirably affect cell behaviour. Also, the use of these bioactive particles 
rather than silica particles, which are inert, is due to the fact that BGs are susceptible 
to physiological environments and that they result in enhanced dissolution and 
solubility, making them ideal applicants for medical applications. Another potential 
application of mono-SMBGs, which is investigated in this study, is their ability to 
stimulate osteogenic differentiation of stem cells for bone regeneration applications 
[141]. This is based on previous studies that have shown the osteogenic potential of 
bioactive glasses (BGs) of similar compositions to mono-SMBG but in the form of 
scaffolds, powders (>900 µm) and also using the dissolution products of BGs [141, 
166-169]. The potential applications of mono-SMBG would require cellular uptake of 
particles by the desired cells. Hence, thorough evaluations of the internalization 
process and the final intracellular location of the particles within the stem cells is 
important to understand.  
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The osteogenic potential of culture-expanded human MSCs in vitro has been 
extensively investigated in a number of studies mostly employing the use of -
glycerophosphate, L-ascorbic acid (vitamin C) and the glucocorticoid dexamethasone 
as differentiation factors. During differentiation the cells gain an osteoblastic 
morphology with up-regulation of alkaline phosphatise (ALP) activity and deposition 
of calcium-rich mineralised extracellular matrix [23]. Adipose tissue, like bone 
marrow, is derived from the mesenchyme and contains a supportive stroma that is 
easily isolated.
 
In the last 6 years a stem cell population has been isolated from human 
adipose tissue, obtained by suction-assisted lipectomy (i.e., liposuction) and has been 
shown to exhibit stable growth and proliferation
 
kinetics in vitro with stable 
population doubling. In addition, these cells have the ability, like MSCs, to 
differentiate
 
in vitro towards the osteogenic, adipogenic, myogenic, and chondrogenic
 
lineages when treated with well-known lineage-specific factors [170].
 
The 
multilineage differentiation capacity of adipose tissue stroma stem cells (ADSCs) has 
led many research groups to speculate that a population of multipotent stem cells, 
comparable
 
with MSCs, can be isolated from human adipose
 
tissue. Indeed, in the past 
year ADSCs have been characterized based on their osteogenic potential and utilized 
successfully for bone tissue engineering applications. 
BGs are well characterised and widely used in bone and tooth biomedical research 
and have been generally regarded as safe and biocompatible materials, as it has 
previously been discussed in Chapters 2-6. However, the properties of materials can 
change when they are at nanoscale. In Chapter 6, the poly-dispersed bioactive glass 
(SMBG) particles with size range of 150-350 nm, were not toxic to MSCs, but caused 
a decrease in cell metabolic activity, measured by MTT, as SMBG concentration 
increased. However, SMBG did not affect the amount of DNA. In Chapter 6, it was 
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demonstrated that SMBG particles with mean diameter of 250 nm were taken up by 
MSCs. In this chapter, the cellular behaviour as a result of uptake of mono-SMBG by 
both MSCs and ADSC is studied using various cytotoxicity assays. The effect of a 
particular particle size will be easier understood with mono-dispersed particles. 
Among many factors such as size, shape and surface charge, particle agglomeration 
state also plays a role in the uptake of particles by cells [171]. It is hypothesised that 
mono-SMBGs would be taken up more readily than SMBGs based on the fact that 
they are in mono-dispersed state. Agglomeration of nanoparticles is due to adhesion 
of particles to each other by weak forces leading to (sub)micronsized entities which 
reduce their surface free energy by increasing their size and decreasing their surface 
area [172]. When particles agglomerate the cell would see them as one big particle 
rather than many small particles and hence affecting uptake. There is a size limit by 
which particle can be taken up by cells which is dependent on the uptake mechanism 
and cell type (Chapter 2). For many biomedical applications, it is necessary to have 
control over the particle size and to have efficient cellular uptake. Hence it is 
important to determine how cells respond to single particles compared to 
agglomerates.  
 
Substances are transported into the cell through different pathways including 
diffusion, phagocytosis and receptor-mediated endocytosis (Chapter 2). In order to 
understand the potential applications in regenerative medicine of these newly 
developed mono-SMBG it is important to understand the mechanisms by which 
particles enter biological systems and furthermore investigate and dissect the uptake 
mechanisms by which particles are endocytosed by MSCs and ADSCs.  The possible 
transport pathway by which mono-SMBG is taken up by the cells is through 
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endocytosis, but there is no clear evidence as to what mechanism of endocytosis is 
involved in the process. An aim of this study was to gain insight into the endocytosis 
mechanism involved in the uptake of mono-SMBG by labelling the particles with 
FITC and image them using confocal microscopy. For drug delivery and sensing 
applications, particles should escape the endosomal/lysosomal pathway since this is 
the way by which cells take up and get rid of the particles. Hence, by escaping the 
endosomal/lysosomal pathway and localising in the cell cytoplasm could mean that 
the particles will not be destroyed prior to achieving their specific target. If the 
particles are to be used as delivery vehicles or sensors, they must not change the cell 
behaviour. Alternatively, if the particles stimulate differentiation down a particular 
pathway, they could be used as a bioactive injectable. A second aim was therefore to 
investigate the effect of mono-SMBG on the differentiation of mesenchymal and 
adipose stem cells. 
 
8.2 Materials and method 
8.2.1 Mono-dispersed bioactive glass particles (mono-SMBGs) 
Mono-dispersed bioactive glass particles (mono-SMBGs) with size of 215 nm (± 20 
nm, n=185) and composition of 80S20C were prepared as described previously 
(Chapter 7) using optimised synthesis route with a Ca (NO3)2.4H2O to TEOS ratio of 
1.3 : 1, calcined at 680 ºC. 
8.2.2 Cell source 
Human MSCs and ADSCs were purchased from Lonza (Lonza, UK) and cultured in 
T75 cell culture treated plastic flasks (Nalgene NUNC, UK) in low glucose, phenol 
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red free, Dulbecco‟s Modified Eagle Medium (DMEM), supplemented with 10% 
(v/v) batch tested Fetal Bovine Serum (FBS), 50 U/ml penicillin and 50 µgml
-1
 
streptomycin, 1% (v/v) L-glutamine (all from Invitrogen, UK) (which will be referred 
to as complete medium).  
 
8.2.3 Cell exposure to mono-SMBGs 
Cells were seeded at a density of 10,000 cells/cm
2
 and cultured with complete 
medium. The next day the medium was changed with complete medium containing 
mono-SMBG at concentrations of 0, 50, 100 and 200 µgml
-1
. Pulse-chase experiments 
(cells were exposed to a pulse of mono-SMBG for 24 h followed by chase periods of 
1, 4 and 7 days) were carried out as described in 6.2.6. MSC and ADSC viability and 
proliferation (growth over time) following a 24 h exposure to mono-SMBG was 
assessed by measuring their metabolic activity with the Alamar Blue and MTT assays 
and their total DNA with the Cyquant assay. 
 
8.2.3.1 Alamar blue 
Alamar Blue® (Invitrogen, UK) is a ready-to-use reagent which is a non-cytotoxic, 
cell permeable compound that allows a quantitative measurement of cell viability and 
proliferation over time. Alamar Blue® uses the natural reducing power of living cells 
to convert resazurin to resorufin (fluorescent molecule). The amount of fluorescence 
is proportional to the number of living cells and corresponds to the cells metabolic 
activity. For Alamar blue assay, cells were seeded in a 24 well-plate (Nalgene NUNC, 
UK). At the end of each time point (1, 4 and 7 days), medium was removed and 500µl 
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of alamar blue solution (1:10 culture medium: Alamar blue reagent) was added to 
each well and incubated for 2 h. Fluorescence was measured on a fluorescence plate 
reader (SpectraMAX GemimXS plate reader) at an excitation/emission wavelength of 
570/585 nm. The results represent the mean values ± SD of two individual 
experiments each in quadruplicate. 
 
8.2.3.2 MTT 
Cell metabolic activity and consequently cell viability and proliferation over time was 
assessed using the (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay. The procedure for this asssay is described in section 6.2.6.2. 
 
8.2.3.3 Cyquant 
The effects of three different concentrations of mono-SMBG on cell proliferation 
were assessed using the CyQUANT
®
 assay (Invitrogen, UK). The starting point for 
the CyQUANT
®
 assay is the use of green fluorescent dye, CyQUANT
®
 which 
displays strong fluorescence enhancement when bound to cellular nucleic acids 
(Invitrogen, UK). Cells were seeded in a 96 well-plate (Nalgene NUNC, UK). At the 
end of each time point (1, 4 and 7 days), medium was removed and the whole plate 
with the cells (no washing) was placed at -80 °C. After 24 hours, the frozen cells were 
thawed and lysed by adding a buffer containing CyQUANT dye to each well and 
incubating for 1 h. The fluorescence, which is directly proportional to the amount of 
DNA, was measured on a fluorescence plate reader (SpectraMAX GemimXS plate 
reader) at an excitation/emission wavelength of 480/520 nm.  
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8.2.4 Uptake 
8.2.4.1 FITC Labelling of mono-SMBGs 
Mono-SMBGs were labelled with FITC (fluorescein isothiocyanate (Sigma, UK)) 
according to Rosenholm et al [173]. Briefly, 25 mg of heat-sterilised mono-SMBG 
particles were suspended in a filter sterilised (0.22µm filter (Nalgene, UK)) 
carbonated buffer (0.212 g of sodium carbonate were dissolved in 20 ml of distilled 
water pH adjusted to 9.0 using drops of hydrochloric acid) and all procedures were 
carried out in aseptic conditions. For the staining, 250 ml of a FITC solution (1 mg/ml 
in 100% EtOH) was added into the buffer containing the particles and the final 
solution was incubated at room temperature for 1 h with continuous stirring. Particles 
were then collected by centrifugation and washed with deionised water.  
 
8.2.4.1.1 Treatment with uptake inhibitors/drugs 
To block clathrin mediated endocytosis and caveolae mediated endocytosis, two 
inhibitors of Genistein and the Dynasore inhibitor were used, respectively, to study 
the route of uptake of mono-SMBG by MSCs and ADSC for confocal studies.  
 
One set of cells were treated with 400 µM Genistein and another set with 80 µM 
Dynasore in complete medium for 30 min at 37 °C. At the end of the incubation 
period, the medium containing the inhibitor was removed and the medium with the 
FITC labelled particles was added for 6 h. At the end of the time point, the medium 
was aspirated and cells were washed twice with PBS, detached from the chamber 
slides by trypsinisation and then re-plated to new 4-well chamber slides to ensure 
removal of the free particles. The next day, fresh medium was added.  
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In order to confirm that the FITC labelled particles had been internalised by the cells 
and to consistently distinguish between particles that were attached to the outer 
surface of the plasma membrane, and therefore not internalised by the cells, the 
fluorescence of the extracellular FITC labelled mono-SMBG was quenched with 
Trypan blue solution, which cannot penetrate the membranes of living cells. Trypan 
blue solution was added for 15 min at room temperature (RT) to quench the 
fluorescence of the non-internalised particles on the exterior surface of the cells. The 
procedure is schematically outlined in Figure 8.1. Then, cells were fixed with 4% 
paraformaldehyde (PFA) for 2 min at room temperature and phalloidin staining was 
performed as described in section 6.2.7.1. 
 
 
 
 
 
 
 
 
Figure 8.1: Schematic representation of the procedure followed for the mono-SMBG 
uptake study using confocal microscopy (drawn by Dr O.Tsigkou, Imperial College 
London).    
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8.2.4.2 Confocal Microscopy 
For assessing uptake of mono-SMBG by MSCs and ADSC with confocal microscopy, 
cells were seeded at 30,000 cell/cm
2
 density in a 4 well chamber slides in complete 
medium. Cells were exposed to a concentration of 100 µgml
-1
 of mono-SMBG 
dispersed in DMEM complete medium as described in section 6.2.6. 
 
8.2.4.3 TEM 
For TEM analysis, the MSCs and ADSC were seeded on glass circle cover slips 
(VWR International, UK), sterilised in ethanol, at a seeding density of                
60,000 cells/cm
2
. Prior to seeding, the glass cover slips were placed in a 12 well plate 
(Nalgene NUNC, UK). The cells were treated with 100 μgml-1 of mono-SMBG for  
24 h. The fixation, osmication and dehydration procedures for TEM analysis are 
described in detail in section 6.2.7.2. However, since in this study the cells were 
grown on cover slips rather than well plates, blocks of resin were prepared prior to the 
last stage of resin exchange. For the last resin exchange, fresh resin was added up to 
the meniscus and then de-gassed. Then the glass cover slips with cells were placed on 
top of the resin block and placed in oven at 60 °C for 24 h. In order to remove the 
glass cover slips, the blocks were placed inside liquid nitrogen and then glasses were 
removed sharply from the resin blocks with forceps. If this step is not achieved 
correctly the glass cover slips will shatter and the sample will be destroyed. 
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8.2.5 Differentiation study 
8.2.5.1 Osteogenic supplement and cell seeding 
For the differentiation studies the complete medium with or without the mono-
SMBGs was supplemented with fetal bovine serum (FBS), L-glutamine (Invitrogen, 
UK) and the osteogenic supplements 10 mM β-glycerophosphate (β-g-P), 50 µgml-1 
L-ascorbate-2-phosphate (L-a-2-P) (Sigma, UK) and 50 µM dexamethasone 
(Dex). Supplementation was performed each time the particles were to be added to the 
cells.  Six conditions were investigated: control (complete medium, no mono-BGP or 
supplements), +ve control (with osteogenic supplements), 100 and 200 µgml
-1
  of 
mono-SMBG with osteogenic supplements, 100 and 200 µgml
-1
 of mono-SMBG with 
complete medium without supplements (Table 8.1). MSCs and ADSCs were seeded at 
a density of 10,000 cells/cm
2 
in 24 well plates (Nalgene NUNC, UK). The mono-
SMBG concentration was determined and sterilised as described in section 6.2.6. 
Initial seeding of the cells was performed in complete medium (without β-g-P, L-a-2-
P and Dex), with a change to osteogenic medium containing the mono-SMBG after 12 
h (if appropriate for the conditions tested). After the incubation time of 24 h the cells 
were washed well to remove any particles which had not been uptake by the cells and 
fresh medium, either complete medium with or without osteogenic supplements, was 
then added. Subsequent media changes were every 3-4 days. Cells were exposed to a 
pulse of mono-SMBG for 24 h followed by culture of 4, 8, 12, 15 and 21 days. 
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Table 8.1: List of conditions tested for osteogenic differentiation of MSCs and 
ADSCs. FBS is Fetal Bovine Serum, L-Glut is L-Glutamine and p/s is penicillin 
added to complete medium. β-glycerophosphate (β-g-P), 50 µgml-1 L-ascorbate-2-
phosphate (L-a-2-P) and dexamethasone (Dex) are the osteogenic supplements.  
Mono-SMBG
µg/ml
FBS
(%)
L-Glut
(%)
p/s
(%)
L-a-2-p
µg/ml
B-g-P
mM
Dex
µM
Control
Supp
Supp + 100 µg/ml
Supp + 200 µg/ml
100 µg/ml
200 µg/ml
-
-
- - -
- - -
- - -
100
100
200
200
10
10
10
10
10
10
1
1
1
1
1
1
1
1
1
1
1
1
50
50
50
10
10
10
50
50
50
 
 
8.2.5.2 Alkaline phosphatase 
Cellular alkaline phosphatase (ALP) enzymatic activity was measured 
colorimetrically using P-nitrophenyl phosphate (p-NPP) as a substrate based on the 
following reaction: 
             
P-nitrophenyl phosphate  + H2O                               P-nitrophenol (PNP) + Pi
(colourless) (yellow)
ALP
 
Mono-SMBGs were prepared and exposed to the cells as described in section 8.2.4. 
At the end of each time point, samples were washed x2 with Tris Buffer Saline 
(dissolve 8g NaCl, 0.2g KCl and 3g Tris base in 1L distilled water, adjust pH at 7.4 
and sterilise by autoclaving). The cells/sample was scraped 250µl buffer (1% Triton-
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X in distilled water) per well. The lysates were centrifuged at 500g at 4°C for 10 min 
and the supernatant were collected for the assay. Then, 50 µl/well of sample 
supernatants were transferred into a 96 well plate and 100µl of working solution (50µl 
of alkaline buffer solution and 50µl of p-nitrophenyl phosphate substrate solution 
prepared in water (all from sigma UK) was added and incubated at 37 °C on heat 
block for 30 min. Absorbance was then read at 405 nm using a plate reader. 
ALP activity was calculated using standard curve constructed using p-nitrophenol 
(PNP) concentration ranges of: 600, 400, 300, 200, 100, 50, 25, 12.5, 6.25, 0 µmol/L. 
To prepare the PNP standards, initially 7 mg of p-nitrophenol (Sigma, UK) was 
dissolved in 5 ml 0.01M NaOH to obtain a 10 mM stock. This stock solution was then 
diluted accordingly in alkaline buffer solution to obtain standards at the above 
concentration range. ALP activity was calculated using a p-nitrophenol (pNP) 
standard curve and normalised to total protein measured using DC
TM
 detergent 
compatible protein assay (Bio-Rad, UK- 8.2.5.3). Alkaline phosphatase activity was 
expressed as nmol pNP/µg protein/h, where activity is defined as the amount of 
enzyme activity that liberates 1nmol pnp per hour under the assay conditions. 
 
8.2.5.3 Total protein 
The DC 
TM
 detergent compatible protein assay (Bio-Rad, UK) was used to measure 
the total protein content of the samples. First, 5µl of sample or standards (Sigma, UK) 
was pipetted into a 96-well plate followed by 25 µl of reagent A (alkaline copper 
tartrate solution) and 200 µl reagent B (dilute Folin reagent). After 15 min incubation, 
the absorbance was read at 650nm. Protein content (in µg) was estimated using a 
standard curve constructed using concentration range of: 1.5, 1.25, 1, 0.75, 0.5, 0.25 
and 0.1 mg/ml.  
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8.2.5.4 Statistical analysis 
All experimental data shown are expressed as mean±SD and were obtained from 
experiments performed at least twice and in quadruplicates or sextaplicates. All data 
analysis was performed in Excel. Statistical analysis was by using multiple 
comparisons (Student t-test) and p-values less than 0.05 and 0.001 were considered 
significant and highly significant, respectively.  
 
8.3 Results  
8.3.1 MSCs and ADSC response to mono-SMBG 
Both Alamar blue and MTT assays measure enzymatic activity; the first assay relies 
on the cytoplasmic reduction potential of metabolically active/viable cells, while the 
latter on the mitochondrial activity of the cells. It is evident from the Alamar blue and 
MTT assays that ADSCs were overall more metabolically active, regardless of 
particle exposure, demonstrating almost 4 times higher fluorescence (Fig. 8.2) and 7 
times higher absorbance (Fig. 8.3) than MSCs after 7 days. Taken together the Alamar 
blue and MTT assay, it is evident that both cell types were still viable at 7 days with 
the only exception being the ADSCs 7 days after exposure (post-pulse) to 200 µgml
-1
 
mono-SMBG, for which cell activity significantly decreased (Fig. 8.2 and 8.3). This 
result was only observed in the Alamar blue assay. Alamar blue (Fig. 8.2) 
demonstrated that all three concentrations of mono-SMBG (50, 100 and 200 µgml
-1
) 
rendered MSCs significantly more active after 4 and 7 days compared to controls. 
This increase was not verified by the MTT assay, which indicated that the mono-
SMBG had no effect on MSC activity (Fig. 8.3). Conversely, the ADSC metabolic 
activity, demonstrated by the Alamar blue assay, was significantly increased only at 
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day 1 and 4 and only by the 100 and 200 µgml
-1
 concentrations, while at day 7 200 
µgml
-1
 decreased ADSC activity (Fig. 8.2). Again, these results were not consistent 
with the MTT results, which demonstrated that all concentrations of mono-SMBG 
resulted in a significant increase of ADSC metabolic activity only after day 1, 
indicating no immediate cell death after exposure to mono-SMBG and no effect 
thereafter.     
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Figure 8.2: Effect of mono-SMBG on MSCs and ADSCs viability was measured by 
measuring cell metabolic activity using the Alamar blue assay. Alamar Blue was 
performed after MSCs and ADSCs were treated with mono-SMBG (50, 100 and    
200 µgml
-1
) for a 24 h pulse and followed after 1, 4 and 7 days in culture. All data 
values are expressed as percentage of the control samples (no mono-BGP) at day 1. 
Values represent the mean ± SD. The samples in each experiment were in sextuplicate 
and the experiment was repeated twice. (*) indicates the statistical significant 
difference (p < 0.05) between the marked bar and the control sample (no mono-
SMBG) at the same time point. 
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Figure 8.3: Effect of mono-SMBG on MSCs and ADSCs viability was measured by 
measuring cell metabolic activity using the MTT assay after the MSCs and ADSCs 
were treated with mono-SMBG (50, 100 and 200 µgml
-1
) for 24 h pulse and followed 
after 1, 4 and 7 days in culture. All data values are expressed as percentage of the 
control samples (no mono-BGP) at day 1. Values represent the mean ± SD. The 
samples in each experiment were in sextuplicate and the experiment was repeated 
twice. (*) indicates the statistical significant difference (p < 0.05) between the marked 
bar and the control sample (no mono-SMBG) at the same time point. 
 
The commercially available kit Cyquant was used for the quantification of MSC and 
ADSC total DNA.  Total DNA is a direct measurement of cell number, which over 
time also reflects cell proliferation. Here total DNA was used to assess how cell 
number and consequently cell proliferation is affected by the mono-SMBG. Total 
DNA data demonstrated that none of the concentrations of mono-SMBG tested 
significantly advanced MSC or ADSC number compared to control (Fig. 8.4) as 
observed by the metabolic activity data (Fig. 8.2 and 8.3). In fact, 100 and 200 µgml
-1
 
mono-SMBG significantly hindered ADSCs total DNA after 7 days, but the same 
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effect was only evident at day 4 for MSCs and only at the highest mono-SMBG 
concentration (200 µgml
-1
). This discrepancy between the total DNA and the 
metabolic activity data perhaps suggests that the mono-SMBG encourage the 
metabolic activity of the cells, but not at the same extent their cell number. 
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Figure 8.4: Effect of mono-SMBG on MSCs and ADSCs on cell number was 
measured by measuring total DNA using th Cyquant assay. Cyquant assay was 
performed after MSCs and ADSCs were treated with mono-SMBG (50, 100 and    
200 µgml
-1
) for 24 h pulse and followed after 1, 4 and 7 days in culture. All data 
values are expressed as percentage of the control samples (no mono-BGP) at day 1. 
Values represent the mean ± SD. The samples in each experiment were in sextuplicate 
and the experiment was repeated twice. (*) indicates the statistical significant 
difference (p < 0.05) between the marked bar and the control sample (no mono-
SMBG) at the same time point. 
Overall, results from total DNA and metabolic activity (using the assays) of MSC and 
ADSC following exposure to mono-SMBGs further proves the non-cytotoxic nature 
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of SMBGs to these two cell types and this is an important finding that would link 
mono-SMBGs to potential medical applications. 
 
8.3.2 Uptake of mono-SMBGs by MSCs and ADSCs 
8.3.2.1 Confocal and TEM analysis of the internalisation of mono-
SMBGs inside MSCs and ADSCs  
The uptake of particles by cells was investigated using confocal fluorescence 
microscopy and TEM. In Chapter 6, the light reflectance property of the SMBGs was 
exploited for their visualisation inside the hMSCs using confocal microscopy without 
the need of a fluorochrome tag (section 6.2.7.1). Here, in order to distinguish between 
the internalised particles and those adhering to the cellular membrane, and to ensure 
that only the internalised SMBGs were visualised by confocal microscopy, mono-
SMBGs were labelled with FITC prior to incubation with the cells. Optical sections 
taken at intervals of 2 μm along the z-axis and reconstructed in 3D images revealed 
green fluorescence (FITC) randomly positioned in the cytoplasm of the MSCs and 
ADSCs (Fig 8.5 and 8.6 respectively) denoting mono-SMBG internalisation by the 
cells. Confocal images clearly show the uptake of particles in both cell types (Fig 8.5b 
and 8.6b) and their absence in the control cells without any mono-SMBG (Fig. 8.5a 
and 8.6a). 
 
Two pharmacological inhibitors for two defined endocytotic pathways were used, 
Genistein and Dynasore. Genistein inhibits clathrin mediated endocytosis while 
dynasor inhibits dynamin in caveolae mediated endocytosis. Confocal images of both 
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MSCs (Fig. 8.5) and ADSCs (Fig. 8.6) following treatment with the inhibitors (Fig. 
8.5c-d and 8.6c-d) revealed that mono-SMBG internalisation was not altered, as 
particles were present in the images, suggesting that mono-SMBG internalisation in 
both cell types is clathrin and dynamin (caveolae) independent.  In addition, confocal 
microscopy revealed that mono-SMBG uptake affects the actin cytoskeleton of the 
MSC‟s but not that of the ADSCs. Specifically, MSCs with internalised mono-
SMBGs demonstrated a less organised actin cytoskeleton (Fig. 8.5b), indicated by less 
defined microfilaments compared to the control MSCs (Fig. 8.5a). While, the actin 
cytoskeleton of the ADSCs (Fig. 8.6) appeared organised with defined filaments 
spread through the cell body in a long fibrillar pattern for both control and mono-
SMBG exposed cells.  
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a)
 
 
b)
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c)
 
d)
 
Figure 8.5: Confocal images of MSCs incubated a) without FITC labelled mono-
SMBGs, b) 100 µgml
-1
 of FITC labelled mono-SMBGs (appears as green), c) 100 
µgml
-1
 of FITC labelled mono-SMBGs after inhibition of clathrin-mediated 
endocytosis (Genistein treatment), and d) 100 µgml-1 of FITC labelled mono-SMBG 
after inhibition of caveolae-mediated endocytosis (Dynasor treatment). Scale bar = 
36 µm. 
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Figure 8.6: Confocal images of ADSCs incubated a) without FITC labelled mono-
SMBG b) 100 µgml
-1
 of FITC labelled mono-SMBG (appears as green) c) 100 µgml
-1
 
of FITC labelled mono-SMBG after inhibition of clathrin-mediated endocytosis 
(Genistein treatment) and d) 100 µgml
-1
 of FITC labelled mono-SMBG after 
inhibition of caveolae-mediated endocytosis (Dynasor treatment). Scale bar = 36 µm. 
 
TEM was employed to further verify the amount of uptake and the distribution of the 
mono-SMBGs inside the MSCs and ADSCs. Here for TEM, the cells were seeded on 
glass culture cover slips and were embedded and cross-sectioned so individual, flat 
and fully extended cells would be visualised as opposed to the TEM sections from a 
pellet of cells prepared for the investigation of SMBG internalisation by MSCs in 
Chapter 6.  
 
In TEM micrographs (Fig. 8.7), the observations indicate that mono-SMBGs are taken 
up into the cytoplasm of both cell types, however the mechanism by which this occurs 
remain unclear. For both cell types mono-SMBGs were mainly distributed within the 
cell cytoplasm (Fig 8.7 a-b, black arrows) with numerous particles localised inside 
cell vesicles that could be endosome or lysosomes (Fig.8.7 a-b, white arrows). In 
Figure 8.7a MSCs endocytosing particles are captured, where protrusions of the 
plasma membrane seem to extend from the cell membrane with a cluster of mono-
SMBG located between these protrusions. A cluster of intracellular particles was also 
present within a vesicle that appears to be undergoing endocytosis. 
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In addition, numerous mono-SMBGs in both MSCs and ADSCs showed a reduction 
in size (average reduction from 215 to 155 nm, n=60) after 24 h, suggesting that the 
particles may have dissolved inside the cells of intracellular dissolution. It is 
noteworthy though, that not all mono-SMBG particles could with certainty be 
identified as being freely located inside the cytoplasm or engulfed in cell vesicles. 
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Figure 8.7: TEM micrographs of a) MSCs, and b) ADSCs, following incubation with 
100 μgml-1 of mono-SMBG for 24 h. Mono-SMBG were found distributed within the 
cell cytoplasm, encapsulated inside endosomes (white) but also within the cytoplasm 
(black arrows). The square shows mono-SMBG particles being endocytosed. Particles 
in both MSCs and ADSCs show reduction in size after 24 h, indicating intracellular 
dissolution. Scale bar = 2 μm. EDX chemical analysis of mono-SMBG‟s taken up by 
c) MSC and d) ADSC. 
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8.3.3 Differentiation 
8.3.3.1 Alkaline phosphatase analysis of MSCs and ADSCs 
The osteogenic differentiation capacity of BGs has been well documented [166-168]. 
Xynos et al [166] investigated the osteogenic potential of Bioglass
® 
45S5 templates 
using osteoblasts and confirmed an increase in ALPase enzymatic activity and also 
the formation of bone nodule on the surface of the templates. Riley et al [167] showed 
that rat and human MSCs differentiated to osteoblasts when treated with Bioglass
®
 
45S5. Christodoulou et al [169] found that dissolution products of 58S sol-gel BG 
increased ALP enzymatic activity of osteoblasts. Therefore, due to the similarity 
between the compositions that were previously investigated and the composition of 
mono-SMBG (80S20C), it is crucial to investigate the effect of these particles on 
MSC and ADSC differentiation. ALPase enzymatic activity is a widely used marker 
of osteoblast differentiation in vitro, here ALPase enzymatic activity of the cells 
cultured after exposure with the mono-SMBG in the presence or absence of the 
osteogenic supplements (β-glycerophosphate, L-ascorbate-2-phosphate and 
dexamethasone) was measured as an indication of osteogenic differentiation and how 
this is affected by the particles. 
Both MSCs and ADSCs presented similar ALPase enzymatic activity profiles both 
with and without the mono-SMBGs, demonstrating similar capacities for osteogenic 
differentiation (Fig. 8.8). In the presence of osteogenic supplements, ALPase activity 
increased steadily from day 4 to 21 for both cell types (Figure 8.8a). Indeed, 
osteogenic supplements significantly (p<0.001) increased ALPase enzymatic activity 
of the cells with mono-SMBG and without, strongly demonstrating that the particles 
did not affect the ability of MSCs and ADSCs to differentiate to osteoblasts. In the 
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absence of the osteogenic supplements the mono-SMBG did not affect MSC or ADSC 
ALPase activity with similar levels as the control.  
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Figure 8.8: Alkaline phosphatase (ALP) enzymatic activity of a) MSCs and b) ADSC 
incubated with 100 and 200 µgml
-1
 mono-SMBG for 24 (pulse) and then washed well 
to remove non internalised particles and cultured for up to 28 days (chase) in the 
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presence and in the absence of β-glycerophosphate, L-ascorbate-2-phosphate and 
Dexamethasone. ALPase activity is expressed as nmols of pnp hydrolysed and 
normalised to total protein (µg) per hour. Values represent the mean ± SD. The 
samples in each experiment were in quadruplicate and the experiment was repeated 
twice. (*) (p < 0.05) and (¥) (p < 0.001) indicate the statistical significant difference 
between the marked bar and the control sample (no mono-BGP) at the same time 
point. 
 
8.4 Discussion 
Silica is generally deemed nontoxic in chemical terms and relatively inert in 
biological systems. Silica nanoparticles have been shown to increase oxidative stress, 
whereas  micron-sized silica particles been shown to be non toxic [174]. In Chapter 6, 
SMBG particles with composition 85 mol% SiO2 and 15 mol% CaO, did not 
demonstrate significant toxicity on MSCs except at the highest concentrations of 150 
and 200 µgml
-1
 after 7 days of culture. Indeed, cell proliferation decreased as SMBG 
concentration increased, but none of the SMBGs tested had a significant effect on 
DNA quantity compared to the control. 
 
In this chapter the effect of mono-dispersed bioactive particles (mono-SMBGs) on 
two different types of human primary stem cells, bone marrow (MSCs) and adipose 
tissue (ADSCs) derived stem cells was investigated. MSCs and ADSCs were exposed 
to three concentrations (50, 100 and 200 µgml
-1
) of mono-SMBG for 24 h (pulse) and 
the remaining non-internalised particles were removed by washing subsequently as 
the media was changed. The cell behaviour was then monitored in culture (chase) 
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compared to cells that had not been exposed to the particles. Evidently, Alamar blue 
demonstrated that MSCs metabolic activity was significantly enhanced by all mono-
SMBG at all times, while the same was obvious for ADSCs only for 100 and          
200 µgml
-1
 and only at day 4. Whereas, 7 days after exposure (post-pulse) with 100 
and 200 µgml
-1
 mono-SMBG, ADSCs metabolic activity was inhibited. However, 
these results were not in agreement with the MTT assay, which demonstrated no 
significant effect on any of the cells. The differences in data obtained from the two 
assays can be explained by the fact that the two assays test for intrinsic cytotoxicity 
using different mechanisms. While Alamar blue assay measures the reduction 
potential of the cells, MTT assay evaluates the activity of mitochondrial enzymes 
[175]. Mono-SMBGs could affect these processes in different ways, which would 
then results in the variation observed. On the other hand, total DNA results was also 
conflicting with the Alamar blue data, showing overall no increase in cell number for 
either cell type, and the 200 µgml
-1
 ceasing cell proliferation of both MSC and ADSC 
at day 4 and 7 respectively. This decrease in cell number however does not indicate 
toxicity but rather a slowing down of cell proliferation. Overall, the cell viability 
results observed in this study further proves the potential of mono-SMBGs in both 
drug delivery applications or for cell labelling. 
 
Cells use endocytosis for uptake of nutrients, down-regulation of growth factor 
receptors and as a master regulator of the signalling circuitry. There are several 
different types of endocytosis, all based on formation of intracellular vesicles 
following invagination of the plasma membrane or ruffling giving rise to larger 
vesicles as described in detail in Chapter 2.   
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Confocal microscopy verified that mono-SMBG, at the concentration of 100 µgml
-1
, 
were internalised by both MSCs and ADSCs and appeared to localise in the cell 
cytoplasm. In order to investigate which endocytic mechanism is involved in the 
uptake of mono-SMBG into MSCs and ADSCs, two endocytosis mechanisms were 
blocked by treating the cells with genistein and dynasore drugs prior to exposure to 
mono-SMBG. Genistein inhibits protein tyrosine kinases and has been shown to block 
internalisation by caveolae [176]. Dynasore on the other hand, was used to block 
vesicular endocytosis by selectively inhibiting dynamin 1 and dynamin 2 GTPases, 
which are responsible for vesicle scission during both clathrin- and caveolin-mediated 
endocytosis and also plays a role in some lipid raft-mediated processes [177]. The 
clathrin-mediated endocytosis was for a long time believed to be the only endocytic 
mechanism, in addition to phagocytosis and macropinocytosis. Clathrin independent 
endocytosis includes dynamin-dependent mechanisms (RhoA and caveolin-
caveolae/lipid raft dependent) and dynamin-independent mechanisms (Cdc42 
dependent and Arf6 dependent) [178]. The confocal images demonstrated that mono-
SMBGs are endocytosed in a clathrin independent endocytic process, since particle 
uptake was not hindered following treatment with genistein. In addition, confocal 
images demonstrated that both MSCs and ADSCs, under the effect of dynamin 
disruption by dynasore, showed no diminution in uptake (Fig. 8.5c,d and 8.6c,d). 
Those data taken together, suggest a clathrin and dynamin independent mechanism 
being involved that needs to be further investigated by looking more extensively in 
other routes of particle endocytosis used by the cells. The mechanism of uptake will 
certainly be important as it will impact the final application of mono-SMBGs. 
TEM images also demonstrated mono-SMBG internalisation and revealed localisation 
of the particles inside endosomal vacuoles/vesicles. Interestingly, some particles 
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appear to have left the vesicles and localise in the cytoplasm, suggesting that the 
particles may have escaped the endosomal pathway (Fig. 8.7). This is similar to what 
was observed previously with mesoporous silica particles and SMBG particles 
(Chapter 6). Escape from the endocytic pathway, is a prerequisite for effective 
therapeutic effect as mono-SMBG should release their load on the cytoplasm if they 
are to be used for drug delivery applications. To accomplish this goal, the endosomal 
escape strategies need to be further investigated to confirm this observation.  
It is clear that the uptake of mono-SMBGs is significantly higher than SMBGs 
(Chapter 6). Mono-SMBGs were taken up more readily than SMBGs (Fig. 8.7), hence 
proving the hypothesis that agglomeration, to a great extend, affects uptake by cells. 
Unlike, the SMBG particles described in Chapter 6 (and in [179]), where deposits and 
hollowing out of the particles were observed, here the mono-SMBG particles were 
seen to reduce in size after 24 h within MSCs and ADSC without apparent loss in 
density of the particles (Fig. 8.7). Particles and other molecules upon endocytosis are 
enclosed within the early endosomes, phagosomes or macropinosomes. All these 
vesicles containing the particles will eventually become late endosomes which then 
fuse with lysosomes or alternatively remain inside the early endosomes and become 
transported back to the cell surface and excreted. In the first scenario, where particles 
remain in the cell endosomes and these fuse with lysosomes, the pH drops to 4.0–5.5. 
In addition, lysosomes also contain proteases and other enzymes that degrade most 
biological substances [180]. In fact, cellular excretion and degradation of 
nanoparticles has been studied mostly using polymer particles [180, 181] and iron 
oxide nanoparticles [182] and have been found to solubilise completely in pH 4-5.5 
which is similar to that found in  endosomes and lysosomes without necessitating the 
use of any enzymes [183], indicating that most likely their degradation is performed 
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by lysosomes. The mono-SMBG particle size reduction seen here could be assigned 
to possible lysosomal degradation, a hypothesis that needs to be further investigated.  
Finally, mono-SMBGs did not appear to alter the phenotype or the differentiation 
capacity of stem cells towards the osteogenic lineage. In vitro cell survival and 
expansion levels have been shown to increase by BGs of similar composition to 
mono-SMBG until the cells start to differentiate towards the osteogenic lineage, at 
which point proliferation decreases at the onset of mineralisation [184, 185]. Here, 
although decrease in cell proliferation was observed, the mono-SMBGs did not induce 
osteogenic differentiation of MSCs or ADSCs. ALPase enzymatic activity is used as a 
biochemical marker of osteoblast phenotype in vivo and as a cell-surface marker of 
stem cells and primary cells differentiating to mature osteoblasts in vitro [186]. 
ALPase enzymatic activity was not affected by the presence of the mono-SMBG even 
after 21 and 28 days for the MSCs and ADSCs respectively. This finding further 
indicates their potential applicability in regenerative medicine methods, such as drug 
or other molecule delivery or even for use in monitoring of transplanted cells over 
time.  
 
8.5 Summary 
Mono-SMBG were not cytotoxic and had minimal effects on primary human bone 
marrow and adipose tissue derived stem cell viability at concentrations of              
100-200 µgml
-1
. Confocal microscopy and TEM demonstrated that the particles 
translocated frequently into the cell cytoplasm and were also degraded by the cells, 
for both types of stem cells. Comparison to the study in Chapter 6 on agglomerated 
heterogeneous SMBGs indicates that dispersion of the SMBGs noticeably increases 
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the amount of uptake of the particles into the cells. The uptake mechanism of mono-
SMBGs into the cells remains unclear because the endocytosis was not remarkably 
affected by any of the inhibitors for clathrin- or caveolin-mediated endocytosis. In 
addition, the mono-SMBG had no effect on the potential of the MSCs and ADSCs to 
differentiate towards the osteogenic lineage. Collectively the data reported in this 
chapter demonstrate the non-toxic nature of the mono-SMBG and their potential use 
as drug/protein or other molecule carriers that could lead to numerous biomedical 
applications. 
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9. Overall conclusion and future work 
Novel sub-micron bioactive glass particles (SMBGs) were synthesised. The aim was 
to investigate adult human stem cell response to the particles for two reasons. First, 
they may have potential as injectables for bone regeneration, either as carriers for 
growth factors or as differentiation agents. Secondly, bioactive glass scaffolds and 
bulk implants during degradation or due to wear may release small particles, so it is 
important to assess the risk of these resultant particles. An integrated array of studies 
combining particle synthesis, characterisation, cytotoxicity assays, cellular uptake and 
differentiation were applied. This chapter summarises the main findings of the thesis 
and suggests potential areas for future investigations. 
 
9.1 Thesis summary 
9.1.1 Optimised sub-micron bioactive glass particles 
A protocol for developing calcium containing SMBGs via the sol-gel process for 
various biomedical applications was established. Previous work on silica 
nanoparticles used a polymer template to reduce agglomeration. Therefore, the effect 
of molar ratio of templating polymer to TEOS on the formation of spherical, dense, 
SMBGs was studied. Electron microscopy images confirmed that the addition of a 
polymer into the processing route had a profound role in controlling the size and 
formation of the spherical dense particles. It was found that in the absence of 
templating polymer many chain-like clusters formed, which were not classified as 
sub-micron SMBG. By increasing the amount of polymer added to the system, 
aggregates resulted showing that there was a threshold value for the amount of 
polymer that led to optimal SMBGs. The optimised synthesis route (templating 
polymer : TEOS ratio of 1 : 2.8 and sintered at 680 °C) resulted in the formation of 
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SMBGs that had a mean particle size of 250 nm ±75 nm (from TEM). Chemical 
analysis revealed that the composition of the SMBGs was 85 mol% SiO2 and            
15 mol% CaO, although the reagents were added in a ratio that should have produced 
a composition of 70 mol% SiO2 and 30 mol% CaO. The polymer also seemed to 
disrupt the incorporation of calcium into the silica network. Hence, using this method, 
it was not possible to synthesise spherical SMBGs with a calcium content greater than 
15 mol% (Chapter 4). TEM imaging and analysis showed that the SMBGs changed in 
morphology and decreased in size when immersed in SBF solution, the particles 
dissolved. The fact that SMBGs dissolve in SBF could also suggest that they may 
dissolve in a physiological environment if they are to be applied in vivo. Chemical 
analysis and SAED showed that crystalline HA formed on SMBGs surface after 120 h 
immersion in SBF (Chapter 5). As HA formation is an important phenomenon for 
bone regeneration materials to show tissue bonding ability in vivo, this finding 
suggested the potential application of SMBGs in bone regeneration. 
 
Cellular uptake depends on many particle properties (outlined and reviewed in 
Chapter 2), including size, which in turn depends on particle dispersion. Mono-
disperse bioactive glass particles are required for better internalisation by the cells as 
opposed to agglomerated particles. In order to obtain mono-disperse SMBGs (mono-
SMBGs), with a higher calcium content, the sol-gel process was modified using a 
protocol previously used to developed dispersed silica nanoparticles [159]. The effect 
of the amount of calcium precursor used on the formation of spherical, dense, 
uniformly shaped particles was investigated. Mono-SMBGs with a diameter of 215 
nm (± 20 nm, n=185) and a composition of 80 mol% SiO2 and 20 mol% CaO, were 
produced. However, it was not possible, using this synthesis route, to produce mono-
190 
 
SMBGs with a calcium content greater than 20 mol% (Chapter 7). A possible reason 
for this may be  the fact that centrifugation of the suspension at the end of the mixing 
stage, which is an inevitable step during the processing,  may result in the removal of 
the pore liquor leading to reduced calcium content and hence effecting the final 
composition of the glass [164]. Therefore, it is challenging to incorporate extra Ca 
into the network. In this study, the optimal condition that resulted in the formation of 
mono-dispersed, dense and spherical SMBG with maximum CaO content of 20 mol% 
in the glass network, was a molar ratio of Ca (NO3)2. 4H2O : TEOS of 1.3 : 1. 
 
9.1.2 Cytotoxicity of SMBGs and mono-SMBGs 
To investigate the toxicity and cellular uptake of the first generation of SMBGs in 
vitro, human mesenchymal stem cells (hMSC) were used due to their potential in 
regenerative medicine. The effect of SMBGs concentration was investigated first. The 
cells were exposed to the particles for 24 h and then toxicity was assessed after 4 and 
7 days using MTT, LDH and total DNA assays (Chapter 6). Cell membrane damage 
and amount of DNA quantified by LDH and total DNA respectively, was not affected 
by the SMBG concentrations tested (100-200 µgml
-1
). (However, hMSCs exposed to 
150 and 200 µgml
-1 
SMBGs demonstrated reduced metabolism (MTT assay) (Chapter 
6).  
Two human primary cell types, bone marrow and adipose tissue derived stem cells, 
were used to assess the toxicity of the mono-SMBGs and correlate their 
physicochemical properties with possible changes in cell behaviour. Overall, mono-
SMBGs in the concentration range of 50-200 µgml
-1
, did not cause significant 
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cytotoxicity according to Alamar blue, MTT and Total DNA assays (Chapter 8), 
leading to the conclusion that mono-SMBGs are less toxic than the SMBGs. 
 
9.1.3 Uptake and intracellular distribution of SMBGs and mono-
SMBGs 
hMSCs were exposed to SMBGs for 24 h to establish whether the cells  uptake the 
particles and what the fate of the particles was inside hMSCs (Chapter 6). In this 
thesis both confocal microscopy and TEM confirmed the uptake and distribution of 
SMBGs inside hMSCs. The SMBGs were encapsulated inside membrane-bound 
endosomes and cell cytoplasm and had also partially dissolved inside the hMSCs. The 
particles appeared to reduce in density in their centre over time in culture, in some 
cases forming hollow spheres. In Chapter 8, MSCs and ADSCs were exposed to 
mono-SMBGs using the same conditions as the SMBGs, a 24 h exposure (Chapter 6). 
The TEM images of MSCs with internalised agglomerated (SMBGs) and dispersed 
(mono-SMBGs) particles demonstrated that particle agglomeration clearly affects 
uptake. More mono-SMBGs compared to SMBGs were observed inside the hMSCs, 
and in fact the mono-SMBGs were frequently present within the cytoplasm. To 
investigate the route of uptake of the mono-SMBGs by MSCs and ADSCs, mono-
SMBGs were fluorescently labelled with FITC. Confocal microscopy was used 
following treatment with Genistein and Dynasor inhibitors of two common 
mechanisms of endocytosis. Confocal images revealed that mono-SMBG 
internalisation was not altered by the inhibitors suggesting that both cell types 
internalised mono-SMBGs through a clathrin and dynamin (caveolae) independent 
endocytosis. Therefore, there is a need for further investigation into different uptake 
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mechanisms to confirm the exact route through which mono-SMBG particles are 
taken up in order to further determine the potential application of these particles in 
regenerative medicine and/or drug delivery. 
 
9.1.4 Differentiation of MSCs and ADSCs in the presence of mono-
SMBGs 
The capacity of mono-SMBGs to stimulate osteogenic differentiation of MSCs and 
ADSCs was also investigated. Cells were exposed to the mono-SMBGs for a 24 h 
pulse followed up to 21 and 28 days chase for MSCs and ADSCs respectively, at 
concentrations of 100 and 200 µgml
-1
, in the presence and absence of the osteogenic 
supplements (β-glycerophosphate, L-ascorbate-2-phosphate and dexamethasone). 
Both MSCs and ADSCs presented similar ALPase enzymatic activity (a widely used 
marker of osteoblast differentiation in vitro) profiles both with, and without, the 
mono-SMBGs, demonstrating similar capacities for osteogenic differentiation. 
Overall, it was found that, based on ALPase enzymatic activity results, the mono-
SMBGs did not induce the differentiation of MSCs or ADSCs towards the osteogenic 
lineage. This finding may suggest their potential applicability in various medical 
methods, such as drug or other molecule delivery, or even for use in monitoring 
transplanted cells over time, since the particles did not inhibit or induce stem cell‟s 
osteogenic differentiation potential. 
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9.2 Future work 
Recommendations for future research strategies include many exciting and 
challenging possibilities. 
- Focus on increasing the CaO mol% in mono-SMBGs if they are to be applied 
in bone regeneration applications. In the current study increasing the CaO to 20 
mol% in mono-SMBGs did not inhibit or induce stem cell differentiation into 
bone cells. The fact that mono-SMBGs did not induce stem cell osteogenic 
differentiation may be a result of CaO content in the glass network since 
previous studies have shown that using porous 3D scaffolds of bioactive glass 
with higher concentration of CaO (up to 30 mol%) induces osteogenic 
differentiation [141]. Nevertheless, increased CaO content in SMBGs or mono-
SMBGs could subsequently result in a different cellular response as higher 
intracellular Ca levels, released from bioactive glasses upon uptake and 
internalisation, could cause an adverse reaction with the cells. Hence, thorough 
studies are required to both investigate calcium incorporation into glass 
particle‟s network and as a result any possible cytotoxic affects they may 
cause.  
- The two inhibitors used in this thesis to investigate the mechanism of uptake of 
mono-SMBGs by MSCs and ADSCs revealed that the two routes of clathrin 
and caveolae mediated endocytosis do not play a role in the uptake of the 
particles. Data from this study suggest a clathrin and dynamin independent 
mechanism being involved, a possibility that needs to be further investigated 
by looking more extensively in other routes of particle endocytosis used by the 
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cells. This will certainly be important for designing the specific biomedical 
functions for which bioactive glass particles would be targeted towards.  
- The mono-SMBGs did not induce osteogenic differentiation of the MSCs and 
ADSCs. Other conditions in which stem cell osteogenic differentiation maybe 
induced should be investigated. These include various exposure times of stem 
cells to the particles such as 48, 72 or 106 h instead of only 24 h, which was 
investigated in this thesis, or continuous exposure (adding the particles with 
medium after every wash) and then follow up the osteogenic differentiation 
capability of mono-SMBGs. Alternatively, quantitative analysis may be used to 
examine the amount of particles taken up by the cells and then establish if there 
is a threshold that would induce osteogenic differentiation. In addition, the 
particles could be mixed with the cells prior to seeding, since particle 
attachment on the surface of the cells may also play a role in cell differentiation 
by releasing soluble Si or Ca locally. However, this requires in depth study as it 
has not previously been addressed. 
- Collectively, the cell data reported in Chapters 6 and 8 demonstrate the non 
toxic nature of the SMBGs and mono-SMBGs and their potential use as 
carriers that could lead to numerous biomedical applications. The fact that the 
particles were shown to dissolve intracellularly can expand their medical 
applications, making it possible for them to be used in drug delivery 
applications. This could be achieved either by 1) coating the particles with the 
desired drug or 2) incorporating the drug into the particles, which would slowly 
release the drug as the particles degrade within the cellular vesicles. In the first 
case, coating would require surface modification, for which further 
investigations into the type of drug and the surface functionalisation (i.e. using 
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functional groups) are required. In the second scenario, incorporating drugs 
into the particles would require the particles to be porous. However, the current 
synthesis route for both SMBG and mono-SMBGs reaches temperatures as 
high as 680 °C hence for drugs or proteins to be incorporated into the bioactive 
glasses. The synthesis process would also require chemical modification for 
SMBGs and mono-SMBGs.  
- Although osteogenic differentiation was not induced by the mono-SMBGs, the 
cells were still able to differentiate in the presence of the particles. This is a key 
finding since it means that the particles can be applied for other medical 
applications. Stem cell cytotherapy in various diseases requires long term in 
vivo stem cell tracking for which magnetic iron oxide, an intracellular contrast 
agent label, could be used for magnetic resonance imaging (MRI)/stem cell 
tracking [187]. Therefore, incorporation of these iron oxides inside (core) the 
SMBGs/mono-SMBGs would be another potential application of bioactive 
glass particles in stem cell tracking.  
However, thorough studies are needed to confirm a suitable application. 
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